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Ventricular chamber morphogenesis is a beautiful example of tissue interactions orchestrating a 
precise gene regulatory network essential for tissue patterning, cellular proliferation and 
differentiation that ultimately lead to a fully compacted and functional adult ventricle.  
The Notch signaling pathway is a crucial regulator of the processes leading to the adult 
ventricular chamber: trabeculation, coronary vessel formation and trabecular compaction. Its 
alteration may lead to disease in the form of cardiomyopathy. Despite its pivotal role, the exact 
mechanisms that regulate endocardial-endothelial Notch activity during chamber development 
remain unclear.  
In this work, using loss- and gain-of-function mouse models of different Notch elements we 
have tried to shed light on the spatio-temporal activation of endocardial Notch1 during ventricular 
morphogenesis. 
We found that in the early mouse ventricle the glycosyltransferase Manic Fringe favors the Dll4-
Notch1 signaling in the endocardium that is essential for trabeculation. The functional relationship 
between the Fringe-modified Notch receptor and its ligand Dll4 was also observed during coronary 
vessel formation. In this tissue, the Dll4-Fringe-Notch signaling axis is necessary for triggering 
Notch activity in the endothelium of developing coronary vessels. In endocardial cells, at later 
stages of chamber development, Manic Fringe and Dll4 expression is down-regulated allowing 
myocardial Jag1 and Jag2 signaling to Notch1 throughout the ventricular endocardium and leading 
to a fully compacted heart. Forced expression of Manic Fringe in the endocardium disrupts chamber 
maturation and compaction, causing a phenotype reminiscent of LVNC, presumably by blocking 
Jag1 and Jag2 signaling to Notch1. In the absence of Manic Fringe, Dll4, Jag1 and Jag2 activate 
Notch to similar levels, whereas in the presence of Manic Fringe, Dll4 becomes a superactivator.  
Comparative transcriptome profiling revealed Gpr126 as a crucial Notch-dependent signal that 
connects chamber endocardium and myocardium, sustaining cardiomyocyte proliferation, 
trabeculation, ventricular patterning and compaction. Further analysis showed that the Jag1 and 
Jag2 ligands from the myocardium play a non-redundant role in activating Notch1 during chamber 
compaction and maturation.  
The post-translational modifications on the Notch1 receptor mediated by Manic Fringe, in 
combination with the differential expression patterns of the ligands Dll4, Jag1 and Jag2 determine a 
spatio-temporal specificity of endocardial Notch1. Perturbation of this signaling equilibrium 
severely disrupts heart chamber formation. 	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El desarrollo de los ventrículos en el corazón es un claro ejemplo de interacción entre distintos 
tejidos. Esta interacción requiere una regulación génica precisa y indispensable para los procesos de 
proliferación y diferenciación celular y la formación del patrón tisular que finalmente darán lugar a 
la formación de un ventrículo compacto y completamente funcional. 
La vía de señalización Notch juega un papel fundamental en la regulación de los procesos que 
conducen al desarrollo de la pared ventricular en el corazón adulto: la trabeculación, la formación 
de los vasos coronarios y la compactación de las trabéculas. La alteración de la correcta activación 
de la vía produce diferentes cardiomiopatías. A pesar de este papel fundamental, los mecanismos 
moleculares que regulan la actividad de Notch en el endocardio y en el endotelio coronario durante 
el desarrollo de la cámaras siguen siendo desconocidos.	  
En este trabajo, utilizando modelos murinos de perdida y ganancia de función de los distintos 
elementos de la vía de señalización de Notch, hemos estudiado la activación espacio-temporal de 
Notch1 durante la morfogénesis ventricular.	  
Observamos que en el comienzo del desarrollo ventricular, la glicosiltransferasa Manic Fringe 
favorece la interacción entre el ligando Dll4 y el receptor Notch1 en el endocardio. La actividad de 
Notch1 es  fundamental en el proceso de trabeculación. Esta misma señalización, Dll4-Notch1, se 
requiere para la formación de los vasos coronarios. En el endotelio coronario, Dll4 interactúa y 
activa al receptor Notch previamente modificado por Fringe. En las células del endocardio, en 
etapas posteriores del desarrollo de las cámaras, la expresión de Manic Fringe y de Dll4 se reduce 
drásticamente. Esto permite a los ligandos expresados en el miocardio, Jag1 y Jag2, activar a 
Notch1 en todo el endocardio ventricular. La actividad de Notch1 mediada por Jag1 y Jag2 es 
necesaria para el proceso de compactación trabecular. La expresión ectópica de Manic Fringe en el 
endocardio durante el proceso de compactación produce un fenotipo similar a la miocardiopatía no 
compactada. Presumiblemente esto se deba a que se bloquea la activación de Notch1 por parte de 
Jag1 y Jag2. En ausencia de Manic Fringe, Dll4, Jag1 y Jag2 activan Notch de manera similar, 
mientras que en presencia de Manic Fringe, Dll4 es en un superactivator de Notch.	  
El análisis del transcriptoma, comparando los distintos mutantes de la vía de Notch, revela que 
Gpr126 es una diana directa de la vía con un papel crucial en la comunicación entre el encocardio y 
el miocardio, manteniendo la proliferación de los cardiomiocitos, la trabeculación, determinación 
del patrón ventricular y compactación. La comparación del transcriptoma de los ratones con perdida 
de función de Jag1 y Jag2 revela que estos dos ligandos desempeñan funciones no redundantes 
durante la maduración y compactación de los ventrículos.   	  
 Las modificaciones post-traduccionales del receptor Notch1 mediadas por Manic Fringe, en 
combinación con los diferentes patrones de expresión de los ligandos Dll4 , Jag1 y Jag2 determinan 
una especificidad espacio-temporal de la actividad del receptor Notch1. La perturbación de este 
Summary/resumen	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equilibrio de señalización  desde el endocardio y el miocardio perjudica gravemente el desarrollo de 
las cámaras cardíacas. 
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Heart development 
In vertebrates, the heart is the first organ to form during embryogenesis. It arises through a complex 
series of morphogenetic interactions involving cells from several embryonic origins (Buckingham, 
Meilhac et al., 2005, Moorman & Christoffels, 2003).  
Cardiac progenitors derive from the mesoderm, which emerges from the primitive streak during 
gastrulation (Buckingham et al., 2005). At E7.0 in mouse embryos (Fig. 1a), in response to 
endodermal signals, the cardiac precursors start to migrate in an anterior-lateral direction forming a 
crescent in the cephalo-medial region (de la Pompa & Epstein, 2012, Moorman & Christoffels, 
2003). This crescent contains two populations of progenitors: the first heart field (FHF) and the 
second heart filed (SHF, Fig. 1b). At E8.0 the precardiac cells from the FHF fuse at the midline of 
the embryo building the primitive heart (Xin, Olson et al., 2013): an endothelial tube surrounded by 
a single layer of myocardial cells (High & Epstein, 2008). Extracellular matrix, termed cardiac jelly, 
separates the two layers (Fig. 1c). Subsequently, the primitive heart tube grows by addition of a 
second group of progenitors that migrate anteriorly (arterial pole) and posteriorly (venous pole) 
contributing to the future outflow tract (OFT), the right ventricle and portions of the atria (Kelly, 
Brown et al., 2001, Zaffran, Kelly et al., 2004). Simultaneously, the heart tube undergoes a 
characteristic rightward looping (R-loop, Fig. 1d). This morphogenetic process changes the initial 
antero-posterior axis of the primitive heart to a left-right orientation (Moorman & Christoffels, 
2003). 
During cardiac looping, in defined regions of the myocardium, a specific gene expression 
program will determine the myocardium of the future chambers (Christoffels, Hoogaars et al., 
2004). Just after looping, this myocardium expands and forms the primitive ventricles and atria. As 
soon as the chamber myocardium is formed, it differentiates in two distinct layers: an outer compact 
zone and an inner trabecular zone (Sedmera, Pexieder et al., 2000). In the remaining myocardium 
the T-box family genes Tbx2 and Tbx3 repress the chamber-specific genetic program (Christoffels 
et al., 2004), forming the myocardium of the atrio-ventricular canal (AVC) and the OFT. This non-
chamber myocardium is an important source of signals for the adjacent endocardium. Endocardial 
cells receiving signals from the overlying myocardium undergo an epithelial-to-mesenchyme 
transition (EMT) forming the endocardial cushions, primordia of the cardiac valves (Eisenberg & 
Markwald, 1995). In addition, this process contributes to completing the septation of the heart. The 
E9.5 heart consists of four anatomically and molecularly distinct regions, the atrium, AVC, OFT 
and ventricle (Fig. 1e), covered by a single layer of epicardial cells. The epicardium develops from 
a transient structure, the proepicardium, a group of coelomic progenitors located at the venous pole 
of the embryonic heart (Perez-Pomares & de la Pompa, 2011).  Once the epicardial cells have 
covered the ventricle, the AVC and the OFT, they undergo EMT, forming the epicardial-derived 
cells (EPDCs). 
Sequential Notch activation regulates chamber development 	  
	  28 
 
 
EPDCs invade the sub-epicardium space between myocardium and epicardium and later, they will 
give rise to different cell types including cardiac fibroblasts, vascular smooth muscle cells (Mikawa 
& Gourdie, 1996) and a subset of coronary endothelial cells (Perez-Pomares, Carmona et al., 2002).  
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Myocardium, endocardium and epicardium, interacting with each other, generate signals necessary 
for the proliferation and differentiation of the developing heart (de la Pompa & Epstein, 2012). At 
E13.5 the main structures of the heart are already formed. Ultimately, via complex morphogenetic 
processes, these structures are remodelled leading to a fully mature heart.  
Endocardium-myocardium crosstalk during early heart development 
Formation of the AVC valves starts at E9.0 (Fig. 1e). In this region, non-chamber myocardium 
emits signals that instruct the adjacent endocardium to undergo EMT. This process will give rise to 
the endocardial cushions, a structure composed of mesenchymal cells derived by EMT from the 
overlying endocardium. The OFT cushions develop one day later. Similar to the AVC, the 
endocardium of the OFT undergoes EMT. In addition, mesenchymal cells derived from migrating 
cardiac neural crest (CNC) cells contribute to the formation of these cushions (de Lange, Moorman 
et al., 2004). Valve morphogenesis involves proliferation of the cushion mesenchyme, followed by 
elongation and remodelling of the valves to form mature, thin, valve leaflets with a characteristic 
trilaminar structure. 
At the molecular level, the key events in the EMT process are the down-regulation of 
intercellular adhesion junctions within the local endocardium and concomitant expression of EMT-
inducing transcription factors in the forming mesenchymal cells (Timmerman, Grego-Bessa et al., 
2004). Many signaling pathways have been described as crucial for the initiation of EMT, among 
them, Tgfβ and Bmp. Bmp2 is expressed in the myocardium and its deletion completely blocks 
EMT in the endocardium of the prevalvular region (Ma, Lu et al., 2005, Rivera-Feliciano & Tabin, 
2006). Moreover, genetic deletion of the Bmp type 1A receptor, Bmpr1a, in the endocardium also 
results in failed cushion formation, indicating that Bmp2 signals directly to the cushion-forming 
endocardium to induce EMT (Ma et al., 2005). 
The cardiac jelly also plays a pivotal role during EMT. In fact, the absence of hyaluronic acid 
(HA), a major component of endocardial cushion extracellular matrix (ECM), impairs EMT. HA is 
synthesized by hyaluronic acid synthetase 2 (HAS2). Has2 null embryos fail to undergo cushion 
Figure 1. Heart development.  
Ventral view of the developing mouse embryo. At E7.0 (a), cardiac progenitors (red) migrate to the center 
of the embryo to form the cardiac crescent (b). At E7.5, two cardiac fields can be distinguished: the first 
heart field (FHF; red) and the second heart field (SHF; blue) (b). At E8.0-E8.5, the cardiac tube consists of 
two layers: endocardium and myocardium (c). At this stage the heart undergoes a characteristic R-loop to 
form a looped heart (d). Transversal section depicting an E9.5 heart (e), which consists of four anatomically 
distinct regions: atrium, atrioventricular canal (AVC), ventricle and outflow tract (OFT). In the developing 
ventricle, endocardial cells (green line) delineate the ventricular myocardium (e). Longitudinal section of an 
E13.5 heart. At this stage valve primordia (shown in blue) are remodelled and trabeculae undergo 
compaction. In the maturing ventricular wall, coronary vessels start to appear (red dots, f). 	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EMT, a defect that is rescued in explant cultures by addition of exogenous HA (Camenisch, Spicer 
et al., 2000). In addition to the myocardium, the endocardial cells are also an important source of 
signals during EMT (de la Pompa & Epstein, 2012).  
The ErbB receptors are critical for heart and valve development and for adult heart function.  
ErbB2, and ErbB3 are expressed in the endocardium of the developing cushions at the onset of 
EMT (Camenisch, Schroeder et al., 2002). In ErbB2−/− or ErbB3−/− null mutants, cushion 
mesenchymal cells do not form in the heart in vivo or in explant cultures in vitro. In the 
endocardium, the Notch signaling pathway is also crucial for the initiation of EMT (Timmerman et 
al., 2004);(Luna-Zurita, Prados et al., 2010, Wang, Wu et al., 2013).  In this tissue, Notch1 
promotes the expression of Snail1 that normally represses vascular endothelial cadherin (Cdh5). 
Abrogation of Notch signaling disrupts EMT due to down-regulation of Snail1 (Timmerman et al., 
2004).   
Similarly to cushion EMT, the endocardium-myocardium crosstalk is also essential for the 
progression of trabeculation in chamber myocardium (Fig. 1e). Cardiac trabeculation is a 
morphogenetic process by which clusters of ventricular cardiomyocytes extrude and expand into the 
cardiac jelly to form sheet-like projections (Sedmera et al., 2000). The endocardial cells overlie the 
growing trabecular myocardium but are separated from it by cardiac jelly. The trabeculae increase 
the myocardial mass and facilitate oxygen and nutrient exchange in the heart muscle prior to 
coronary vascularization (Sedmera et al., 2000). These myocardial protrusions are present in all 
vertebrates and their formation constitutes the first step in chamber development for which 
endocardial-myocardial signaling is a prerequisite. Although the process of trabeculation is highly 
conserved (Brutsaert, 2003), the first event by which cardiomyocytes extend into the luminal part of 
the ventricle remains largely unknown. 3D analysis of cell polarity markers in fixed and 
immunostained mouse embryos reveals that very few cells divide in parallel to the trabeculae. The 
majority of the cells, deeper or on the luminal side, tend to divide parallel to the heart surface (Le 
Garrec, Ragni et al., 2013). In contrast, in zebrafish embryos, trabeculation occurs via a process of 
delamination (Staudt, Liu et al., 2014). Using 3D time-lapse imaging of beating zebrafish hearts, it 
has been shown that cardiomyocytes constrict their abluminal surface and enter in the trabecular 
layer. The neighboring cardiomyocytes move into the space left behind to maintain a cohesive 
compact layer (Staudt et al., 2014). 
One of the first evidence that highlighted the existence of an intimate link between endocardium 
and myocardium was a study performed in the cloche mutant zebrafish embryos. In these mutants 
that lack the inner endocardial tube, the developing outer myocardial layer remains somewhat 
smaller and dysmorphic and fails to develop trabeculation within the ventricle (Liao, Bisgrove et 
al., 1997, Stainier, Weinstein et al., 1995). Myocardial VEGF and its receptor VEGFR-2 (Flk-1) 
represent another excellent example of a signaling pathway connecting endocardium and 
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myocardium that is required for the initiation of trabeculation. Flk-1 is expressed at an early stage in 
all endothelial cells, including the endocardium. As in the cloche mutant zebrafish embryo, targeted 
inactivation of Flk-1 in the mouse also resulted in the absence of endocardial endothelium, with 
subsequent failure of myocardial trabeculation (Shalaby, Rossant et al., 1995). In the developing 
heart, the ligand VEGF is expressed in trabecular cardiomyocytes (Miquerol, Gertsenstein et al., 
1999, Sugishita, Takahashi et al., 2000). VEGF binding to its receptor is required for initial 
differentiation and proliferation of endocardial endothelium, as demonstrated more recently using 
the Collagen2a1-Cre driver. Heterozygous VEGF-A conditional mutant embryos died at E10.5 and 
showed dramatic decrease in the thickness of the myocardium as well as impaired trabeculation 
(Haigh, Gerber et al., 2000). 
As previously described for the EMT in the AVC region, Neuregulin-ErbB signaling is also 
necessary for the initiation of trabeculation. Neuregulin1 expression is confined to the endocardial 
cells. It is secreted from the endocardium and it works as a paracrine factor signaling to ErbB2 and 
ErbB4 receptors, expressed in nearby cardiomyocytes. Activation of the ErbB2/ErbB4 receptor 
complex by neuregulin1 is required for trabeculation of the primitive heart. Mutant embryos lacking 
any of these three genes do not form trabeculae and die in utero at an early stage (Kramer, Bucay et 
al., 1996, Lee, Simon et al., 1995, Meyer & Birchmeier, 1995). During trabeculation, paracrine 
factors have to traverse the cardiac jelly separating the endocardium and myocardium. Interestingly, 
both endocardial Neuregulin and myocardial VEGF signals are modified by extracellular matrix 
components (Camenisch et al., 2002).  
The formation of cardiac jelly results critical for appropriate receiption of signals between 
ventricular myocardium and endocardium not only during EMT, as described before, but also for 
trabeculation. In agreement with this, Has2 or Versican null mutants do not develop trabeculae 
(Camenisch et al., 2000, Mjaatvedt, Yamamura et al., 1998). The pivotal role of the cardiac jelly 
during chamber morphogenesis was recently described by use of conditional endocardial Brg1 
mutant embryos. Brg1, a chromatin remodeling protein, blocks endocardial expression of Adamts1, 
a secreted matrix metalloproteinase. In E9.5 Brg1 mutants, de-repressed expression of Adamts1 
induces early extracellular matrix degradation and trabeculation is abrogated. In physiological 
conditions, as development proceeds, the metalloproteinase starts to be expressed in the 
endocardium in order to break down cardiac jelly and prevent excessive trabeculation (Stankunas, 
Hang et al., 2008). This study highlights how the cardiac jelly plays an essential role during the 
initiation of trabeculation, while at later stages its degradation is required for the compaction of the 
trabeculae, a morphogenetic process that stars at around E14.5 in the mouse embryo. 
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Chamber compaction 
At later stages of chamber development, as ventricular volume increase, trabeculae become 
compressed within the ventricular wall resulting in significant increase of proportion and thickness 
of the compact myocardium. In this process, termed compaction, the majority of trabeculae have 
become compacted by E14.5 in the mouse contributing to the formation of a thicker, compact 
ventricular wall (Sedmera et al., 2000). Just after the formation of primitive trabecular ridges, the 
myocardium undergoes extensive expansion by recruiting cardiomyocytes from the myocardial wall 
into the trabecular ridges as well as, via cellular proliferation within the trabecular cardiomyocytes. 
The cellular recruitment mechanism forces the outer myocardial layer to proliferate more than the 
trabecular myocardium. Such a gradient of proliferation has been recently demonstrated by 
quantitative 3D proliferation analysis (de Boer, van den Berg et al., 2012). This gradient increases 
during chamber development reaching its maximum at E13.5, when proliferation within the 
trabecular cardiomyocytes ceases.  
As the myocardium grows and the trabeculae are compacting, a hypoxic environment facilitates 
the invasion of coronary vessels in the outer myocardial layer. The origin of coronary endothelium 
is controversial. Chick-quail chimera experiments (Perez-Pomares et al., 2002) and more recently 
lineage-tracing approaches (Red-Horse, Ueno et al., 2010, Tian, Hu et al., 2013, Wu, Zhang et al., 
2012) indicate that different cell types contribute to the assembly of mature vascular coronary 
endothelium. Despite the controversy in the matter of coronary vessel formation, their function in 
the heart is very well known. Myocardial growth requires enhanced oxygen delivery triggering an 
influx of endothelial cells that undergo vasculogenesis to form a capillary plexus (Mikawa & 
Fischman, 1992). A fully compacted and irrigated ventricular wall is the result of complex 
morphogenetic processes that come to completion just after birth. Reduced vasculogenesis as well 
as defects in trabecular remodeling (compaction) during ventricular wall formation, are the causes 
of different types of human cardiomyopathies such a Left Ventricular Non Compaction (LVNC, 
OMIM 601493). 
Left Ventricular Non Compaction 
LVNC is a cardiomyopathy of poorly understood etiology that is characterized by prominent and 
excessive trabeculation with deep recesses in the ventricular wall (Jenni, Oechslin et al., 2007). It is 
a cardiomyopathy with developmental bases, caused by the intrauterine arrest of myocardial 
morphogenesis that leads to the presence of persistent trabeculae (Ritter, Oechslin et al., 1997). The 
first case of LVNC was diagnosed in 1984, in a 33-year old woman assessed by echocardiography 
(Engberding & Bender, 1984). LVNC is the third most common cardiomyopathy after dilated and 
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hypertrophic cardiomyopathy, and its prevalence ranges from 0.05% to 0.3% of the general 
population (Oechslin, Attenhofer Jost et al., 2000, Ritter et al., 1997, Stollberger & Finsterer, 2004). 
Although LVNC can manifest as depressed systolic function (Captur & Nihoyannopoulos, 2010), 
its clinical manifestation and the age of the affected individual at symptom onset are highly 
variable. Classical complications include systemic embolism, malignant arrhythmias, heart failure 
and sudden death (Oechslin et al., 2000). LVNC is generally associated to mutations in genes 
encoding mainly structural proteins of the muscle fibres (Klaassen, Probst et al., 2008), cytoskeletal 
(Ichida, Tsubata et al., 2001), nuclear-membrane (Hermida-Prieto, Monserrat et al., 2004) and 
chaperone proteins (Shou, Aghdasi et al., 1998). Familial forms of LVNC are transmitted as an 
autosomal dominant trait (Captur & Nihoyannopoulos, 2010). Recently, it has been shown that 
mutations in Mib1, an E3 ubiquitin ligase that regulates the endocytosis of Notch ligands, lead to 
LVNC (Luxan, Casanova et al., 2013). This work highlights the essential role of endocardial cells 
during chamber compaction and maturation suggesting that also at later stages of chamber 
development, endocardium and myocardium are intimately connected. 
The NOTCH signaling pathway 
Notch is an evolutionary conserved cell-to-cell signaling pathway (Artavanis-Tsakonas, Rand et 
al., 1999). Notch signals, in a context dependent manner, promote or suppress proliferation, cell 
death, acquisition of specific cell fates and activation of differentiation programs throughout 
development and during maintenance of self-renewing adult tissues (Kopan & Ilagan, 2009). Notch 
signaling regulates many fundamental processes in a wide range of tissues. Thereby it is not 
surprising that mutations of NOTCH signaling components have been directly linked to multiple 
human disorders, from developmental syndromes, such as Alagille (Oda, Elkahloun et al., 1997), 
Tetralogy of Fallot (Krantz, Smith et al., 1999), Familial Aortic Valve Disease (Garg, Muth et al., 
2005) and LVNC (Luxan et al., 2013), to adult onset diseases, like CADASIL (Joutel, Corpechot et 
al., 1996), hematological (Ellisen, Bird et al., 1991) or solid tumors.  
Notch receptors are large single pass Type I transmembrane proteins (Fig. 2a). In fly only one 
Notch receptor exists. Mammals have four Notch paralogues that display both redundant (Krebs, 
Iwai et al., 2003) and unique functions (Cheng, Kim et al., 2007). The extracellular domain of 
Notch (NECD) contains 29–36 tandem Epidermal Growth Factor (EGF)-like repeats, required for 
interactions with the ligands. Repeats 11–12 mediate the binding between the receptor and a ligand 
expressed in neighboring cells (trans interactions), whereas inhibitory interactions with a ligand co-
expressed in the same cell (cis interactions) are mediated by repeats 24–29 (de Celis & Bray, 2000). 
Some of the EGF repeats can bind calcium, especially the EGF-repeats in proximity to the ligand 
binding sites. It has been shown that calcium plays an important role in determining the structure 
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and affinity of Notch to its ligands (Cordle, Redfieldz et al., 2008b). The EGF repeats are followed 
by three Lin/Notch repeats (LNR) and a heterodimerization domain (HD), forming a unique 
negative regulatory region (NRR), adjacent to the cell membrane. The NRR plays a critical role in 
preventing receptor activation in the absence of ligand (Fig. 2a). The intracellular domain of Notch 
(NICD) contains a RAM (RBPJK Association Module) domain, seven ankyrin repeats (ANK), a 
transcription activation domain (TAD) and a PEST domain (Fig. 2a). Both the RAM domain and 
the ANK repeats have been identified as regions involved in the interaction with CSL transcription 
factors (Tamura, Taniguchi et al., 1995), RBPJK in mouse. The TAD region is present in Notch-1 
and -2 but not in Notch-3 and -4 (Fig. 2a). The C-terminal PEST domain is involved in NICD 
degradation by proteolysis. Mutations in this region are associated with T-cell leukemias, 
emphasizing the important functional role of regulated NICD degradation (Weng, Ferrando et al., 
2004). The NECD and NICD are synthetized as a single polypeptide, which is directly cleaved after 
translation by a Furin-convertase in the Golgi. This first (S1) cleavage (Blaumueller et al., 1997, 
Logeat et al., 1998) is necessary to form the functional heterodimeric receptor that will be 
translocated to the membrane where the two domains are still associated by Ca2+- dependent non-
covalent bonds (Rand et al., 2000).  
 
In mammals there are two families of Notch ligands, homologous to the ones present in Drosophila; 
the Delta family, composed by Delta-like-1 (Bettenhausen, Hrabe de Angelis et al., 1995), Delta-
like-3 (Dunwoodie, Henrique et al., 1997) and Delta-like-4 (Shutter, Scully et al., 2000) and the 
Figure 2.Notch receptors and ligands  
In mammals there are four Notch receptors (Notch1-4). Mature Notch proteins reside on the cell surface as 
heterodimers formed by a transmembrane domain (NECD) and an intracellular domain (NICD) (a). The 
ECD comprise of a variable number of EGF-like repeats. Repeats 11-12 (blue squares) mediate the binding 
with ligands expressed in the neighbouring cell (trans-activation). Repeats 24-29 (red squares) mediate the 
binding with ligands expressed in the same cell (cis-interaction.) The EGF-like domain is followed by the 
Lin/Notch (LNR) repeats and the heterodimerization domain. NICD is formed by a RAM domain, which 
mediates interaction with several cytosolic and nuclear proteins; the Ankyrin (ANK) domain, which is also 
important for protein–protein interactions; two nuclear-localization sequences (NLSs); a carboxy-terminal 
transactivation domain (TAD), which is important for activating transcription; and a PEST (proline-, 
glutamate-, serine- and threonine-rich) domain, which is important for regulating Notch degradation. Notch 
receptors interact with two types of ligands (b), Delta (Delta1, 3 and 4) and Serrate (Jagged1-2) that are also 
transmembrane proteins with a long extracellular domain composed of a variable number of EGF-like 
repeats depending on the ligand and a DSL domain, and a short intracellular domain related with their 
recycling. The Serrate family also presents a cystein-enriched domain (CR). 	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Serrate family, composed by Jagged-1 (Lindsell, Shawber et al., 1995) and Jagged-2 (Shawber, 
Boulter et al., 1996).  
As well as the Notch receptor, the ligands are type I transmembrane proteins and all of them 
present an extracellular domain formed by EGF-like repeats (Fig. 2b). The ECD of the Jagged 
family contains 16 EGF repeats, whereas the Delta family contains 5–9, followed by a DSL 
(Delta/Serrate/Lin12) domain. Serrate family ligands also present a cystein-enriched domain (CRD) 
(Fig 2b). On the cytosolic side, a PDZL domain was identified in some vertebrate ligands (Jagged-
1, Delta-like-1, 4). This domain facilitates the interaction with proteins at adherens junctions, 
promoting cell–cell adhesion and inhibiting cell motility (Mizuhara, Nakatani et al., 2005). The 
intracellular domain of the DSL ligands interacts with E3 ubiquitin ligases Neuralized (Neurl) 
(Deblandre, Lai et al., 2001) and Mind bomb (Mib) (Itoh, Kim et al., 2003) to promote ligand 
ubiquitylation and internalization in the signaling cell (see below). 
Post-translational modifications of the ECD Notch receptor tune the amplitude of Notch 
activity 
Many of the EGF modules in the NECD are modified by O-fucose and/or O-glucose glycans 
(Moloney, Shair et al., 2000). The protein O-fucosyltransferase (Pofut)-1 in mammals (Ofut1 in 
Drosophila) adds O-fucose to Serine or Tyrosine (Ser/Thr) residues in the consensus sequence C2-
X-X-X-X-(S/T)-C3 (Fig. 3a). This post-translational modification is essential for optimal Notch 
signaling in flies and mice (Okajima & Irvine, 2002, Shi & Stanley, 2003). Similarly, O-glucose can 
also be added to a Ser in the consensus C1-X-S-X-(P/A)-C2 by protein O-glucosyltransferase 
(Poglut). O-glucosylation is also essential for Notch signaling in mouse and Drosophila (Acar, 
Jafar-Nejad et al., 2008, Fernandez-Valdivia, Takeuchi et al., 2011). The presence of O-fucose can 
enhance ligand binding by mammalian Notch receptors, whereas O-glucose does not appear to 
affect ligand binding but a subsequent step before receptor cleavage. Many of the O-fucose 
monosaccharides on Notch can be extended with GlcNAc by a β-1,3-N-
acetylglucosaminyltransferase Fringe (Fig. 3b).  The vertebrate fringe family comprises of three 
members: Lunatic fringe (LFng), Manic fringe (MFng), and Radical fringe (RFng) (Moran, Shifley 
et al., 2009), each of which affects Notch activity in slightly different ways (Johnston, Rauskolb et 
al., 1997). The effects of glycosylation on Notch signaling are complex and almost all studies have 
focused on the role of O-linked glycosylation on the Notch receptor itself. This modification alters 
the responsiveness of the receptor to different DSL ligands (Fig. 3c). Dynamic expression pattern of 
Fringe leads to spatial regulation of Notch sensitivity to its different ligands, triggering patterns of 
Notch activation within a developing tissue. Perhaps the best understood example of Fringe-
dependent Notch modulation involves the up-regulation of Notch in a stripe of cells separating the 
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dorsal and ventral compartments of the Drosophila wing margin (Panin, Papayannopoulos et al., 
1997). In the presumptive wing margin tissue, Notch and Delta are widely expressed, but both 
Fringe and the ligand Serrate are restricted to the dorsal compartment. Expression of Fng allows 
dorsal cells to respond to Delta, resulting in Notch activation. This leads to transcription of 
downstream genes, including Serrate. Serrate signals back from dorsal to ventral cells, activating 
Notch, and leading to the transcription of downstream genes, including Delta. Fng blocks the ability 
of Serrate to signal to other dorsal cells (Panin et al., 1997).   
 
 
After this pioneer work, the effect of Fringe to shift the activation balance towards Delta ligands 
at the expense of Jagged has been described in many other biological processes. It has also been 
demonstrated that in cells expressing both ligands, Jag1 acts as an inhibitor on the Fringe-modified 
Notch receptor. This is the case of retinal angiogenesis (Benedito, Roca et al., 2009), pancreas 
development (Golson, Le Lay et al., 2009) or during early hematopoiesis (Van de Walle, De Smet 
et al., 2011). More recently, X-ray crystallographic analysis has shown that Fringe-mediated 
elongation of O-fucose on the residue EGF12 of Notch1 effectively enhances the affinity of the 
Notch/DLL1 complex, but the same modification also increases the binding with Jagged1 (Taylor, 
Takeuchi et al., 2014). These data explain the Delta-Notch signaling increase in the presence of 
Figure 3. Post-translational modifications of NECD tune ligand-receptor interactions. 
A schematic representation of an EGF-like repeat is shown, highlighting the cysteines involved in 
internal disulfide bonds (black lines). Sugars (coloured symbols, see key) are added in a sequential 
process by distinct glycosyltransferases. POFUT-1 mediates the fucosylation on the Ser/Thr residues 
of the EGF domain (a) that can be glycosylated by  β-1,3-N-acetylglucosaminyltransferase Fringe (b). 
Fringe modification of the ECD of Notch receptors enhances the affinity with Delta ligands and 
prevents the interaction with Jagged ligands (c). 	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Fringe and suggest that the inhibitory effect of the Jagged/Serrate ligands on Notch may be 
mediated by other regions of the receptor. Interestingly, prior studies have demonstrated that the O-
fucose modifications on EGF26 and 27 are both elongated by Fringes and play important roles in 
ligand-mediated Notch activation (Rampal, Arboleda-Velasquez et al., 2005).  
Notch Pathway Activation  
In the receiving cell, the ECD of Notch receptor interacts with an exposed ligand in the 
neighboring cell (signaling cell, Fig. 4b). Ligand-receptor binding induces in the signaling cell, 
ligand endocytosis mediated by ubiquitin-ligases such as Mib1	   (Itoh et al., 2003) and Neuralizad 
(Neu) (Deblandre et al., 2001, Lai, Deblandre et al., 2001), (Fig. 4b). This process is critical for 
signaling since its blockage inhibits the proteolytic cleavage required for NICD release in the 
receiving cell (Itoh et al., 2003). The force generated by the signaling cell during the endocytosis of 
the ligand bound to NECD produces a conformational change exposing the S2 cleavage site (Parks, 
Klueg et al., 2000). Once the S2 is exposed, a metalloprotease from the ADAM family cleaves in 
S2 (Hartmann, de Strooper et al., 2002), and the NECD joined to the ligand is released and is 
endocytosed by the signaling cell (Fig. 4d). Subsequently, a γ-secretase activity (Okochi, Steiner et 
al., 2002) mediates the cleavages (S3) in the transmembrane domain (De Strooper, Annaert et al., 
1999) producing the release of NICD (Fig. 4e). Once released, the NLS facilitates the nuclear 
translocation of NICD. In the nucleus, NICD binds to the transcriptional repressor Cp-binding 
factor 1 (CBF-1) also termed recombination signaling binding protein for immunoglobulin Kappa J 
region (RBPJ) or Suppressor of Hairless (SU(H)) (Artavanis Tsakonas, 1999) (Fig. 4f). RBPJ is 
bound to DNA and is associated with transcriptional co-repressors such as SMRT (Silencing 
Mediator of Retinoic and Thyroid hormone receptors) or Mint (Tanigaki & Honjo, 2007) and 
Histone-deacetylases (Pursglove & Mackay, 2005) inhibiting gene expression. The interaction 
between NICD and RBPJK converts the latter from a transcriptional repressor to an activator (Lu & 
Lux, 1996). In this process the co-repressors will be released and transcriptional, co-activators such 
as Mastermind (Mam or Master Mind like (MAML) in mammals), will be recruited	  (Wu, Aster et 
al., 2000), forming a ternary complex that recruits proteins like p300/PCAF (Kurooka & Honjo, 
2000, Wallberg, Pedersen et al., 2002). This protein complex promotes the expression of target 
genes (Fig. 4f).  
There are also intracellular regulators of the pathway such as Deltex (RING-domain E3 ubiquitin 
ligase) (Matsuno, Ito et al., 2002) or Numb and Numb-like (Campos-Ortega, 1996, Jafar-Nejad, 
Norga et al., 2002) that will interact with NICD and, depending on the cellular context, they will 
function as activators or repressors. The spectrum of target genes that are activated by the Notch 
pathway is very large and it depends on the cellular context.  
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Figure 4. Notch signaling pathway. 
Notch proteins are synthesized as a single polypeptide of approximately 300 kDa. In the Golgi, it is 
cleaved by a furin-like protease at the S1-cleavage site to generate the non-covalently linked Notch 
heterodimer. The heterodimer can undergo glycosylation by several specific glycosylases, including 
MFng, LFng and RFng (a). Once in the membrane Notch interacts with its ligand expressed in the 
neighbouring cell (b). Upon ligand interaction, Mib1 induces ligand endocytosis (c). This produces a 
conformational change in the NECD that allows the cleavage (S2) by an ADAM metalloproteinase 
and (S3) by presenilin (d), which release the Notch intracellular domain (NICD, e). Intracellular 
Notch then travels to the nucleus, and forms a transcriptional activation complex after binding to 
Mastermind (MAML) and RBPJk (f). This ternary complex activates the transcription of a set of 
target genes. 	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The most known targets are the basic helix-loop-helix (bHLH) repressor transcription factors of 
the Hes (Davis & Turner, 2001) (Hairy and enhancer of split) and Hey (Iso, Kedes et al., 2003) 
(HESR) (Hairy and enhancer of split repressor) families. They respond to Notch in the endocardium 
during embryogenesis, but not in the myocardium where Notch is not active. Others well known 
targets of Notch are the Snail1/2 transcription factors, implicated in the induction of the EMT 
process during heart valve development (Timmerman et al., 2004), the cell cycle regulator p21 
(Devgan, Mammucari et al., 2005), the c-Myc oncogene, described as a Notch target gene 
promoting cell growth in leukemia (Palomero, Lim et al., 2006, Weng, Millholland et al., 2006) and 
EphrinB2/EfnB2 (Grego-Bessa, Luna-Zurita et al., 2007) among others.  
Mechanisms of Action 
The complex expression pattern of receptors, ligands and modulators of the Notch pathway 
anticipates the tight regulation of the pathway by its elements during development and adult tissue 
homeostasis. There are several modus operandi (lateral inhibition, lateral induction or cis-
inhibition) in which Notch determines cell fate specification, promotes or suppresses proliferation 
or induces cell death, but the crucial event that triggers Notch activity is the ligand-receptor 
interaction.  
The classical view of Notch-mediated lateral inhibition is based on the pioneering studies of 
neurogenesis in Drosophila (Artavanis-Tsakonas et al., 1999). In Drosophila, loss of function of 
either Notch or its ligands, leads to the overproduction of neurons. Lateral inhibition is the process 
by which a cell that stochastically expresses high levels of ligand becomes a signaling cell. In the 
neighbouring cells, the Notch pathway is activated and by a negative feedback mechanism ligand 
expression is inhibited (Heitzler, Bourouis et al., 1996). Thus, cells with high levels of ligand 
acquire a fate different from cells with lower levels of ligand in which the pathway is active. This 
mechanism has been described in several developmental processes, including early neurogenesis in 
frogs (Chitnis, Henrique et al., 1995, de la Pompa, Wakeham et al., 1997) and sensory hair cell 
formation in the vertebrate inner ear (Eddison, Le Roux et al., 2000, Petrovic, Formosa-Jordan et 
al., 2014). The Notch pathway can also generate cell clusters with the same fate. In this mechanism, 
called lateral induction (Lewis, 1998), cells expressing both ligand and receptor, activate the 
pathway in all neighboring cells. In this mechanism the expression of the ligand is regulated by a 
positive feedback mechanism. This is the case of Notch signaling during early cardiac valve 
development (Timmerman et al., 2004) In this context, inactivation of Notch in the endocardium 
results in decreased ligand expression. Indeed, RBPJk and Notch1 mutants show reduced Dll4 
expression in the endocardium (Grego-Bessa et al., 2007, Timmerman et al., 2004), while Notch 
gain-of-function expands Dll4 expression (Luna-Zurita et al., 2010, Rutenberg, Fischer et al., 2006, 
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Watanabe, Kokubo et al., 2006), suggesting the existence of a Notch-dependent positive feedback 
loop regulating Dll4 expression in embryonic endocardium. This mechanism has also been 
described in processes such as the formation of the wing margin in Drosophila (Panin et al., 1997), 
as well as in the mouse in the induction of proneural domains in the inner ear (Daudet & Lewis, 
2005), limb bud margin formation (Irvine & Vogt, 1997) and formation of the edges of somites 
(Lewis, 1998). Studies performed mostly in Drosophila but also in vertebrates indicate that ligand–
receptor interactions can also take place within the same cell. These cis-interactions reduce the 
ability of a cell to receive signals from neighboring cells by a process called ‘cis-inhibition’ of the 
receptor by the ligand (del Alamo, Rouault et al., 2011). A recent structural analysis further 
suggests that Notch may interact with the DSL domain of its ligands via two modes of interaction, 
referred to as parallel and antiparallel binding. Interaction of Jagged with Notch in trans would 
follow antiparallel binding, leading to activation of Notch, whereas interaction in cis would be 
mediated by parallel binding, resulting in inhibition of Notch (Cordle, Johnson et al., 2008a). 
Interaction of Notch with its ligands in cis may inhibit signaling either by forming complexes that 
are inactive for signal reception or by regulating a catalytic process that results in Notch inhibition, 
for instance by promoting the internalization and degradation of Notch whereas ligands are recycled 
(del Alamo et al., 2011). Lateral inhibition or lateral induction, cis-interactions and the 
glycosylation of NECD mediate the specificity of ligand-receptor interactions and selectively 
control Notch activity.  
Notch signaling during heart development  
Endocardial Notch signaling is involved in several morphogenetic processes during cardiac 
development (de la Pompa & Epstein, 2012, High & Epstein, 2008). The receptor Notch1 is widely 
expressed in endocardial cells as soon as the primitive heart tube is formed (Grego-Bessa et al., 
2007). In contrast Notch activated cells show restricted localization (Del Monte, Grego-Bessa et al., 
2007, Grego-Bessa et al., 2007) as a consequence of differential expression of the ligands. During 
AVC valve development Notch elements are expressed in the endocardium of the valvulogenic 
region (Del Monte et al., 2007, Timmerman et al., 2004). Targeted inactivation of Notch1 (or RBPJ) 
results in severely hypoplastic endocardial cushions at E9.5 due to impaired EMT (Timmerman et 
al., 2004). The endocardial N1ICD-RBPJ complex directly activates the EMT drivers Snail1/2, 
whose expression is severely reduced in the AVC and OFT endocardium of RBPJk mutants 
(Sahlgren, Gustafsson et al., 2008, Timmerman et al., 2004). Loss of Snail expression prevents 
down-regulation of vascular endothelial cadherin (Cdh5)-mediated endocardial cell adhesion and 
thus EMT is blocked. These in vivo observations were confirmed by the defective EMT of AVC 
and OFT explants of Notch1 and RBPJ mutants, or wild type (WT) explants treated with a Notch-
signaling inhibitor, cultured in vitro on collagen gels, indicating that Notch is essential for this 
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process (Timmerman et al., 2004). More recently, by using conditional loss-of-function alleles, the 
role of Notch1 during EMT was confirmed (Wang et al., 2013).  
Notch activity also regulates OFT morphogenesis. As aforementioned, the endocardial cushions 
of the OFT are populated by mesenchymal cells derived from EMT as well as by cells coming from 
the CNC (High, Zhang et al., 2007). The cross talk between these two populations is essential for 
OFT septation, formation of the semilunar valves and remodeling of the aortic arch arteries. 
Deficient CNC investment into the OFT results in persistent truncus arteriosus (PTA) and a 
perimembranous ventricular septal defect (VSD) (Neeb, Lajiness et al., 2013). Conditional 
inhibition of Notch signaling using a dominant-negative form of the transcriptional co-activator 
mastermind (DNMAML; Fig. 4f) induced with the CNC driver lines Wnt1-Cre or Pax3-Cre 
resulted in a variety of defects with variable penetrance: pulmonary artery stenosis, VSD, atrial 
septal defect (ASD), and OFT misalignment similar to the TOF (High et al., 2007).  
At E9.5, Notch1 is expressed throughout the endocardium of the developing ventricles, but it is 
only active at the base of the trabeculae. Systemic or endocardium-specific Notch mutant embryos 
show defective trabeculation, defective trabecular marker expression and reduced ventricular 
cardiomyocyte proliferation (de la Pompa & Epstein, 2012, Grego-Bessa et al., 2007, High & 
Epstein, 2008). Notch signaling abrogation affects the expression of three pathways required for 
trabeculation: Bmp10, Nrg1/ErbB and EphrinB2. Endocardial EphrinB2 is a direct transcriptional 
target of N1ICD/RBPJK (Grego-Bessa et al., 2007) and its expression and activity is abrogated in 
Notch mutants. In addition, endocardial Ngr1 or myocardial Bmp10 expression was impaired in 
Notch mutants. These findings suggest that endocardial Notch1 signaling is required for 
proliferation and differentiation of chamber myocardium during trabeculation (de la Pompa & 
Epstein, 2012, Grego-Bessa et al., 2007, High & Epstein, 2008). Furthermore, Notch1 in the 
endocardium triggers downstream signaling events that sustain normal trabecular patterning, 
maturation and myocardial compaction at later stage of chamber development (Luxan et al., 2013). 
Conditional inactivation of myocardial Mib1 gene causes a phenotype strongly reminiscent of 
LVNC. In fact, E16.5 Mib1flox;cTnT-Cre embryos show a dilated heart with a thin compact 
myocardium and large, non-compacted trabeculae, protruding toward the ventricular lumen (Luxan 
et al., 2013). These embryonic features are present in newborn and adult mutant mice as revealed by 
echocardiographic analysis of 6 month-old mice that also show reduced ejection fraction and a ratio 
of non-compacted to compacted myocardium (non-compaction index) of 2.0, diagnostic of LVNC 
in humans (Jenni, Oechslin et al., 2001). Analysis of chamber-specific markers in Mib1flox;cTnT-cre 
mutant embryos revealed the expansion of compact myocardium markers to the trabeculae and 
reduced expression of trabecular markers. These observations suggest that trabecular patterning and 
maturation is impaired after Mib1 abrogation in the embryonic myocardium.  
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The data presented above highlight the importance of endocardial Notch signaling and regulation 
in many aspects of heart development, namely the formation of the valves and the processes of 
ventricular trabeculation and compaction. Indispensable to these events is the intimate and tightly 
regulated interaction between endocardium and myocardium.  
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The Notch1 receptor, shown to be the most relevant Notch receptor in the context of cardiac 
chamber development, is ubiquitously expressed throughout the endocardium of the forming heart. 
Endocardial Notch1 activation is crucial for proper ventricular trabeculation and compaction. Its 
activity is also of pivotal importance in the endothelium of the coronary vessels, affecting their 
formation but also indirectly contributing to chamber maturation. Published work strongly point 
towards a tight spatio-temporal regulation of endocardial Notch1 signaling. 
 
The objectives of this thesis were: 
• To evaluate the detailed expression pattern of specific Notch components during the 
process of ventricular chamber development: the three Notch ligands Dll4, Jag1 and 
Jag2, as well as the three Fringe paralogs (Manic, Radical and Lunatic).  
• To generate the corresponding tissue-specific loss- and gain-of-function models in order 
to decipher the tissues and time points that are important for triggering Notch1 signaling.  
• To determine the exact contribution of Fringe modifications in the regulation of Notch1 
signaling in the context of chamber development, mediated by changes in the affinity of 
ligand-receptor interactions.  
• To unravel new Notch targets by thorough transcriptome analysis of different mutants 
with a particular interest in understanding: a) whether different Notch ligands, 
individually or in combinations, trigger distinct target responses, and b) which Notch-
induced molecules could be involved in the communication between endocardium and 
myocardium that is crucial for proper chamber differentiation, proliferation and 
maturation. 
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Mouse strains and genotyping.  
Mouse strains were CBF:H2B-Venus (Nowotschin, Xenopoulos et al., 2013), R26R (Soriano, 1999), 
R26R-YFP (Srinivas, Watanabe et al., 2001), Notch1 (Conlon, Reaume et al., 1995), RBPJk (Oka, 
Nakano et al., 1995), Tie2-Cre (Kisanuki, Hammer et al., 2001), Nfatc1pan-Cre (Wu et al., 2012), 
cTnT-Cre (Jiao, Kulessa et al., 2003), Cdh5(PAC)-CreERT2 (Wang, Nakayama et al., 2010), Dll4flox 
(Koch, Fiorini et al., 2008), Jag1flox (Mancini, Mantei et al., 2005), Jag2flox (Xu, Krebs et al., 2010), 
Notch1flox (Radtke, Wilson et al., 1999), Mib1flox (Koo, Yoon et al., 2007). Fringe mutant strains (M-/-
;	  L-/-;R-/-) were bred and maintained as described (Moran et al., 2009). For the generation of Rosa26-
MFng Tg mice (Acc. No. CDB0917K: http://www.cdb.riken.jp/arg/mutant%20mice%20list.html), a 
cDNA encoding a native form of murine MFng was cloned into a modified version of the 
pROSA26-1 vector, preceded by the ubiquitous CAG promoter and a loxP-flanked ‘NeoR-STOP’ 
cassette and followed by a frt-flanked IRES-EGFP cassette and a bovine polyadenylation sequence. 
Gene targeting was done with TT2 ES cells and confirmed by Southern blotting. Mice were 
generated by injection of targeted ES cells into ICR embryos, and were backcrossed with the 
C57BL/6 strain. In the case of the different mutants analyzed, the WT embryos were the littermates 
who did not express the Cre-recombinase. To simplify the nomenclature we used the following 
names to refer the different mutant and transgenic line.  
Name Genotype 
CBF:H2B-Venus CBF:H2B-Venus;WT 
CBF:H2B-Venus;Notch1KO CBF:H2B-Venus ;Notch1-/- 
CBF:H2B-Venus;RbpjKO CBF:H2B-Venus;RbpjKO-/- 
R26R;Nfatc1-Cre R26R/+; Nfatc1pan-cre+/- 
R26R-YFP;Nfatc1-Cre R26R-YFP /+; Nfatc1pan-cre+/- 
Dll4flox;Tie2-Cre Dll4flox;flox;Tie2-Cre+/- 
Dll4flox;Nfatc1-Cre Dll4flox;flox /+; Nfatc1pan-cre+/- 
Notch1flox;Nfatc1-Cre Notch1flox;flox; Nfatc1pan-cre+/- 
Dll4flox;Cdh5-Cre  Dll4flox;flox;Cdh5-Cre+/- 
  Jag1flox;cTnT-Cre Jag1flox/flox ;cTnT-cre+/- 
Jag2flox;cTnT-Cre Jag2flox/flox ;cTnT-cre+/- 
Jag1flox; Jag2flox; cTnT-Cre Jag1flox/flox ;Jag2flox/flox ;cTnT-cre+/- 
 M-/-;	  L-/-;R-/- MFng-/-;	  LFng-/-;RFng-/- 
MFngtg; Tie2-Cre MFngtg/tg;Tie2-Cre+/- 
MFngtg; Tie2-Cre MFngtg/tg;Tie2-Cre+/- 
Genotyping of the different genes was performed using the primers listed in Table1. 
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Table 1. PCR primers and conditions for genotyping 
Gene Oligos 5' to 3' 
Annealing 
Temperature 
(ºC) 
Product  
RbpjKO 5´CAGTGGGGAGCATTTTAQCAT 3´ 
55 
415 bp 
5´GAGGAAATTGCATCGCATTGT C 3´ 
Notch1KO 5´GATATCGTGGTGCATACCCTCCTG3´ 
60 
400 bp 
5´GTCAGTTTCATAGCCTGAAGAACG3´  
Dll4flox 5´ GTGCTGGGACTGTAGCCACT 3´ 
60 
455 bp -Flox 
5´ TGTTAGGGATGTCGCTCTCC 3´ 408 bp -WT 
Notch1flox 5´ CTG ACTTAGTAGGGGGAAAAC 3´ 
60 
350 bp -Flox 
5´ AGTGGTCCAGGGTGTGAGTGT 3´ 300 bp -WT 
Jag1flox 5´ AGGTTGGCCACCTCTAAATC 3´ 
60 
417 bp -Flox 
5´ GCAAGTCTGTCTGCTTTCATC 3´ 267 bp -WT 
Jag2flox 5´ GGCAGAGTAGCACATCACCA3´ 
60 
453 bp -Flox 
5´ CAAGCGCACAGGTTGAGTAG3´ 401 bp -WT 
MFngtg 5´ AAAGTCGCTCTGAGTTGTTAT  3´ 
60 
300 bp -Tg 
5´ GCGAAGAGTTTGTCCTCAACC  3´ 650 bp -WT 
5´ AGGCTGCAGAAGGAGCGGGA 3´ 	  
Tie2-Cre 5´ GGGAAGTCGCAAAGTTGTGAGTT 3´ 
60 
500 bp -Cre 
5´ CTAGAGCCTGTTTTGCACGTTC 3´ 
Nfatc1-Cre 5´ AATAAG CCTGCCGTGGTCACTGG 3´ 
60 
1000 bp -Cre 
5´ AACCCTGGACGCCTGGGACAC 3´ 290 bp -WT 
5´ GAAGCAACTCAT CGATTGATTTACG 3´ 	  
cTnt-Cre 5´ TACTCAAGAACTACGGGCTGC 3´ 
57 
350 bp -Cre 
5´ GCACTCCAGCTTGGTTCCCGA 3´ 
Cdh5-Cre 5´CTGGGATGCTGAAGGCATCAG 3´ 
55 
760 bp -Cre 
5´ TTGCGAACCTCATCACTCGTT 3 
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Tissue Processing. 
Embryos were fixed in 4% paraformaldehyde (PFA) at 4ºC. In the case of immunostaining, 
embryos from E9.5 were fixed for 2 hours whereas older embryos were fixed for 4 hours. For in situ 
hybridization (ISH) studies embryos were fixed overnight. Embedding was performed following a 
dehydratation using a graded ethanol series, xylene washes, a xylene-paraffin step and a final 
paraffin-embedding step. Adult hearts were perfused with PBS and fixed overnight in PFA 4%. 
Neonatal mouse hearts (P1-P3) were dissected and washed in PBS and fixed overnight. Fixed hearts 
were rinsed 2-3 times in PBS, ethanol/xylene processed and embedded in paraffin. 
Histology and in situ hybridization.  
Hematoxylin/eosin (H&E) staining, in situ hybridization (ISH) on sections, and whole-mount ISH 
were performed as described (de la Pompa et al., 1997, Kanzler, Kuschert et al., 1998).  
Whole-mount immunofluorescence  
E9.5 CBF:H2B-Venus embryos were dissected and fixed for 2h in 4% PFA at 4°C, permeabilized 
for 1h with 0.5% Triton X‐100/PBS and subsequently blocked for 1h in Histoblock solution (5% 
goat serum, 3% BSA, 0.3% Tween‐20 in PBS). Primary and secondary antibodies used are listed in 
Supplementary Table 2. After several washes in PBS‐T (PBS containing 0.1% Tween‐20) embryos 
were mounted in a 60mm petri dish with 1% agar. To detect endogenous GFP, fixed E9.5 
CBF:H2B-Venus; CBF:H2B-Venus;N1KO and CBF:H2B-Venus;RBPJkKO embryos were imaged 
with a Zeiss 780 confocal microscope fitted with a 20X objective with a dipping lens. Z-stacks were 
taken every 5µm. 3D images were reconstructed with IMARIS software (Bitplane Scientific 
Software). 
Immunohistochemistry  
Paraffin sections (7µm) were incubated overnight with primary antibodies, followed by 1h 
incubation with a fluorescent-dye‑conjugated secondary antibody. N1ICD, Dll4, Jag1 and p21 
staining was performed using Tyramide signal amplification (TSA) (Del Monte, Casanova et al., 
2011). All the primary antibodies antibodies used are listed in Table 2. 
Proliferation analysis and quantification.  
Cell proliferation was analyzed by detection of BrdU incorporation. Pregnant females were 
intraperitonally injected with 300ul BrdU at 10mg/ml and two hours later embryos were isolated in 
sterile PBS. Embryos were fixed overnight in PFA 4%. BrdU positive cells were detected following 
the protocol described in (Del Monte et al., 2007). Total cells and BrdU-positive cells in the 
compact myocardium were counted in sections (at least five) in three embryos of each genotype. 
For p21 and N1ICD quantification, positive nuclei were divided by the total number of nuclei 
counted on sections (≥4) in six embryos of each genotype. Images were processed with ImageJ 
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software. Statistical significance was assessed by Student's t-test.  
Table 2. List of primary antibody used for the IHC 
Antobody Cardiac expression 	  Source Ig	  	  
IHC 
dilution 
a-SMA-Cy3 CM/SMc Mouse 100 
BrdU BrdU  Mouse 50 
CD31/Pecam-1 Endo/CV Rat 100 
cTnT CM Mouse 200 
Dll4 Endo/CV Rabbit 100 
Endomucin Endo Rat 200 
GFP GFP expressing cells Mouse 200 
Jag1 CM/CV Rabbit 100 
Myosin Heavy Chain (MF-20) CM Mouse 20 
Cleaved Notch1 (Val1744)_N1ICD Endo/CV Rabbit 100 
p21 p21 expressing cells Goat 100 
(CM) cardiomyocytes;( SMc) Smooth muscle cells; (Endo) Endocardium; (CV) coronary Vessels; 
(PC)=proliferating cells. 
 
 
Quantification of compact myocardium thickness and trabecular complexity  
The method used was a modification of that described by (Chen, Zhang et al., 2009, Yang, Bucker 
et al., 2012). Briefly, 7µm paraffin sections from E9.5 WT and mutant hearts were stained with anti-
CD31 and anti-MF20 to facilitate visualization of ventricular structures. In E16.5 wild type and 
mutant hearts endocardial cells were stained with anti-endomucin and myocardium with anti-cTnT. 
Confocal images were obtained with a NIKON A1R confocal microscope. ImageJ software was 
used for the measurements. In E16.5 heart sections, left and right ventricles were analysed 
separately. For each measurement, settings were kept constant for all images using the scale bar 
recorded in each image as the reference distance. Several measurements were taken in each region 
and the mean was expressed in µm. The complexity of trabecular myocardium indicates the size of 
the trabecular mesh of myocardial fibres and is considered a landmark of cardiomyopathy(Captur, 
Lopes et al., 2014). It was represented as the mean ratio, expressed in µm, obtained by dividing the 
length of each trabecula by its thickness. The ratio of trabecular area and compact myocardial 
thickness was measured by dividing the surface occupied by trabeculae in the ventricle (µm2) by the 
length of compact myocardium expressed in µm. 
 
Imaging, photography and 3D reconstruction.  
E9.5 whole-embryos or hearts were imaged with a Zeiss 780 confocal microscope fitted with a 20X 
objective with a dipping lens. Z-stacks were taken every 5µm. 3D images were reconstructed with 
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IMARIS software (Bitplane Scientific Software). WT E9.5 embryos were sectioned at 10µm and 
stained for Dll4, Jag1 and N1ICD. Images were acquired with a confocal microscope (Leica TCS 
SPE) taking 10 optical sections per histological section. After acquisition, 3D reconstructions were 
performed as described(Soufan, van den Berg et al., 2006) and the resulting surfaces were exported 
to Adobe Acrobat Professional 9 Extended version to generate 3D interactive pdf files (de Boer, 
Soufan et al., 2011).  
Lentiviral production and infection.  
Full-length murine Manic Fringe (MFng) (Benedito et al., 2009) was subcloned into the lentiviral 
vector pRLL-IRES-eGFP (Addgene). Concentrated lentiviruses expressing pRLL-IRES-eGFP or 
pRLL-MFng-IRES-eGFP were obtained as described (Esteban, Mendez-Barbero et al., 2011). 
Viruses were titrated in Jurkat cells, and infection efficiency (GFP-expressing cells) and cell death 
(propidium iodide staining) were monitored by flow cytometry.  
Isolation and immortalization of MEVEC.  
Mouse embryonic ventricular endocardial cells (MEVEC) were obtained from ventricles of E10.5 
embryos. Embryos were dissected in PBS and hearts were collected. Atria and the atrioventricular 
canal were removed and the remaining ventricles were mechanically dissociated. Isolated cells were 
collected in DMEM containing 20% FBS and centrifuged at 400 x g for 5 min. The cells were 
finally resuspended in 500 µl culture medium (DMEM, 20% FBS supplemented with 
penicillin/streptomycin and 100 µg/mL endothelial cell growth supplement (ECGS, Sigma-
Aldrich), and seeded into one-well of a MW24 plate pre-treated with collagen type I (4.08 mg/ml) 
(BD Bioscience). After 1 week, a confluent cobblestone morphology culture was observed and cells 
were transferred to one gelatinized p60 flask. MEVEC in passage 1 were infected with lentivirus 
expressing SV40-large T antigen (Fig. 5) in the presence of polybrene (8 µg/ml). Overexpression of 
SV40-large T antigen was determined by qRT-PCR.	   MEVEC cultures expressed the chamber 
endocardial markers Notch1, Dll4, Nfatc1, Nrg1 and Gpr126 (Fig. 19o) and maintained their 
endocardial phenotype and cobblestone morphology over 20-25 passages. 
Cell culture  
Human umbilical vein endothelial cells (HUVEC) were purchased from Lonza, and cultured on 
gelatin-coated dishes until passage 9 in EGM-2 complete medium (Lonza) supplemented with 
penicillin/streptomycin. For expression analysis by qPCR, HUVEC were pre-treated with 10 µM γ-
secretase inhibitor (RO4929097, Selleckchem) or vehicle (DMSO) and stimulated with Notch 
ligands as described above for MEVEC.  
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Bovine aortic endothelial cells (BAEC) were purchased from Lonza and cultured in DMEM 
supplemented with penicillin/streptomycin plus 10%FBS. 
Luciferase assays with Gpr126 genomic DNA fragments 
The Evolutionary Conserved Region web platform (ECR;http://ecrbrowser.dcode.org/) was used to 
identify RBPJ motifs in the Gpr126 gene. Two conserved RBPJ binding sites were found in the 
intronic region, flanking the 5th and 6th exon of human, monkey, rat and mouse Gpr126. In human 
the conserved RBPJ sites are separated by 445bp. Genomic DNA from HUVEC was used as 
template to amplify 726bp of GPR126 containing the two conserved sites and the product was 
cloned into the KpnI and XhoI sites of pGL3 promoter luciferase plasmid (Promega). The primer 
sequences were: 5’-ATGCGGTACCATTTATACTTGTTACTGTGC-3’ (forward, KpnI site 
underlined) and 5’- ATCGCTCGAGGGCCAAGAATTATAAAGAATGAG-3’ (reverse, XhoI site 
underlined). For luciferase assays we transiently co-transfected BAEC with the hGPR126 reporter 
plasmid (pGL3-hGPR126-Luciferase), Renilla plasmid, and increasing amounts of vector 
expressing the intracellular domain of Notch1 (0-200ng) (pCS2-N1ICD). Twenty-four hours after 
transfection the cells were lysed, and luciferase activity was measured with the Dual Luciferase 
Assay System (Promega).  
 
Figure 5. Isolation and immortalization of MEVEC. 
Cartoon illustrating the different steps used to obtain MEVEC. 	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Notch stimulation with recombinant ligands and luciferase assays 
For Notch stimulation with recombinant ligands, MW24 plates were incubated with anti-human-
IgG-Fc, anti-mouse-IgG2a-Fc (Jackson), anti-His (Zymed), or a 1:1 mixture of antibodies (6.48 
mg/ml) for 30 min at 37ºC. After washing with PBS, plates were blocked for 1 hr at 37ºC with 10% 
FBS in DMEM. Recombinant Dll4 (mouse Dll4-His R&D Systems #1389-D4), Jagged1 (rat Jag1-
Fc, R&D Systems #599–JG) or Jagged2 (mouse Jag2-Fc, R&D Systems #4748–JG) were diluted in 
PBS and added to the dishes individually or in a 1:1 mixture	  at a final concentration of 18 nM. After 
2h at 37ºC, wells were washed and GFP-MEVEC and MFng-MEVEC were incubated on the coated 
plates at subconfluency overnight. For luciferase assays, stimulated cells were transiently co-
transfected with the Notch reporter plasmid pGL3-10xCBF1-Luciferase and pGL3-Renilla 
luciferase at a 5:1 ratio using Lipofectamine and Plus reagents (Life Technologies). Twenty hours 
after transfection, luciferase activity was measured with the Dual Luciferase Assay System 
(Promega). Data are expressed as Firefly/Renilla luciferase ratios. Experiments were performed at 
least three times, with quadruplicate samples each experiment. Data are presented as mean ± 
standard deviation. Differences were considered statistically significant at p<0.05 (Student’s t test).  
Quantitative RT-PCR 
WT and mutant embryos at different stages were dissected in ice-cold PBS. Whole E8.5 hearts, 
ventricles of E9.5-16.5 embryos and P1 hearts were separated from the rest of the body and RNA 
was extracted. For RNA extraction from cells stimulated in vitro with recombinant Notch ligands, 
the stimulation protocol was conducted as above in MW6 dishes and RNA was extracted after 
overnight incubation. Total RNA was purified using Trizol (Invitrogen). cDNA was synthesized 
with SuperScript III First Strand (Invitrogen), with 1µg total RNA per reaction. Quantitative PCR 
was performed with Power SYBR Green Master Mix (Applied Biosystems, 4367659). 
Oligonucleotide sequences for real-time PCR analysis performed in this study are listed in Table 3. 
Data are presented as mean ± standard deviation. Differences were considered statistically 
significant at p<0.05 (Student's t test). 
RNA-Seq 
RNA was isolated at E9.5 from whole hearts of WT and Dll4flox;Nfatc1-Cre embryos (32 per 
genotype), WT and Notch1flox;Nfatc1-Cre embryos (24 per genotype), and WT and Dll4flox;Tie2-Cre 
embryos (27 per genotype). RNA was pooled into four replicates for the first genotype pairs and 
three replicates for the last two genotype pairs. For Jag1flox;cTnT-Cre hearts, RNA was isolated 
from the ventricles of 12 WT and 12 mutant hearts at E15.5 and then pooled into three replicates. 
RNA was prepared using the standard Illumina TrueSeq RNASeq library preparation kit. Libraries 
were sequenced in a GAIIx Illumina sequencer using a 75bp single end elongation protocol. For 
Jag2flox;cTnT-Cre and Jag1flox;Jag2flox;cTnT-Cre hearts, RNA was isolated from the ventricles of 8  
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Table 3. List of primers used for qPCR experiments. 
Gene Forward primer Reverse primer 
mouse-Notch1 AGCCTCTCCACCAATACCTT GGCTGGAGCTGTAAGTTCT 
mouse-Dll4 GGACTCTATGTACCAATCAG CCTGCCTTATACCTCTGT 
mouse-Jag1 ACACAGGGATTGCCCACTTC AGCCAAAGCCATAGTAGTGGTCAT 
mouse-Jag2 GACGCCAATGAGTGTGAA ACAGTAATAGCCGCCAATC 
mouse-Hey1 CTCTGCCTTCTCATTCATT TAGTCACAACACATCAATACA 
mouse-Gpr126 GTCTACAATGCTACCAATAACG GCCTCAGTCCATCCTCTA 
mouse-Cxcl12 GAAAGCTTTAAACAAGAGGC GTGAAAGTACAGCAAAACTG 
mouse-MFng TCCAGGATCAGGCAACAGA GTCTCTCCTGGAGGCGTTC 
mouse-Nrg1 AACTGGTGAATCAATATGTATCT GTGTAGTGACTGGTGGAA 
mouse-Nfatc1 CCAAGTCAGTTTCTATGTCTG ATAATTGGAACATTGGCAGG 
mouse-Gapdh AACTTTGGCATTGTGGAAGG ACACATTGGGGGTAGGAACA 
human-DLL4 GTTACACAGTGAAAAGCCAG CTCTCCTCTGATATCAAACAC 
human-HEY1 CCGGATCAATAACAGTTTGTC CTTTTTCTAGCTTAGCAGATCC 
human-HEY2 GGATTATAGAGAAAAGGCGTC GTTTTTCAAAAGCAGTTGGC 
human-HEYL GTGGGACAGGATTCTTTG GTTGAGGTGGGAGAGAGAAG 
human-GPR126 GATGGATTTTGAGAGTGGAC GGAAAAGTCCAGTTTTGTTG 
human-NRARP AAATCCGTGAGTTTTGGAAG AAAAGGTAACGAAGGTTCAC 
human-GAPDH ACAGTTGCCATGTAGACC TTTTTGGTTGAGCACAGG 
 
WT and 12 mutant hearts at E15.5 and then pooled into two and three replicates respectively. For 
MFngtg;Tie2-Cre hearts, RNA was isolated from the ventricles of 16 WT and 16 transgenic hearts at 
E15.5 and then pooled into four replicates each. RNA was prepared using the NEBNext Ultra RNA 
Library Prep Kit for Illumina. Libraries were sequenced in a HiSeq2500 Illumina sequencer using a 
61bp single end elongation protocol. Sequenced reads were QC and pre-processed using cutadapt 
v1.6 (Martin, 2011) to remove adaptor contaminants. Resulting reads were aligned and gene 
expression quantified using RSEM v1.2.3 (Li & Dewey, 2011) over mouse reference GRCm38 and 
Ensembl genebuild 70. Gene differential expression was analysed using the EdgeR R 
package(Robinson, McCarthy et al., 2010). Data from Dll4flox;Tie2-Cre and Dll4flox;Nfatc1-Cre 
experiments were analysed together, as were data from and Dll4flox;Nfatc1-Cre and 
Notch1flox;Nfatc1-Cre experiments, by applying batch correction using ComBat (Johnson, Li et al., 
2007) to account for experimental differences. For Jag1flox-, Jag2flox;cTnT-Cre and double 
Jag1flox;Jag2flox;cTnT-Cre experiments, data were analysed together applying batch correction to 
account for technical differences and adding the genotypes of both alleles as covariates. Genes 
showing altered expression with adjusted P<0.05 were considered differentially expressed. For the 
set of differentially expressed genes a functional analysis was performed using Ingenuity Pathway 
Analysis Software and DAVID (Huang da, Sherman et al., 2009), and some of the enriched 
processes were selected according to relevant criteria related to the biological process studied. 
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Unsupervised hierarchical clustering with Genesis Software(Sturn, Quackenbush et al., 2002) was 
used to group genes according to the similarity of their expression profiles across the different Dll4 
and Notch1 deficiency experiments. Using a new R visualization package called GOPlot (Walter, 
Sanchez-Cabo et al., 2015) a chord plot (Krzywinski, Schein et al., 2009) was generated to better 
visualize the relationships between genes and the selected enriched processes. 
Accession number 
Data are deposited in the NCBI GEO database under accession number GSE67889. 
Ultrasound 
Left ventricle (LV) function and wall thickness were analysed by transthoracic echocardiography in 
6-month-old male mice and in the same mice at 9 months of age. Mice were mildly anesthetized by 
inhalation of isoflurane/oxygen (1-2%/98.75%) adjusted to obtain a target heart rate of 450 ±50 
beats per minute and examined with a 30 MHz transthoracic echocardiography probe. Images were 
obtained with Vevo 2100 (VisualSonics, Toronto, Canada) from Jag1flox;cTnT-Cre, Jag2flox;cTnT-
Cre and WT littermates. LV long axis M-Mode views were obtained as described (Cruz-Adalia, 
Jimenez-Borreguero et al., 2010). From these images, interventricular septum end-diastolic 
thicknesses was measured, and LV systolic function was assessed by estimating LV shortening 
fraction (SF) and LV ejection fraction (EF) (Cruz-Adalia et al., 2010). 
Cardiac MRI 
6-month-old male mice were anaesthetized by inhalation of isoflurane/oxygen (2%) and monitored 
by ECG and breathing rhythm (Model 1025, S.A. Instruments Inc.) Images were acquired with an 
Agilent/Varian 7 Tesla system equipped with a DD1 console and an active shielded 205/120 
gradient insert coil with 130 mT/m maximum strength and a combination of volume coil/two 
channel phased-array (Rapid Biomedical GmbH, Rimpar, GermainY) for transmit/receipt. Data 
were collected in a triggered cine gradient echo sequence with TE=1.45 ms and TR= 7ms, FA 25º, 
20 cardiac phases, and NA (number of averages) =3. A total of 13 contiguous slices in short axis 
view were acquired, with a slice thickness of 0.8 mm. The field of view was 3x3cm, with a 256x256 
matrix. Left ventricle (LV) and right ventricle (RV) function, end-diastolic volume, mass and wall 
thickness of right ventricle were estimated by the Simpson method, which sums the RV end-
diastolic areas from the 13 slices in short axis view and multiplies this figure by the 0.8 mm slice 
thickness. Images were processed using OsiriX (Pixmeo, Geneva, Switzerland) and Medis MASS 
software (The Netherlands) to calculate every RV area by segmentation of end-diastolic epicardial 
and endocardial edge (van de Weijer, van Ewijk et al., 2012). 
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3D structure prediction 
In-silico models for the extracellular domain (ECD) of mature Notch1 (N1), Dll4, Jag1 and Jag2 
proteins were calculated using a “de novo” prediction method with structural homologue 
comparison.  A partial X-ray or NMR structure was used as template/constrain for each model. The 
Fasta sequences of the ECD for mature Notch1 (UniProtKB: Q01705,N-term of 1499 aa), Dll4 
(UniProtKB: Q9JI71, 506 aa), Jag1 (UniProtKB: Q9QXX0, 1034 aa) and Jag2 (UniProtKB: 
Q9QYE5, 1059 aa) were used for modeling with local implementation of iTASSER suite. A model 
template restraint (2rr2 for Notch1 or 2vj2B for DLL4, Jag1 and Jag2) was used for prediction. The 
PDB model with the best C-score (more stability) compatible with previously established biological 
and structural properties previously established for each prediction was selected. Notch1 dimer 
(N1d). To find the region implicated in dimerization, two Fasta sequences of the mature NECD 
were submitted to the Spring Server (http://zhanglab.ccmb.med.umich.edu/spring). The X-ray 
structure 3etoA was selected and aligned with two monomers previously modeled with PyMol 
application v1.6.0.0 (http://www.pymol.org/). The aligned structures were assembled, remodeled 
and refined in a new final homodimer model using the Backrub application of the Rosseta suite v 
3.5 (https://www.rosettacommons.org/). The model with the best score (more stability and smaller 
free energy) was selected. Docking. The stoichiometry of the Dll4:Notch1 ligand-receptor pair was 
previously established as 1:1 and we assumed that this stoichiometry holds for all Notch1 ligands.  
To model ligand-receptor docking, we pre-aligned the Notch1 homodimer (chain A) with one 
monomer of each ligand close to the interaction-binding site using PyMol v1.6.0.0 
(http://www.pymol.org/). Each very preliminary structure was modeled using the docking protocol 
of the Rosseta suite v 3.5 (https://www.rosettacommons.org/) with the local refinement and energy 
minimization option selected. For each structure, 1000 models with a side-chain conformer range 
between 50000 and 100000 (average 70000) were calculated, scored, clustered and filtered by 
biological, topological and energy properties. The model most compatible with biological and 
topological properties and with the smallest free energy was selected. To obtain the final models for 
N1d-2Dll4, N1d-2Jag1, N1d-2Jag2, N1d-Jag1Jag2 and N1d-Jag2Jag1, a second ligand was pre-
aligned with the Noch1 B chain of the previous models and the pipeline was repeated. 
Statistics. 
 Statistical analyses were performed using Student’s t test inGraph Pad (Prism 5.0). Data are 
presented as means ± s.d., unless otherwise indicated. Differences were considered statistically 
significant at P < 0. 
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Endocardial Dll4 and myocardial Jag1 are candidate Notch ligands in the early mouse heart 
In the developing ventricle the Notch activity was monitored using a recently described murine 
transgenic line CBF1:H2B-Venus, a bright single-cell resolution Notch reporter activity (Nowotschin et 
al., 2013). The CBF:H2B-Venus reporter carries human histone H2B fused to the bright yellow 
fluorescent protein Venus under the control of four RBPJK/CBF1 responsive elements (CBFRE) 
and the simian virus 40 (SV40) minimal promoter.  
From E8.5, the CBF:H2B-Venus reporter was observed in the somites and in the endocardium of 
the forming heart (Fig. 6a). At E9.5 we detected expression of the reporter in endothelial cells of the 
dorsal aorta, as well as in the intersomitic vessels and in the pharyngeal arch arteries. In the heart 
the expression of the reporter was restricted to endocardial cells of the developing ventricle and the 
AVC (Fig. 6b). To better characterize the expression pattern of CBF:H2B-Venus during 
trabeculation, we performed triple-whole-mount staining of E9.5 CBF:H2B-Venus hearts. We used 
α-smooth muscle actin (SMA) as a marker of myocardium, CD31/Pecam1 to stain endocardial cells 
and GFP to label the CBF:H2B-Venus positive cells. Confocal imaging and 3D reconstruction of 
E9.5 CBF:H2B-Venus hearts revealed colocalization of Venus-positive cells with CD31/Pecam 
staining confirming Notch reporter activity only in endocardial cells (Fig. 6c-c’’ and video 1). The 
endocardial expression of CBF:H2B-Venus throughout chamber endocardium was confirmed with 
two-photon imaging at E9.5 (Fig. 6d), while its  expression was strongly down-regulated in the 
endocardium of Notch1 (Fig. 6e) and  RBPJk (Fig. 6e) null mutant embryos carrying the 
CBF1:H2B-Venus transgene. The finding that the abrogation of Notch1 dramatically impaired 
Notch activity in the endocardium suggests Notch1 as the main receptor triggering Notch activity 
during early chamber development. 
To elucidate which ligand was responsible for endocardial Notch activitation during myocardial 
trabeculation we stained E8.5 and E9.5 CBF1:H2B-Venus reporter embryos with antibodies against 
Dll4 and Jag1. A GFP antibody was used to detect CBF1:H2B-Venus expression and myocardium 
was counterstained with SMA. At E8.5, the ligand Dll4 was preferentially expressed in the 
endocardium (Fig. 6g-g’’), while Jag1 was expressed all over the chamber myocardium with 
stronger expression in the cardiomyocytes forming the trabeculae (Fig. 6h-h’’). At E9.5, Dll4 was 
strongly detected in the endocardium at the base of the trabeculae and to a lesser extent in 
interventricular endocardium (Fig. 6i-i’’). Jag1 expression remained confined to the developing 
trabecular myocardium (Fig. 6k-k’’). The expression of both ligands was coincident with sites of 
CBF:H2B-Venus activity (Fig. 6g-k’’). 
Sequential Notch activation regulates chamber development	  
 
 
62 
 
Endocardial Dll4-Notch1 Signaling is necessary for Trabeculation  
To determine the role of Dll4 during heart development we crossed mice bearing a conditional 
Dll4flox allele (Koch et al., 2008) with two different Cre-lines according to the Dll4 expression 
pattern. We used the pan-endothelial and pan-endocardial driver line Tie2-Cre (Kisanuki et al., 
2001). To avoid possible secondary effects due to the lack of Dll4 in the vasculature, where it plays 
a pivotal role during vasculogenesis (Krebs, Shutter et al., 2004), we also used the pan-endocardial 
driver line Nfatc-Cre (Wu et al., 2012). 
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Initially, we monitored Cre activity by crossing the R26R;LacZ reporter line (Soriano, 1999) 
with Nfatc1-Cre. Whole-mount X-gal staining in E8.5 and E9.0 Nfatc1-Cre;LacZ embryos revealed 
strong expression of the reporter gene in endocardial cells of the developing heart (Fig. 7a-b). At 
mid-gestation the endocardial-Cre activity was confirmed by Nfatc1-Cre transgenic mice bearing 
the R26R;YFP reporter (Srinivas et al., 2001). At E9.5 YFP expression was restricted to the 
endocardium confirming Nfatc-1-Cre line as a perfect tool for the endocardial-specific deletion of 
Dll4 (Fig. 7c). In addition, we crossed mice bearing a conditional Notch1flox (Radtke et al., 1999) 
allele with Nfatc1-Cre. Based on previous observations that Notch1 is the main Notch receptor 
involved in trabeculation, we compared the heart phenotype of this mutant with Dll4 conditional 
mutants. 
Targeted inactivation of Dll4 with the Tie2-Cre driver caused embryonic lethality at day E10. 
Conditional deletion of Dll4 or Notch1 with Nfatc1-Cre delayed embryonic lethality until E11.5-
E12.0. To characterize the morphology of the heart, we stained heart sections of E9.5 Dll4flox;Tie2-
Cre, Dll4flox;Nfatc-Cre and Notch1flox;Nfatc1-Cre embryos with an antibody against the rod-like tail 
region of myosin heavy chain protein (MF20) to mark the myocardium and with an antibody 
against CD31/Pecam1 to delineate the endocardium. The Dll4flox;Tie2-Cre (Fig. 7e-e’) as well as  
the Dll4flox;Nfatc1-Cre (Fig. 7e-e’) mutant embryos showed hypoplastic ventricles and impaired 
trabeculation compared to controls (Fig. 7f-f’). In both mutants a strong phenotype was also 
observed in the AVC, where very few endocardial cells were able to undergo EMT (Fig. 7d-f’). The 
phenotypes caused by the inactivation of Dll4flox with either of these driver lines were very similar 
to those observed in the E9.5 Notch1flox;Nfatc1-Cre mutant embryos (Fig. 7g-g’).  
Figure 6. Dll4, Jag1 and Notch activity in ventricular endocardium.  
(a-b) Stereo widefield image of a frontal view of an E8.5 (a) and later view of E9.5 (b) embryo 
expressing CBF:H2B-Venus. Arrowheads indicate strong expression of the reporter (Notch activity) in 
endocardial cells and somites (a), intersomitic vessel, pharyngeal arch arteries and endocardium in the 
looped heart (b). (c-c’’) 3D view of triple whole-mount immunohistochemistry (IHC) for smooth-
muscle actin (SMA), CD31/PECAM-1 and GFP in a E9.5 WT CBF:H2B-Venus heart. In c’, note that 
Notch activity detected by GFP expression (arrowheads) colocalizes with CD31-positive cells (green) 
in the endocardium. (d-f) Two-Photon whole-mount images of the left ventricle of E9.5 WT 
CBF:H2B-Venus mice (d), CBF:H2B-Venus;Notch1KO mice (e) and CBF:H2B-Venus;RbpjKO mice 
(f). Arrowheads indicate endocardial Venus expression in WT mice (d) and the much lower 
expression in Notch1KO and RbpjKO mice (e,f). Triple IHC of Dll4, SMA, and GFP in E8.5 (g-g’’) 
and E9.5 (i-i’’) WT CBF:H2B-Venus paraffin sections. GFP-positive cells (gray, arrowheads) are in 
contact with cells expressing Dll4 (green, arrows) in the endocardium of the developing chamber (g-
g’’). At E9.5 a similar expression pattern is observed at the base of the trabeculae (i-i’’). (h-k’’) Triple 
IHC of Jag1, SMA, and GFP in E8.5 (h-h’’) and E9.5 (k-k’’) WT CBF:H2B paraffin sections. GFP-
positive cells are adjacent to developing trabeculae expressing Jag1 (green, i-k’’). In h’;k’ note that 
myocardial Jag1 is more strongly expressed in cardyomyocytes forming trabeculae comparing with 
those delineating the outer layer of the ventricle (i-k’’). In (c-c’’ and g-k’’) nuclei are counterstained 
with DAPI. a= atrium; lv= left ventricle; avc=atrio-ventricular canal; oft= outflow tract. 	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Figure 7. Abrogation of endocardial Dll4-Notch1 signaling disrupts trabeculation.  
(a-b) LacZ-expressing cells (blue) in Nfat-Cre;R26R E8.5 (a) and E9.0 (b) WT embryos. Arrowheads indicate 
the strong expression of the reporter gene in the endocardium. (c) Stereo widefield image of a lateral view of an 
E9.5 Nfat-Cre;YFP mouse embryo shows YFP-expressing cells (green) only in the endocardium. (d-g’) IHC for 
MF20 (gray) and CD31 (red) in sections from E9.5 WT (d,d'), Dll4flox;Tie2-Cre (e,e'), Dll4flox;Nfat-Cre (f,f') 
and Notch1flox;Nfat-Cre embryos (g,g'). Arrowheads indicate the endocardium and arrows the trabecular 
myocardium. Note the absence of mesenchymal cells in the AVC (asterisks) of the mutants (d-g’). The yellow 
bars indicate the thickness of the nascent compact myocardium. (h)	   Quantification of compact myocardium 
thickness and (i) trabecular length in E9.5 WT, Dll4flox;Tie2-Cre, Dll4flox;Nfat-Cre and Notch1flox;Nfat-Cre 
embryos. Data are represented as mean ± S.D. (3 WT and 3 mutant embryos of each genotype, ***P < 0.001, 
determined by Student’s t test). ra= right atrium; la=left atrium; rv= right ventricle; lv= left ventricle; avc=atrio-
ventricular canal. Scale bar=50µm.	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Endocardial inactivation of Notch1 caused hypotrabeculation in the ventricle and reduced EMT 
in the AVC region. Parameters of ventricular morphology were quantified by measuring the 
thickness of the primitive compact myocardium (Fig. 7h) and trabecular length (Fig. 7i) of MF20- 
and CD31/Pecam1-stained E9.5 WT and mutant hearts. Both parameters were significantly reduced 
in mutant embryos (around 28% and 50% reduction, respectively; Fig. 7h-i). The morphological 
analysis suggested that from the endocardium Dll4 interacts and activates Notch1. To confirm this 
hypothesis we performed immunostaining against the activated form of Notch1 (N1ICD) in E9.5 
WT and Dll4 mutant heart sections. In E9.5 WT embryos, in the developing chamber the expression 
of N1ICD is restricted to the endocardium, particularly in the endocardial cells located at the base 
of the forming trabecuale (Fig.  8a-a’). The N1ICD expression was almost 50% below normal in 
E9.5 Dll4flox;Nfatc1-Cre (Fig. 8b-b’ and Fig. 8d). The number of endocardial cells expressing the 
active form of Notch1 was even lower, reaching 70% of reduction in the Dll4flox;Tie2-Cre mutant 
embryos (Fig. 8c-c’ and Fig. 8d) comparing with controls. This result confirmed that during early 
heart development Dll4 is required for Notch1 activation. We then assayed by in situ hybridization 
(ISH) the expression of different cardiac markers implicated in chamber morphogenesis. In the 
ventricle of E9.5 Dll4flox;Tie2-Cre embryos Hey2 transcription delineates a thin compact 
myocardium layer with a reduction in the endocardium, where this gene is a direct target of Notch 
activity (Fig. 8e-f). Mutant embryos also displayed reduced transcription of EfnB2 (Fig. 8g-h) and 
Nrg1 (Fig. 8i-j) in endocardial cells as well as reduction of myocardial Bmp10 (Fig. 3k-l), 
previously shown to depend on Notch activity (Grego-Bessa et al., 2007).  All these data clearly 
identified Dll4 as the ligand indispensable for triggering Notch1 activity during trabeculation. 
Comparative transcriptome analysis of E9.5 WT and mutant hearts indicates Dll4-Notch1 
signaling as crucial for cardiomyocyte proliferation 
To identify the molecular targets downstream of Notch activation, we performed comparative 
transcriptome profiling by RNA sequencing (RNA-seq) analysis of gene expression in WT, 
Dll4flox;Tie2-Cre, Dll4flox;Nfatc1-Cre and Notch1flox;Nfatc1-Cre hearts at E9.5. RNA-seq identified 
2101 affected genes in Dll4flox;Tie2-Cre mutants (1179 up-regulated and 922 down-regulated), 1321 
in Dll4flox;Nfatc1-Cre mutants (916 up-regulated and 405 down-regulated) and 631 (472 up-
regulated and 159 down-regulated) in Notch1flox;Nfatc1-Cre mutants (P ≤0.05; Fig. 9a and 
supplementary table1).  
Comparison of expression profiles showed that the three mutants shared 142 differentially 
expressed genes, while Dll4flox;Tie2-Cre and Dll4flox;Nfatc1-Cre mutants shared 702 altered genes, 
Dll4flox;Tie2-Cre and Notch1flox;Nfatc1-Cre mutants shared 238 and Notch1flox;Nfatc1-Cre and 
Dll4flox;Nfatc1-Cre mutants shared 202 (Fig. 9b and supplementary table1).  
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Figure 8. Dll4 activates Notch1 in the ventricular endocardium during trabeculation.  
(a-c’) IHC of N1ICD (red nuclei) in E9.5 WT (a,a'), Dll4flox;Nfat-Cre (b,b') and Dll4flox;Tie2-Cre (c,c'). The 
myocardium was counterstained with MF20 (gray) and the endocardium with isolectinB4 (IB4, green). 
Arrowheads indicate the nuclear expression of N1ICD in the endocardium expressing IB4.  Note the 
reduced number of N1ICD positive cells in the ventricle of Dll4flox;Tie2-Cre (c,c'). (d) Ratios of N1ICD-
positive to total endocardial nuclei. Data are represented as mean ± S.D. (3 WT ;3 Dll4flox;Nfat-Cre and 3 
Dll4flox;Tie2-Cre mutant embryos, **P<0.01, ***P<0.001 by Student’s t test) . (e-l) WISH analysis of E9.5 
WT and Dll4flox;Tie2-Cre embryos. Expression levels of Hey2 (e-f), EphrinB2 (g-h) and Nrg1 (i-j) are lower 
in the endocardium of mutant embryos Arrowheads indicate endocardial expression of the gene whereas 
arrows its myocardial expression. lv= left ventricle. Scale bar =50µm. 	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Gene ontology (GO) classification revealed deregulation of several genes involved in 
cardiovascular development and disease (Wnt4, Gja5, Irx4), cell cycle, growth and proliferation, 
cell death (Ccne1/cyclin E1, Cited1), dilated cardiomyopathy (Myh6, Tnnc1, Tnnt2) and several 
intercellular signaling pathways  (Insulin, Vegf and mTOR pathways, Fig.9c and supplementary 
table1). Dll4flox;Tie2-Cre and Dll4flox;Nfatc1pan-Cre mutants showed up-regulation of the negative 
regulators of cellular proliferation Cdkn1a/p21, Cdkn1b, Gadd45a, Foxo3, Cbx7, Ccng2, Ndrg1, 
Myct1 and Runx1 (Fig. 9c and supplementary table1).  
In agreement with these findings, cardiomyocyte proliferation in Dll4flox;Nfatc1pan-Cre mutants 
as measured by 5-bromodeoxyuridine (BrdU) incorporation was 42% below normal (Fig. 9d-f). In 
contrast, in the mutant hearts the proliferation of endocardial cells was similar to WT (Fig. 9d-f). 
These results show that abrogation of the Dll4-Notch1 interaction impairs cardiomyocyte 
proliferation in a non-cell-autonomous manner, suggesting that endocardial Dll4-Notch1 activity 
mediates expression of genes encoding signals that link ventricular endocardium and myocardium 
and are essential for trabeculation.  
 
 
Figure 9. Comparative gene expression profiling of E9.5 WT, Dll4 and Notch1 mutant hearts. 
Notch signaling mediates trabecular proliferation. 
(a)	   Heat map from hierarchical clustering of differentially expressed genes (P<0.05) identified by 
RNA-seq in the indicated genotypes. For each genotype up-regulated genes are indicate in yellow; 
down-regulated genes are represented in blue. Note that the vast majority of dysregulated genes in the 
three mutants change in the same direction. (b) Venn diagram representation of the comparative 
analysis of the dysregulated genes in the three genotypes. Numbers in black indicate the total number 
of genes common to all pair-wise genotype combinations. (c) Circular plot of 257 differentially 
expressed genes belonging to various functional categories relevant to this study, simultaneously 
presenting a detailed view of the relationships between expression changes (left semicircle perimeter) 
and processes (right semicircle perimeter). In the left semicircle perimeter, the inner ring represents 
Notch1flox;Nfat-Cre data, the middle ring Dll4flox;Nfat-Cre data, and the outer ring Dll4flox;Tie2-Cre 
data. Twenty-eight of the 257 genes are named. (d-e') BrdU proliferation analysis of E9.5 WT (d,d') 
and Dll4flox;Nfat-Cre mutants (e,e') performed in paraffin sections. The myocardium is counterstained 
with SMA (red). Arrowheads indicate the proliferative cells (BrdU-positive nuclei) in the 
myocardium; arrows indicate BrdU-positive nuclei in the endocardium. (o) Quantification of BrdU-
positive nuclei as a percentage of total nuclei in myocardium (Myo) and endocardium (Endo). Data 
are represented as mean ± S.D. (3 WT and 3 Dll4flox;Nfat-Cre, *P<0.05, n.s. not significant, by 
Student’s t test). Scale bar=50µm. 	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Dll4-Notch1 signaling triggers the expression of Gpr126 in the endocardium  
One of the most downregulated gene in all three genotypes was that encoding the signaling 
molecule Gpr126 (DREG) (Fig. 9c and supplementary table1), a member of the orphan adhesion G 
protein-coupled receptor family whose expression in the developing heart is restricted to the 
endocardium. In a recent work, it has been shown that targeted inactivation of Gpr126 in mice 
causes hypotrabeculation and a thinner ventricular wall (Patra et al., 2013, Waller-Evans, Promel et 
al., 2010). In this report, Patra and co-workers, hypothesized that the N-terminal fragment (NTF, 1-
783 aa) of Gpr126 functions independently of its C-terminal fragment (CTF) during heart 
development presumably in a paracrine fashion as an important signal linking endocardium and 
myocardium.  
At E9.5 Gpr126 was transcribed in the endocardium with a remarked expression at the base of 
the trabeculae where Notch1 activity is predominant (Fig. 10a-a’). Gpr126 expression was severely 
down-regulated in the endocardium of Dll4flox;Nfatc1-Cre mutants (Fig. 10b-b’). Interestingly, 
zebrafish cardiac expression of the Gpr126 homolog was abrogated in Mib1ta52b mutant larvae, 
which are deficient for the Notch pathway (Fig. 10c-d'), and after treatment of WT larvae with the 
Notch inhibitor RO4929097 (Munch, Gonzalez-Rajal et al., 2013) (Fig. 10e-e'). Endocardial 
expression of Gpr126, the trabecular phenotype of the targeted mutant mice (Patra et al., 2013, 
Waller-Evans et al., 2010) and its down-regulation in mouse and zebrafish Notch mutants suggested 
it as a Notch target during trabeculation.   
To substantiate the relationship between Notch and Gpr126, we conducted qRT-PCR analysis on 
human umbilical vein endothelial cells (HUVEC) stimulated with immobilized Dll4 ligand. Dll4 
stimulation increased Gpr126 expression in HUVEC, while simultaneous incubation with 
RO4929097 blocked this increase (Fig. 10f). As a control we determined the effect of Dll4 
stimulation on the transcription of Notch targets Hey1, Hey2, HeyL, Dll4 and Nrarp. Upon Dll4 
stimulation the expression of all targets examined was significantly increased comparing with 
unstimulated cells (Fig. 10g).  
In silico comparative genomic analysis of Gpr126 revealed two conserved putative RBPJ-
binding sites in the intronic region between exons 4 and 5 (Fig. 10h). The predicted RBPJ-binding 
sites were located 445 base pairs apart and were highly conserved among distantly related mammals 
(mouse, rat, monkey, pig and human) (Fig. 10i). We cloned the human genomic region containing 
these sites upstream of the firefly luciferase gene and performed luciferase assays in bovine aortic 
endothelial cells (BAEC). BAEC co-transfected with the reporter plasmid and empty vector showed 
basal luciferase activity, whereas increasing amounts of N1ICD were able to transiently activate the 
Gpr126 reporter construct up to 5-fold in a dose-dependent manner (Fig. 10j). All these data 
indicate Gpr126 as a possible new target of Notch1 activity in the endocardium during 
trabeculation. 
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Dll4 is required for coronary vessel development during compaction 
During late midgestation Dll4 expression in the heart is progressively reduced in the 
endocardium. In E12.5 WT heart sections we detected expression of Dll4 in the endothelium of the 
AVC region and in the endocardium of the right and left ventricle (Fig. 11a-a’).  Interestingly, as 
coronary vessel development proceeds, its mRNA expression was dramatically reduced in the 
endocardium of both ventricles but in the forming coronary artery Dll4 transcription was abundant 
(Fig. 11b-b’). 
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We therefore wanted to determine if this ligand plays a role at later stages of chamber 
development, when compaction occurs. In order to do this we combined the conditional Dll4flox 
allele with the tamoxifen-inducible Cre driver line Cdh5-CreERT (Luna-Zurita et al., 2010, Wang et 
al., 2010), which is active in both the endocardium and the vascular endothelium. Dll4flox/+;Cdh5-
CreERT/+ males were crossed with Dll4flox/flox females. Pregnant females were administered with 4-
hydroxy-tamoxifen (4-OHT) once by oral gavage at E12.5 and embryos were dissected at E15.5. 
Dll4flox;Cdh5-CreERT embryos were notably smaller in size than control littermates and showed 
edema in the back region, suggesting circulatory problems due to impaired vascularization (Fig. 
11c;g). Histological analysis revealed reduction in the thickness of the ventricular wall in both left 
and right ventricles as well as hypoplastic trabeculae (Fig. 11d;h). To validate the efficiency of 
tamoxifen-inducible-Cre activity we performed Dll4 ISH in heart sections at E15.5. At this stage, 
the transcript was markedly reduced in the intramyocardial coronary artery of the mutants (Fig. 
11e;i). These data confirmed that a single tamoxifen administration at E12.5 was sufficient to 
achieve a robust Dll4 deletion in endothelial cells.  Immunostaining revealed that N1ICD was still 
expressed in Dll4flox;Cdh5-CreERT chamber endocardium but was very weak in coronary vessels 
(Fig. 11f ;j). The compact myocardium of Dll4flox;Cdh5-CreERT mutant hearts showed normal Hey2 
expression (Fig. 11k;o) as well as normal expression of Gja5 in the trabeculae  (Fig. 11i;p). 
Figure 10.  Dll4-Notch1 sigaling induces endocardilal expression of Gpr126. 
(a-b’) WISH of Gpr126 in E9.5 WT (a,a') and Dll4flox;Nfat-Cre hearts (b,b'). Gpr126 is down-
regulated in the endocardium (arrowheads) of mutant embryos. Scale bar=100µm. (c-e') Reduced 
gpr126 expression in zebrafish larvae with impaired Notch signaling. Panels show lateral and ventral 
views. Lateral and ventral views of the ISH of gpr126 in WT (c,c', 27 out of 29; 93%), Mib1ta52b 
mutant (d,d', 35 out of 38; 92%) and RO-treated WT (e,e', 19 out of 22; 86%), 48-h.p.f. zebrafish 
embryos showing gpr126 transcripts in the heart tube (arrowhead) and ear region (arrow) in c, and 
reduced expression in d,e. Scale bar=50µm. (f-g) qRT-PCR analysis in HUVEC stimulated with 
immobilized Dll4 alone or in the presence of the γ-secretase inhibitor RO. Dll4 significantly increases 
expression of Gpr126 (f), Dll4, Nrarp, Hey1, Hey2 and HeyL (g) in HUVEC and simultaneous 
incubation with RO abolishes this effect (f-g). Data are represented as mean ± S.D. (3 independent 
biological replicates for each condition ***P<0.001, by Student’s t test.). (h) Screening for 
evolutionarily conserved sequences using rVista 2.0 of Gpr126 locus in Homo sapiens (Hs), Bos 
taurus (Bt), Macaca mulatta (Mm), Rattus norvegicus (Rn) and Mus musculus (Mmus). The chart 
shows a 17 Kb of the genomic region of Gpr126 in the different species analyzed. Two potential 
RBPJk binding sites were identified in the region between exon 4 and exon 5 (dot line). (i) Genomic 
alignment of the intronic region containing the two potential Rbpjk binding (blue box). Note the 
RBPJk consensus is highly conserved in all sequences analysed. (g) Gpr126 reporter activity 
measured by luciferase assay in BAEC. Transfection with an increasing gene dose of N1ICD 
significantly increases reporter activity. Data are representaed as mean ± S.D. (3 independent 
biological replicates for each condition  *P<0.05, ***P<0.001, by Student’s t test.). Scale bar=50µm. 
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Figure 11.  Dll4-Notch1 activity is required for coronary vessel formation. 
(a,a’) IHC of Dll4 and SMA in an E12.5 WT heart section. Dll4 (green) is widely expressed in the 
endocardium lining the AVC (a) and to a lesser extent in endocardial cells in the ventricle (a’, 
arrowheads). (b-b’) ISH of Dll4 in an E14.5 heart section. Dll4 is transcribed in the developing 
coronary endothelial cells (arrowhead) but not in the endocardium. (c,g) Images of whole-mount 
E15.5 WT (c) and Dll4flox;Cdh5-Cre mutant embryos (c). Note the dorsal edema (arrowhead) in the 
mutant embryos. Scale bar=2mm. (d,h) H&E stained sections of E15.5 WT (d) and Dll4 mutant 
hearts (h). The heart in the mutant has thinner ventricular walls (h, yellow bars) than its WT littermate 
(d). (e-i) ISH of Dll4 in E15.5 WT (e) and Dll4 mutant hearts (i) shows reduced expression in the 
mutant (i). (f-j) N1ICD immunostaining. N1ICD marks the endocardium (arrowhead) and the 
coronary vessels (arrowhead) of WT ventricle (f) and is weak in coronary vessels of mutant embryos 
(j). (k-r) ISH analysis. (k-o) Hey2 expression is similar in the compact myocardium of WT embryos 
(k) and mutants but it delineates a thinner compact myocardium in the mutant (yellow line, k,o). (l,p) 
Cx40 is detected in the trabecular myocardium of WT (l) as well as in the trabeculae of Dll4flox;Cdh5-
Cre (arrowheads, p), but not in the endothelium. The expression of coronary artery endothelial cell 
markers HeyL (m-q), EphrinB2 (n-r) is markedly lower in mutant embryos. The arrowheads mark 
expression in coronary vessels in WT. Scale bar in (a-b’and d-r)=100µm. 	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In contrast in coronary vessels the expression of Gja5 (Fig. 11 i;p), HeyL (Fig. 11m-q) and 
EfnB2 (Fig. 11n-r) was abrogated. These results indicate that at the stages when trabecular 
compaction occurs, Dll4-Notch1 signaling is required for coronary vessel development, but Dll4 
does not play a major role in the activation of Notch1 in chamber endocardium 
  
Myocardial Jag1 is dispensable during trabeculation 
We next examined the implication of the Jag1 ligand in chamber development. From early heart 
morphogenesis the expression pattern of Jag1 is restricted to the myocardium (Fig. 6h-h’’ and Fig. 
6k-k’’). To specifically delete Jag1 in this tissue, we crossed mice bearing a conditional Jag1flox 
allele (Koch et al., 2008) with the early myocardial driver cTnT-Cre (Jiao et al., 2003).  
Histological analysis of heart sections from E10.5 Jag1 mutants revealed no obvious defects in 
the morphology of the heart (Fig. 12a-b). In Jag1 mutants, the trabeculae were well formed and the 
thickness of the myocardial outer layer was similar to controls (Fig. 12a-b). To exclude that the lack 
of heart phenotype in the Jag1flox;cTnT-Cre mice was due to a weak Cre-recombinase activity, we 
stained mutant heart sections with a Jag1 antibody (Fig. 12c-d).  
At E10.5 the expression of Jag1 in mutant hearts was detected only in the endocardium of the 
AVC confirming that TnT-Cre efficiently drives the deletion of Jag1flox in ventricular myocardium 
(Fig. 12c-d). Despite the complete absence of myocardial ligand, in E10.5 Jag1 mutant embryos we 
did not detected significant differences in the expression of N1ICD compared to their WT 
counterparts (Fig. 12e-f and Fig. 12g). Additionally, the expression of Hey2 (Fig. 12h-i), EfnB2 
(Fig. 12j-k), Nrg1 (Fig. 12l-m) and Bmp10 (Fig. 12n-o) appeared normal when compared with 
E10.5 control hearts. These results indicate that Jag1 is not required for Notch1 activation during 
early ventricular chamber development. 
Myocardial Jag1 signals to Notch1 and is required for adult heart function 
Interestingly, the expression of Jag1 in ventricular myocardium persisted at later stages of heart 
development. At E12.5 Jag1 was strongly expressed in the trabeculae and at lower levels in the 
compact zone whereas the CBF:H2B-Venus reporter, detected by GFP,  was expressed throughout 
the endocardium (Fig. 13a-a’’) revealing Notch activity in this tissue. At E14.5 in the ventricles, the 
expression pattern of Jag1 was similar to those observed at E12.5. Moreover, at this stage Jag1 
delineated the endothelium of the developing coronary vessels (Fig. 13b-b’’). These data suggested 
that Jag1 from the myocardium could interact with Notch receptor in the adjacent endocardial cells 
during chamber compaction.  
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Figure 12. Myocardial Jag1 is dispensable for Notch signaling activation during trabeculation. 
(a,b) H&E staining of sections of E10.5 WT (a) and Jag1flox/flox;cTnT-Cre/+ (Jag1flox;cTnT-Cre) 
mutant hearts (b). Trabeculae and compact myocardium thickness are similar in WT and mutant 
hearts. (c,d) Immunostaining of Jag1 in E10.5 WT and Jag1flox;cTnT-Cre mutant embryos. Jag1 (red) 
is strongly expressed in the trabeculae of the WT ventricle (arrows, c) but is absent from the mutant 
ventricle (d). (e,f) N1ICD immunostaining (red, arrowheads) in the endomucin-delineated 
endocardium (green) of WT (e) and Jag1flox;cTnT-Cre mutant embryos (f). (g) Quantification of 
N1ICD-positive nuclei as the mean percentage of total nuclei in WT and Jag1flox;cTnT-Cre mutant 
embryos. Data are represented as mean ± S.D. (3 WT and 3 mutant embryos, determined by Student’s 
t test, n.s. not significant).  (h-o) ISH in E10.5 WT and mutant hearts. Hey2 (h,i), EphrinB2 (j,k), 
Nrg1(l,m), and Bmp10 (n,o),  are normally expressed in mutant hearts. Arrowheads indicate the 
endocardial expression of the genes; arrows myocardial expression of Bmp10. Scale bar=100µm. 	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Histological analysis of E16.5 WT mice showed well-developed compact myocardium and 
trabeculae (Fig. 13c-c’), whereas by comparison Jag1flox;cTnT-Cre embryos had thinner compact 
myocardium and disorganized trabeculae (Fig. 13d-d’).  Newborn WT mice had a well-structured 
myocardium with muscular ventricular walls (Fig. 13e-e’), while Jag1flox;cTnT-Cre littermates had 
dilated ventricles and a thin compact myocardium (Fig. 13f-f’). These features were also apparent in 
the hearts of 6 month-old mutant mice (Fig. 13g-h’). We stained adult WT and mutant heart 
sections with Masson’s trichome. Histological analysis evidenced that in mutants the wall of both 
ventricles was thinner and the heart appeared dilated compared with WT. In all sections analyzed 
we did not detect signs of fibrosis in the ventricles of the Jag1flox;cTnT-Cre. 
We next asked if the morphological heart defects observed at different stages in Jag1flox;cTnT-
Cre embryos may reflect impaired cardiac function in the mutant mice. Ultrasound analysis at 6 and 
9 month old mice, revealed significantly impaired systolic function in the left ventricle of 
Jag1flox;cTnT-Cre mutants, with reduced ejection fraction, fractional shortening and diastolic 
interventricular septal wall thickness (Fig. 14a-b; g and video 2). As the majority of the 
morphological defects in Jag1flox;cTnT-Cre were observed in the right ventricle, to decipher 
possible cardiac dysfunction in the RV we submitted 6 month old Jag1flox;cTnT-Cre to high-
resolution cardiac magnetic resonance imaging (CMRI). CMRI confirmed significant reduction in 
the thickness of the free wall of the right ventricle in Jag1flox;cTnT-Cre animals (Fig. 14c-f-b; h and 
video 3) that also showed segmental dyskinesia (video 4). Functional parameters as cardiac output, 
end-systolic (ES) mass, and end-diastolic (ED) volume in the LV and RV were below normal in 
mutant mice (Fig. 14h).  
Notably, CMRI analysis confirmed significant reduction in Jag1 mutant mice in left ventricular 
ejection fraction (EF, Fig. 14h), previously observed by ultrasound analysis (Fig. 14g). In the right 
ventricle we did not observe differences in EF between mutant and control animals. These results 
indicate that myocardial Jag1 signaling to Notch1 in the endocardium is not required for 
trabeculation but is later crucial for adult heart structure and function.  
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Figure 13. Myocardial inactivation of Jag1 impairs chamber compaction and maturation. 
(a-b’’) Triple IHC of Jag1 (green), SMA (red), and GFP (grey) in E12.5 (a-a’’) and E14.5 (b-b’’) WT 
CBF:H2B-Venus ventricles. GFP+ cells (Notch activity) in the endocardium are adjacent to trabeculae 
expressing Jag1 (blue arrowheads). In E14,5 Jag1 is express also in the endothelium of the coronary 
vessels (red arrowhead, b´,b’’). In (a-b'’) nuclei are counterstained with DAPI. Scale bar =50µm. (c-
f’) H&E staining of heart sections from WT and Jag1flox;cTnT-Cre E16.5 embryos (c-d’) and postnatal 
day 3 (P3) neonates (e-f’). Mutant hearts show thinner and disorganized compact myocardium (d’,f’). 
Masson’s trichome staining of 6-month-old adult hearts. The myocardium is fully compacted in the 
WT heart (g, enlarged in g’) but appears thinner in the mutant (h, enlarged in L). The yellow bars 
indicate the thickness of the compact myocardium. lv=left ventricle; ra=right atrium; rv=right 
ventricle; ivs= interventricular septum. Scale bar=100µm. 	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Figure 14. Myocardial Jag1 leads to cardiomyopathy and systolic dysfunction. 
(a,b) Echocardiography analysis in 6- and 9-month-old mice (6-9m), M mode views of the left 
ventricles (lv) of WT (a) and Jag1flox;cTnT-Cre (b) 6m mice. CMRI analysis in a 6m WT mouse (c,d) 
and a Jag1 mutant (e,f). Images show four-chamber (4c) and short axis (sa) views. Arrowheads mark 
the ventricular wall, which is thinner in the mutant heart. Scale bar=2mm. (g) Echocardiography 
analysis of left ventricular ejection fraction (EF) and fractional shortening (FS) measured at 6m and 
9m and diastolic interventricular septal wall thickness (IVSd) in WT and mutant mice. Data are 
represented as mean ± S.D. (n=10WT and 9 mutants at 6m, n=11WT and 10 mutants at  9m * P<0.05 
and ** P<0.01 by Student’s t test). (h) CMRI analysis of physiological and morphometric parameters 
in the left  (lv) and right ventricles (rv) of 6m WT and Jag1flox;cTnT-Cre mice. ES Mass, mass in end-
systole. Data are represented as mean ± s.e.m. (n=7 WT and 7 mutants, * P<0.05 and ** P<0.01 by 
Student’s t test).	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Jag1-Notch1 signaling sustains Ventricular Chamber Maturation and Cardiomyocyte 
Proliferation 
Analysis of chamber markers in E16.5 Jag1flox;cTnT-Cre mice revealed expansion of the 
compact myocardium marker Hey2 to the trabeculae (Fig. 15a-b’) and low expression of the 
trabecular markers Bmp10 (Fig. 15c-d’), Anf (Fig. 15e-f’) and Gja5/Cx40 (Fig. 15g-h’), especially 
in the right ventricle. The expression of Hey2 within the trabecular myocardium concomitant with 
an impaired expression of trabecular markers suggests defects in the maintenance of trabecular 
maturation and patterning. BrdU incorporation analysis in E16.5 Jag1flox;cTnT-Cre embryos 
revealed a 25% lower than normal cardiomyocyte proliferation in the compact region of the 
ventricles (Fig. 15i-k).  The altered gene expression and the reduced proliferation in the compact 
zone of E16.5 Jag1 mutant embryos indicate Jag1-Notch interaction as crucial for chamber 
maturation. 
To find molecular targets downstream of Jag1-Notch signaling during compaction, we carried 
out RNA-seq experiments with E15.5 WT and Jag1flox;cTnT-Cre ventricles. We identified 97 
differentially expressed genes (P <0.05), 74 of them up-regulated and 23 down-regulated relative to 
WT embryos (Fig. 16a and supplementary table1). GO classification revealed that most of these 
deregulated genes were involved in cell growth and proliferation (Cdkn1a, Cdk6, E2f1), 
differentiation (Sort1, Acta1, Robo1), fibrosis (Mmp12, Casq1), cardiovascular development and 
disease (Cxcl12, Flnb, Cacna2d2), focal adhesion (Spp1, Thbs2), ECM-receptor interaction 
(Lama5, Col6a6) and dilated cardiomyopathy (Itga1, Socs2) (Fig. 16b and supplementary table1). 
The gene encoding the chemokine ligand Cxcl12 was one of the most strongly down-regulated in 
Jag1flox;cTnT-Cre mutants (Fig. 16b). Interestingly, Cxcl12/Cxcr4 signaling has recently been 
shown to be crucial for coronary artery development (Ivins, Chappell et al., 2015), a process 
occurring simultaneously with and is essential for compaction (Tian, Pu et al., 2015). ISH of Cxcl12 
in E16.5 heart sections revealed strong expression in the trabecular myocardium of WT embryos. In 
agreement with the RNA-seq data, its expression was strongly down-regulated in Jag1flox;cTnT-Cre 
mutants (Fig. 17a-b’). The reduction of the transcript was also validated by qRT-PCR analysis (Fig. 
17i). Indeed, by qRT-PCR on mutant ventricles we estimated a 70% reduction of Jag1 levels 
compared with WT (Fig. 17i). ISH and qRT-PCR analyses also revealed markedly reduced Gpr126 
transcription in the endocardium of E16.5 Jag1flox;cTnT-Cre mutant endocardium (Fig. 17c-d’; i). 
Interestingly, the low expression of endocardial Gpr126 was coincident with reduced myocardial 
proliferation observed in E16.5 Jag1flox;cTnT-Cre mutants (Fig. 15i-k) likewise the situation 
observed in Dll4 mutants during trabeculation. This observation suggests that Gpr126 is an 
important component of Notch-mediated endocardium-myocardium interplay during ventricular 
chamber development. 
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Figure 15. Defective ventricular maturation and myocardial proliferation in E16.5 
Jag1flox;cTnT-Cre mutants.  
(a-h’) ISH in E16.5 WT and Jag1flox;cTnT-Cre heart sections. rv (right ventricle), lv (left ventricle). 
(a-b’) Hey2 expression in compact myocardium (arrow in a’) is expanded to the trabeculae in mutant 
embryos (arrow in b’) and the trabecular markers Bmp10 (c-d’), Anf (e-f’) and Cx40 (g-h’) are down-
regulated. Arrowheads indicate where the genes are expressed. (i-j’) IHC of incorporated BrdU in 
E16.5 WT (i.i’) and Jag1flox;cTnT-Cre heart sections (j,j’). Arrowheads indicate BrdU-positive nuclei 
(red). Below normal proliferation is observed in the myocardium of the mutant heart (Z). Data are 
represented as mean ± S.D. (n=3 WT and 3 Jag1flox;cTnT-Cre mutants * P < 0.05 by Student’s t test). 
Scale bar=100mm. 	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One of the most strongly up-regulated genes was the cell cycle inhibitor Cdkn1a/p21 (Fig. 16b 
and supplementary table1). To determine if the reduced cardiomyocyte cell division was the cause 
of the thinner compact myocardium observed at E16.5 in mutant hearts, we performed the 
proliferation analysis earlier than the onset of the cardiac phenotype. Consistent with the RNA-seq 
data, p21 expression in E13.5 Jag1flox;cTnT-Cre mutant hearts was 30% above normal (Fig. 17e-f’; 
j). However, in the already formed trabeculae, the number of p21 positive cells was similar to the 
WT. This observation suggested that in controls, as well as in mutant embryos, proliferation of 
trabecular myocardium is arresting. In agreement with an increasing p21 expression in the compact 
myocardium, BrdU analysis from E13.5 WT and Jag1flox;cTnT-Cre hearts showed a remarkable 
reduction of cell division in the compact region of mutant embryos (Fig. 17g-h’; j).  
Figure 16. Gene expression analysis of E15.5 Jag1flox;cTnT-Cre mutant ventricles. 
 (a) Heat map from hierarchical clustering of differentially expressed genes (P<0.05) identified by 
RNA-seq in the three different pools of WT and Jag1flox;cTnT-Cre ventricles. The total number of 
down-regulated genes is indicated to the right side of the blue line; the total number of up-regulated 
genes is indicated to the right side of the yellow line. (b) Circular plot showing 39 representative 
differentially expressed genes in Jag1flox;cTnT-Cre hearts selected from a total of 97 genes belonging 
to various functional categories (yellow, up-regulated; blue, down-regulated). The most represented 
functional categories correspond to genes involved in cell growth and proliferation, cell differentiation 
and cardiovascular development and disease.  
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Figure 17. Jag1-Notch1 signaling is required for myocardial growth and differentiation. 
 (a-b') ISH of Cxcl12 in E16.5 WT (a,a’) and Jag1flox;cTnT-Cre (b-b’) hearts. Myocardial expression 
(arrows) is impaired in mutant hearts. (c-d') ISH of Gpr126 in E16.5 WT (c,c’) and Jag1flox;cTnT-Cre 
(d,d’)  hearts. Gpr126 (arrowheads) is reduced in mutant hearts. (e-h') IHC for p21 (red nuclei), 
N1ICD (red nuclei) and BrdU (green nuclei) in E13.5 WT and Jag1flox;cTnT hearts. In the WT heart 
(e,e'), p21 expression is observed in the trabeculae (e', arrowhead) and in dispersed compact 
myocardium cardiomyocytes; in the mutant, expression is expanded throughout the ventricle (f,f') and 
is significantly higher (f'). N1ICD is expressed throughout the endocardium in the WT ventricle (g,g', 
arrowheads) and is markedly lower in the mutant heart (h,h', arrowheads). In the WT, BrdU is 
predominantly incorporated in the compact myocardium (g,g', yellow arrowheads) and is significantly 
lower in the Jag1flox;cTnT ventricle (h,h', arrowhead). (m) qRT-PCR analysis of Gpr126, Jag1 and 
Cxcl12 in E15.5 WT and Jag1flox;cTnT-Cre ventricles. Data are represented as mean ± S.D. (n=3 
pools of 3 WT ventricles each and 3 pools of 3 mutants ventricles each, * P<0.05, **P<0.01, 
determined by Student’s t test). (j) Quantification of p21-, N1ICD- and BrdU-positive nuclei in E13.5 
Jag1flox;cTnT ventricles. Data are represented as mean ± S.D. (3 WT and 3 mutant embryos, for p21 
staining and 6 WT and 6 mutant embryos for BrdU and N1ICD staining; ** P<0.01, determined by 
Student’s t test). lv=left ventricle; rv=right ventricle; ivs= interventricular septum. Scale bar=100mm. 	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Concomitant to a 56% reduction of BrdU, N1ICD expression in the endocardium was 28% 
lower than WT (Fig. 17g-h’; j). These results indicate that Jag1-mediated Notch1 activation in the 
endocardium is essential for compact myocardium proliferation and trabecular myocardium 
differentiation and patterning. 
Morphological and functional differences between Jag1 and Mib1 mutants 
We initially predicted that the cardiac phenotypes of Mib1flox;cTnT-Cre and Jag1flox;cTnT-Cre 
mutants would be similar, based on the assumption that Jag1 was the only ligand expressed in the 
myocardium and was therefore the only potential substrate for the ubiquitin ligase action of Mib1, 
responsible for Notch activation at later stages. We performed comparative morphological analysis 
of Jag1flox;cTnT-Cre and Mib1flox;cTnT-Cre mutants measuring the thickness of the compact 
myocardium and trabecular complexity in E16.5 heart sections. Myocardium was counterstained 
with cardiac Troponin T antiboby (cTnT). To delineate the chamber endocardium we used 
endomucin. Mibflox;cTnT-Cre mutant hearts showed thinner compact myocardium in the left and 
right ventricle (31% and 35% reduction respectively, Fig. 18c-c’’), comparing with the well-
developed structures in WT embryos (Fig. 18a-a’’). In the Jag1 mutant hearts the reduction of 
compact zone was observed only in the right ventricle and it was less accentuated (20%, Fig. 18b-
b’’). In addition, Mibflox;cTnT-Cre mutant embryos showed an 80% and 68% increase in trabecular 
complexity in the left and right ventricles, respectively (Fig. 18c-c’’). A significant increase was 
also observed in both left and right ventricle of Jag1 mutants (30% and 42% respectively, Fig. 18b-
b’’), although less accentuated than in Mibflox;cTnT-Cre mutant embryos. These results showed 
morphological differences between Jag1 and Mib1 mutant embryos. The chamber phenotype of 
Jag1 mutant only in part resembled the features observed in Mib1 mutant embryos. Notably, the 
morphological discrepancies between the two mutants reflected differences in the cardiac function. 
Mib1flox;cTnT-Cre mutants develop LVNC cardiomyopathy (Luxan et al., 2013); in contrast 
Jag1flox;cTnT-Cre mutants showed structural and functional signs of dilated cardiomyopathy and 
systolic dysfunction but no signs of LVNC.  
These observations prompted us to examine whether a different Notch ligand expressed in the 
myocardium, non-redundant with Jag1, could account for the phenotypic differences between Mib1 
and Jag1 mutants.  
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Figure 18. Morphological differences between Jag1flox;cTnT-Cre and Mib1flox;cTnT-Cre E16.5 
mutant embryos. (a-c’’) E16.5 heart sections stained with endomucin and cTnT. The WT heart (a-
a'') shows a thick compact myocardium (red) in both ventricles, with compacting trabeculae (red) The 
Jag1flox;cTnT-Cre heart (b-b''), shows thin compact myocardium, especially in the right ventricle and 
uncompacted and dispersed trabeculae. In the Mib1flox;cTnT-Cre (c-c'') stronger chamber phenotype is 
observed comparing with Jag1flox;cTnT-Cre. Note the very large and uncompacted trabeculae 
invading the lumen of the ventricles (c’,c’’). The yellow bars indicate compact myocardium thickness. 
(e,d) Quantification of compact myocardium thickness (e) and complexity of trabecular myocardium 
(d) in Jag1flox;cTnT-Cre and Mib1flox;cTnT-Cre hearts comparing with corresponding WT. Data are 
mean ± S.D. (n=3 WT; 3 Jag1flox;cTnT-Cre and 3 Mib1flox;cTnT, *P<0.05, **P<0.01, ***P<0.001, n.s. 
not significant, determined by Student’s t test). lv=left ventricle; rv=right ventricle; ivs=	  
interventricular septum. Scale bar=100µm. 	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Jag2 is required for chamber maturation and compaction 
The full-length of human Jag2, a mammalian Jag1 paralogue, was isolated by Biao Luo and co-
workers in 1997. In this report, expression of the murine Jag2 mRNA was also investigated. 
Northern blot analysis performed on RNA isolated from various tissues of 2-week-old mice 
revealed high expression of Jag2 in the heart (Luo, Aster et al., 1997). More recently, myocardial 
expression of Jag2 was detected in embryonic heart sections by immunohistochemistry during post-
mid-gestation (van den Akker, Molin et al., 2007). Considering these data, we evaluated the 
expression of Jag2 during chamber development. ISH analysis of E10.5 WT heart sections showed 
basal Jag2 expression in the E10.5 WT heart (Fig. 19a). Progressively, from E12.5 to E16.5 Jag2 
expression increased in the myocardium (Fig. 19b-d). Strong expression of the transcript was 
detected in the myocardium of the atria, especially in the region of the septum primum (SP) and in 
the trabecular myocardium of the ventricles (Fig. 19b-d). From E14.5 remarked Jag2 expression 
was also detected in the endothelium of coronary vessels. qRT-PCR analysis showed that Jag2 up-
regulation paralleled the down-regulation of Jag1 (Fig. 19f).  Interestingly, during myocardial 
compaction, from E12.5 to E14.5, expression levels of both ligands were similar. Once myocardial 
compaction ends, Jag2 levels were significantly higher (Fig. 19f). Expression analysis suggested 
Jag2 as an important ligand for Notch activity during chamber compaction and maturation.  
To investigate its role we crossed Jag2flox mice with the cTnT-Cre driver line to generate 
homozygous Jag2flox;cTnT-Cre mice. ISH showed strong down-regulation of Jag2 expression in the 
myocardium of E16.5 Jag2flox;cTnT-Cre. The Notch ligand was transcribed only in the endothelium 
of the coronary vessels where the Cre is not active (Fig. 19d-e). At this stage, the WT heart showed 
thick compact myocardium and the trabeculae were almost fused with each other (Fig. 19g-g’). In 
contrast, the mutant embryo had a thinner compact myocardium especially in the right ventricle, 
which appeared dilated and full of disorganized trabeculae (Fig. 19h-h’). Quantification of compact 
myocardium thickness revealed a 38% reduction in the right ventricle, paralleled by a 20% increase 
in trabecular complexity (Fig. 19i-f). To confirm that myocardial Jag2 is a potential activator of 
endocardial Notch1, we assayed N1ICD expression in E16.5 WT and Jag2flox;cTnT-Cre mutant 
embryos. Notch activity was 35% below normal in the right ventricle of mutants (Fig. 20 a-c). This 
data indicated that Jag2 is the second ligand interacting with Notch1 during chamber compaction. 
Jag1flox;cTnT-Cre mutants had reduced endocardial Notch activity concomitant with  impaired 
cardiomyocyte proliferation. To strengthen the hypothesis that, during compaction, endocardial 
Notch signaling is necessary to sustain proliferation of cardiomyocytes in the compact layer, we 
performed BrdU incorporation analysis in E13.5 Jag2flox;cTnT-Cre heart sections. 
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Figure 19. Myocardial Jag2 is required for ventricular maturation and compaction. 
(a-e) ISH of Jag2 in E10.5 (a), E12.5 (b), E14.5 (c), E16.5 (d) WT and Jag2flox;cTnT-Cre mutant (e) 
heart sections. Jag2 is expressed in trabecular myocardium (arrows), atria and septum primum 
(arrowheads) from E12.5 onwards. At E16.5 Jag2 is also observed in coronary vessels (e, 
arrowheads). (d) cTnT-Cre-mediated deletion completely abrogates Jag2 expression in the 
myocardium but does not affect expression in coronary vessels (d, arrowheads). No expression is 
detected in E10.5 WT embryos (a). (f) Relative ratios of Jag1 and Jag2 gene expression in WT 
ventricles from E10.5 to P1 measured by qRT-PCR. Expression levels of Jag1 and Jag2 are similar at 
E12.5 and E14.5. Afterwards the levels of Jag2 are higher compared to Jag1. Data are represented as 
mean ± S.D. (n=3 pools of 3 WT ventricles per pool for each stage analyzed, ***P<0.01, n.s. not 
significant, determined by Student’s t test). (g-h’) IHC in E16.5 WT (g,g’) and Jag2flox;cTnT-Cre 
(h,h’) stained with endomucin and cTnT. WT ventricles show a very thick compact myocardium (g, 
yellow line in g’) and compacting trabeculae. In contrast, the mutant heart shows a thinner compact 
myocardium (h, yellow line in h’), especially in the right ventricle. (i-f) Chart showing quantification 
of compact myocardium thickness (i) and complexity of trabecular myocardium (f) in Jag2flox;cTnT-
Cre hearts comparing with corresponding WT. Data are mean ± S.D. (n=3 WT; 3 Jag2flox;cTnT-Cre 
*P<0.05, **P<0.01, n.s. not significant, determined by Student’s t test). ra=right atria; la=left atria; 
rv=right ventricle; lv=left ventricle; avc=atrioventricular canal. Scale bar=100µm. 	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Figure 20. Jag2 interacts and activates Notch1 in the endocardium during ventricular 
compaction. (a,b) N1ICD immunostaining (red nuclei). In the E16.5 WT heart (a), N1ICD is 
expressed throughout the endocardium (yellow arrowheads), delineated by endomucin staining 
(green), and in coronary vessels (white arrowheads). (b) Jag2flox;cTnT-Cre heart shows below-normal 
N1ICD expression. The yellow and white arrowheads mark remnant endocardial- and coronary 
N1ICD-positive cells, respectively. (c) Quantification of N1ICD-positive cells in the left and right 
ventricle. Data are mean ± S.D. (n=3 WT and 3 Jag2flox;cTnT-Cre mutants, * P < 0.05, **P < 0.01, 
determined by Student’s t test). (d,e) BrdU (green) and SMA (red) immunostaining in E13.5 WT (d) 
and Jag2flox;cTnT-Cre (e). BrdU is predominantly incorporated in WT compact myocardium (c); the 
mutant hearts show reduced BrdU incorporation in the compact layer. Within the trabeculae, 
cardiomyocyte proliferation is very low as indicated by the few BrdU positive cells in this region (c-
d). Nuclei are counterstained with DAPI (blue). (e) BrdU quantification. The total number of BrdU 
positive nuclei was divided by the total number of cells (DAPI) for each region of interest; compact 
zone and trabecular myocardium of left and right ventricle. Data are represented as mean ± S.D. (n=3 
WT and 3 Jag2flox;cTnT-Cre mutants, **P < 0.01, determined by Student’s t test). (g-l) ISH analysis. 
Hey2 is prominent in WT compact myocardium (g, yellow bar), which is thin in Jag2flox;cTnT-Cre (j, 
yellow bar). Bmp10 labels trabecular myocardium in WT (h) and Jag2flox;cTnT-Cre (k). Gpr126 
delineates the endocardium in WT ventricles (i, arrowhead) and its expression is severely reduced in 
Jag2flox;cTnT-Cre mutants (l). lv=left ventricle; rv=right ventricle. Scale bar=100mm. 	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The total number of proliferative cardiomyocytes located in the compact myocardium of the 
Jag2 mutants was 30% lower than WT, especially in the right ventricle (Fig. 20d-f). This result 
confirmed the strict relationship between endocardial Notch activity and cardiomyocyte 
proliferation. This result confirmed the strict relationship between endocardial Notch activity and 
cardiomyocyte proliferation. 
Furthermore, the expression of Hey2 and Bmp10 evidenced clear defects of compaction in the 
right ventricle of E16.5 Jag2flox;cTnT-Cre embryos (Fig. 20g-k). In addition, Gpr126 was down-
regulated in the endocardium of Jag2 mutants (Fig. 20i-l). All these data indicate that Jag2 plays a 
non-redundant role to Jag1 in heart development during ventricular chamber maturation and 
compaction.  
 
Molecular docking suggests binding of Jag1 and Jag2 to the same Notch1 homodimer 
To explore the interaction of Notch1 with its ligands, we in-silico modeled the 3D structure of 
the complexes formed by the extracellular domains of two Notch1 receptors (Fig. 21a) interacting 
with its ligands (Fig. 21b-e and video 5). The models generated for the N1ECD monomer show a 
linear, rigid structure with a low degree of compaction, in line with published results (Blacklow, 
2013, Chillakuri, Sheppard et al., 2012, Hambleton, Valeyev et al., 2004). Interaction of Notch1 
with its ligands occurs in an antiparallel head-to-tail orientation of N1ECD EGF-like repeat 12 and 
DSL-EGF-like repeats 1-2 of the ligands expressed in neighboring cells (Andrawes, Xu et al., 2013, 
Chillakuri, Sheppard et al., 2013, Chillakuri et al., 2012). The biologically active Notch1 dimer 
binds Dll4 in a 1:1 stoichiometry (Narui & Salaita, 2013) and we assumed that this stoichiometry 
would be the same also for Jag1 and Jag2. In addition, we generated a 3D complex composed by a 
homodimer of N1ECD interacting with Jag1 and Jag2 (Fig. 21e). 
According to data on the stability and free energy of the docking, the most favored ligand-
receptor interaction in terms of strength and affinity/avidity is 2Dll4:2N1ECD (Fig. 21b;f and video 
5). For Jag1 and Jag2 combinations, the Jag1/Jag2:2N1ECD complex had a slightly higher 
predicted stability (a smaller global energy, indicated by the lower total score) than the 
2Jag1:2N1ECD complex, a consequence of the stronger Van der Waals attraction forces in the 
Jag1/Jag2:2N1ECD complex (smaller fa_atr term). In contrast, the repulsion (fa_rep) and solvation 
(fa_sol) forces were very similar for these complexes and smaller than for the 2Jag2:2N1ECD 
complex (Fig. 21f). This suggests that the affinity/avidity of the Jag1/Jag2:2N1ECD heterocomplex 
would be higher than that of the 2Jag1:2N1ECD complex, and that the presence of both ligands 
would favor formation of the Jag1/Jag2:2N1ECD heterocomplex (Fig. 21c-f and video 5). These 
results, together with the Jag1 and Jag2 expression observed in vivo support the idea that the Jag1 
and Jag2 ligands activate the same Notch1 homodimer.  
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Figure 21. In silico modeling of Notch ligand-receptor interaction. 
(a) 3D model of the extracellular domain of Notch1 forming a homodimer (2N1ECD, green). The 
inset highlights the EGF domains of one of the N1ECD involved in the ligand-receptor interaction (a). 
Docking between the Notch1 extracellular domain homodimer (NECD, green and cyan) and Dll4 (a, 
yellow), Jag1 (b, orange), Jag2 (c, gray), or Jag1 and Jag2 (d) dimers. (e) Summary of energy and 
force measurements. Total score indicates the total free energy, which is smallest for the most stable 
interaction (2Dll4-2NECD, b;f). Jag1/Jag2:2N1ECD (e;f) complex shows lower free energy 
compared to Jag1/Jag1:2N1ECD (c;f) or Jag2/Jag2:2N1ECD (d;f). 	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Both Jag1 and Jag2 are required for Notch1 activity during chamber compaction  
The data collected from single myocardial Jag1- or Jag2- mutants indicated that both ligand 
interact and activate Notch1 in the endocardium during chamber compaction. However, in 
comparison with Mib1flox;cTnT-Cre embryos, the  Jag1flox or Jag2flox;cTnT-Cre embryos showed a 
milder cardiac phenotype. This observation suggested that in the myocardium Mib1 regulates the 
endocytosis and the recycling of both ligands, therefore the loss of myocardial Mib1 would cause a 
stronger heart phenotype than single Jag1- or Jag2-deletions.  
To test this hypothesis, we generated mice doubly deficient for Jag1- and Jag2- in the 
myocardium. We stained E16.5 WT and Jag1flox;Jag2flox;cTnT-Cre heart sections with antibodies 
against cTnT and endomucin to label the myocardium and endocardium, respectively, in order to 
perform morphological analysis (Fig. 22a-b’’). This analysis revealed significant reduction in the 
thickness of right and left compact myocardium of double mutant embryos (Fig. 22c).	  Interestingly, 
in the single Jag1 or Jag2 myocardial mutants, we observed significant reduction only in the right 
ventricle. The trabecular complexity was 26% above normal in the right ventricle of 
Jag1flox;Jag2flox;cTnT-Cre mice (Fig. 22c), indicating defective trabecular compaction. The cardiac 
phenotype observed in E16.5 Jag1flox;Jag2flox;cTnT-Cre heart sections, was exacerbated in 
comparison to Jag1flox or Jag2flox;cTnT-Cre mutants and it was reminiscent of Mib1flox;cTnT-Cre  
mice (Luxan et al., 2013).  
Endocardial Notch1 activity was monitored by immunostaining of N1ICD in E16.5 WT and 
double mutant heart sections. (Fig. 22d-e’). The expression of N1ICD was significantly lower in the 
left and right ventricle of Jag1flox;Jag2flox;cTnT-Cre  mutants, with an average of 32% reduction 
(Fig. 22f). In the single Jag1 or Jag2 mutant hearts, we observed a significant reduction of N1ICD 
positive cells, as well as, impaired cardiomyocyte proliferation only in the right ventricle. 
Proliferation analysis performed in E13.5 double Jag1;Jag2 mutant embryos (Fig. 23a-b’’) 
highlighted once again the strict relation between endocardial Notch activity and myocardial 
proliferation. Indeed, the number of BrdU positive cells in the compact myocardium of both 
ventricles was 40% below normal (Fig. 23c). ISH analysis in E16.5 WT and Jag1flox;Jag2flox;cTnT-
Cre heart sections showed that Hey2 delineated a very thin compact myocardium with deep recesses 
(Fig. 23d-g). In the mutant hearts Bmp10 delineated very large and disorganized trabeculae (Fig. 
23e-h). In addition, endocardial Gpr126 expression was markedly attenuated (Fig. 23f-i). These 
results demonstrate that Jag1 and Jag2 are indispensable during ventricular myocardial compaction 
and both are necessary to trigger endocardial Notch1 activity in this process. The functional study 
performed on Jag1flox;Jag2flox;cTnT-Cre indicates that the two myocardial ligands are play a non-
redundant role during chamber development and are substrate of the ubiquitin ligase Mib1.  
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Figure 22. Myocardial deletion of Jag1 and Jag2 exacerbates the chamber phenotype observed 
in the single mutants. (a-b’’) E16.5 heart sections from WT (a,a’’) and Jag1flox;Jag2flox;cTnT-Cre 
(b,b’’) embryos stained with endomucin (endocardium) and cTnT (myocardium). The WT ventricles 
show a thick compact myocardium in the left (yellow line in a’) and right ventricle (yellow line in a’’) 
and compacting trabeculae. In contrast, the mutant heart shows very thin compact myocardium 
(yellow line in b’,b’’) with enlarge and disorganized trabeculae (b’,b’’). (c) Chart showing 
morphological parameters of compact myocardium thickness and complexity of trabecular 
myocardium in Jag1flox;Jag2flox;cTnT-Cre hearts comparing with corresponding WT. Data are mean ± 
S.D. (n=3 WT and 3 Jag1flox;Jag2flox;cTnT-Cre **P<0.01, ***P<0.001, n.s. not significant, 
determined by Student’s t test). (d-e’) N1ICD immunostaining (red nuclei). In the E16.5 WT heart 
(d,d’), N1ICD is widely expressed in the endocardium (yellow arrowheads) marked by endomucin 
(green), and in coronary vessels (white arrowheads). (d) Jag1flox;Jag2flox;cTnT-Cre heart shows 
below-normal N1ICD expression. The yellow and white arrowheads mark remnant endocardial- and 
coronary N1ICD-positive cells, respectively. (f) Quantification N1ICD-positive cells in the left and 
right ventricle. Data are mean ± S.D. (n=3 WT and 3 Jag1flox;Jag2flox;cTnT-Cre * P < 0.05, **P < 
0.01, determined by Student’s t test). lv=left ventricle; rv=right ventricle; ivs=	  interventricular septum. 
Scale bar=100µm. 	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Figure 23. Reduced myocardial proliferation and impaired chamber gene expression in Jag1 
and Jag2 double mutants. (a-b’) BrdU (green) and SMA (red) immunostaining in E13.5 WT (a-a’’), 
and Jag1flox;Jag2flox;cTnT-Cre (b-b’’) hearts. In the WT BrdU is predominantly incorporated in right 
(arrowheads in a’) and left ventricular (arrowheads in a’’) compact myocardium; in both ventricles 
the trabecular cardiomyocytes proliferate less than in the compact layer (a-a’’). In the mutant hearts 
the total number of BrdU positive cardiomyocytes in the compact layer of both ventricles (arrowheads 
in b’ and b’’) is reduced compared to the WT. (a-b’’). Nuclei are counterstained with DAPI (blue).  
(c) BrdU quantification. The total number of BrdU positive nuclei was divided by the total number of 
cells (DAPI) for each region of interest; compact zone and trabecular myocardium of left and right 
ventricles. Data are represented as mean ± S.D. (n=3 WT and 3 Jag1flox;Jag2flox;cTnT-Cre *P < 0.01, 
determined by Student’s t test). (d-i) ISH analysis. In E16.5 WT Hey2 delineates very thick compact 
myocardium (d, yellow bar), which is thin in Jag1flox;Jag2flox;cTnT-Cre (i, yellow bar). Bmp10 
expression is found in the trabecular myocardium of WT (arrowhead in h) and in 
Jag1flox;Jag2flox;cTnT-Cre it shows how trabeculae are disorganized and uncompacted (arrowhead in 
h). Gpr126 marks the endocardium in WT ventricles (f, arrowhead) and its expression is severely 
reduced in Jag1flox;Jag2flox;cTnT-Cre (i). rv=right ventricle; lv=left ventricle; avc=atrioventricular 
canal. Scale bar=100µm. 
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Manic Fringe modulates Notch selectivity towards its ligands in ventricular endocardial cells  
We next investigated the mechanism underlying the spatio-temporal specificity of Dll4, Jag1 and 
Jag2 towards the Notch1 receptor during chamber development. The Fringe family of 
glycosyltransferases catalyses the elongation of O-linked fucose on the EGF-like repeats of Notch, 
contributing to receptor selectivity towards its ligands (Panin et al., 1997). Upon Notch 
glycosylation, Delta-Notch signaling is enhanced, and Jag/Ser-Notch signaling is diminished (Panin 
et al., 1997, Yang, Nichols et al., 2005). We evaluated the expression in the embryonic heart of the 
three mammalian Fringe paralogs by ISH and qRT-PCR. Manic Fringe (MFng) was strongly 
transcribed in chamber endocardium at E8.5 (Fig. 24a). Its expression declined progressively to a 
minimum at E11.5 and was detected only in the endocardium of the AVC (Fig. 24a-d). qRT-PCR 
analysis confirmed high levels of the transcript at E8.5 and significant down-regulation from E9.5 
to E11.5 (Fig. 24m). In contrast, from E9.5 to E11.5, Lunatic Fringe (LFng) was only detected in 
the proepicardium and epicardium (Fig. 24f-h). Radical Fringe (RFng) was not expressed in the 
heart during these stages (Fig. 24j-l). qRT-PCR confirmed the basal levels of RFng mRNA in the 
ventricle and increasing expression of LFng from E8.5 to E11.5 (Fig. 24n). 
We next performed ISH of MFng and LFng at later stages of heart development. At E14.5 MFng 
was expressed in the developing coronary vessels but not in the endocardium (Fig. 24e-e’). Its 
expression pattern resembled that of Dll4 at this stage (Fig. 24b-b’). In E14.5 heart sections LFng 
was detected in the subepicardial endothelium and in the cells forming the mural leaflet of the left 
mitral valve (Fig. 24i-i’). Different studies based on linage tracing analysis described that EPDCs 
contribute to the development of these two regions, consistent with the epicardial expression of 
LFng during mid-gestation (E9.5-E11.5, Fig. 24f-h).  
The endocardial expression of MFng during trabeculation (E8.5-10.5), in addition to the 
functional studies performed with Dll4, Notch1, Jag1, Jag2 and double Jag1;Jag2 mutant embryos, 
suggested that MFng activity would favor endocardial Dll4 signaling to the Fringe-modified Notch 
receptor. Furthermore, as development proceeds, the down-regulation of MFng expression after 
E11.5 would allow Jag1 and Jag2 signaling from the myocardium to activate Notch in the 
endocardium, but still favoring the Dll4-Notch signaling in the developing coronary vessels.  
To understand how glycosylated Notch receptor interacts with its ligands, we performed an in-
vitro stimulation assay, as previously described (Benedito et al., 2009). For this experiment we 
isolated mouse embryonic ventricular endocardial cells (MEVEC) from E10.5 WT ventricles. To 
avoid the rapid senescence of the primary cell cultures, we immortalized MEVEC with SV40 T 
antigen expressing lentivirus (Fig. 5). Upon infection, the cells maintained their characteristic 
cobblestone-like morphology, proper of endothelial-like cells, and proliferated very fast. We next, 
transduced MEVEC with a lentiviral vector encoding the full-length of murine MFng-IRES-eGFP 
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(MFng-MEVEC) or with the lentiviral vector alone as control (GFP-MEVEC). The efficiency of 
transduction was evaluated measuring the levels of MFng by qPCR analysis (Fig. 24o). Transduced 
cells showed very high levels of MFng expression compared with GFP-MEVEC counterparts, 
whereas expression levels of Notch1 and Dll4, as well as the chamber endocardium markers Nfatc1, 
Nrg1 and Gpr126 were normal. (Fig.24o).  
We first compared the response of control-transduced MEVEC to stimulation with immobilized 
Dll4, Jag1 or Jag2, all of which can activate Notch in a cell-contact-independent manner (Benedito 
et al., 2009). As read-outs of Notch activation we measured by luciferase assay the activation of the 
Notch reporter CBF1-Luc (McKenzie, Stevenson et al., 2005) (Fig. 24p) and by qPCR the levels of 
Hey1 expression (Fig. 24q), a well-known endocardial Notch target (Timmerman et al., 2004). Dll4 
and Jag1 activated the Notch reporter to a similar extent in control-transduced MEVEC, whereas 
Jag2 elicited a weaker response (Fig. 24p); in contrast, all three ligands induced a similar increase in 
Hey1 expression (Fig. 19q). Pairwise combinations of the ligands produced additive effects on 
Notch activation (Fig. 19p).  
MFng overexpression in MEVEC strongly potentiated Notch reporter activity and Hey1 
expression in response to Dll4, whereas the response to Jag1 and Jag2 and subsequent Hey1 
expression remained weak (Fig. 24p-q). Combinations of Dll4+Jag1 and Dll4+Jag2 produced a 
similar response to stimulation with Dll4 alone (Fig. 24p-q), but the Jag1+Jag2 combination 
stimulated Notch signaling weakly (Fig. 24p-q). In vitro experiments indicated that upon MFng 
glycosylation, Notch activity was highly enhanced in response to Dll4, converting it in a 
"superactivator" of Notch signaling. In addition, combination of Jag1 or Jag2 with Dll4 did not 
reduce Notch activity. This result was in contrast with the inhibitory effect of Jag1 previously 
described (Benedito et al., 2009). In our system, overexpression of MFng mirrors the scenario 
during trabeculation in which Notch activity strongly depends on Dll4. In MEVEC, all ligands 
analyzed, similarly activated un-glycosylated Notch.  
Interestingly, their combination enhanced Notch activity at least 2–fold more than single ligand 
stimulation, indicating an additive effect of Notch activity. These results suggested that the absence 
of MFng frees Jag1 and Jag2 to cooperate in the activation of Notch1 resembling the scenario 
during chamber compaction. 
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Systemic Fng inactivation affects coronary vessel development  
The expression pattern of MFng, the phenotyope of Dll4 mutant embryos, the strong reduction 
of endocardial Notch activity in the double Jag1;Jag2 mutants and the ligand stimulation assay 
performed on MEVEC suggested that MFng may regulate the spatio-temporal specificity of Notch 
ligand-receptor interactions in the developing chamber. To elucidate the effect of Fringe-modified-
Notch receptor in vivo, we used mice triply deficient for MFng, LFng and RFng (M-/-;L-/-;R-/-). 
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Systemic inactivation of Fng allowed us to avoid possible redundancy between the three 
different paralogs. Previous studies demonstrated that triple mutant mice develop to term and, 
although they are not found at the expected Mendelian frequency at weaning,	  no embryonic lethal 
phenotypes have been reported. M-/-;L-/-;R-/- deficient embryos were examined by histological 
analysis at E16.5, when chamber development is well advanced  (Fig. 25a-b). M-/-;L-/-;R-/- mice 
showed a significant reduction in the thickness of the compact myocardium in both ventricles, 
indicating that Fng is required for chamber development at this stage (Fig. 25c). Interestingly, the 
mutant hearts did not display any difference in the complexity of the trabecular myocardium (Fig. 
25c). ISH analysis of Hey2, a compact myocardial marker, was not expanded in the trabeculae, but 
clearly evidenced a reduced compact layer in M-/-;L-/-;R-/- deficient embryos (Fig 25d,g). In triple 
mutants, Cx40/Gja5 was normally transcribed in trabeculae, but its expression was reduced in the 
coronary vessels (Fig 25e,f). The morphological defects observed in triple mutant mice and the low 
expression of Cx40/Gja5 in the coronary artery indicated that Fng glycosyltransferases might be 
required for proper coronary vessel development during chamber compaction.  We next assayed the 
expression of N1ICD in M-/-;L-/-;R-/- heart sections (Fig. 25f-i’). N1ICD appeared relatively normal 
Figure 24. Endocardial-endothelial MFng would favor Dll4-Notch1 signaling during 
trabeculation and coronary artery development. (a-e’) ISH analysis of Manic Fringe (MFng). At 
E8.5-10.5, MFng is transcribed in ventricular endocardium (a-c, arrowheads) and is downregulated at 
E11.5 (d). At E16 (e-e’), MFng is expressed in coronary vessel endothelium (arrowheads in e’) but 
not in endocardium (arrow in e’). ISH analysis of Lunatic Fringe (LFng) and Radical Fringe (RFng) 
in WT hearts at the indicated developmental stages. (f-l) LFng expression is detected in proepicardial 
cells of E9.5 WT embryos (f) and is restricted to the epicardium of E10.5 (g) and E11.5 (h) WT 
hearts. At E16.5 (i,i’), LFng is found in subepicardial veins (arrowheads in i’) but not in endocardium 
(arrow in i’). (j-l) ISH of RFng from E9.5 (j), E10.5 (k) and E11.5 (l) WT heart sections. RFng is not 
expressed in the heart at these stages. (m) Relative MFng expression measured by qRT-PCR from 
E8.5-11.5 indicates a progressive downregulation of the transcript from E10.5 onwards. Data are 
represented as mean ± S.D. (n=3 pools of 6 hearts at E8.5 and 3 pools of 3 ventricles each for other 
stages *P <0.05, **P < 0.01, determined by Student’s t test). (n) Relative mRNA expression of LFng 
and RFng in E.9.5, E10.5 and E11.5 ventricles. (o) MEVEC stimulation assay. qRT-PCR analysis of 
Notch pathway genes and endocardial markers, indicating similar expression levels of these genes in 
GFP-MEVEC and MFng-MEVEC. (p) Notch signaling activity measured by 10xCBF1-Luc reporter 
assay in MEVEC infected with control GFP lentivirus (GFP-MEVEC, solid black bars) or with a 
MFng-lentivirus (MFng-MEVEC, grey bars) and stimulated with immobilized Notch ligands. 
Stimulation of GFP-MEVEC with Dll4, Jag1 or Jag2 (or their combinations) triggers similar reporter 
activation. Stimulation of MFng-MEVEC with Dll4 strongly activates the Notch reporter, while Jag1 
and Jag2 have a weak effect. Combinations of Dll4 with Jag1 or Jag2 trigger a response similar to that 
of Dll4 alone, while the Jag1+Jag2 combination has a weak effect. Control represents the activity of 
the Notch reporter in non-stimulated MEVEC. (q) qRT-PCR analysis of Hey1 expression in GFP-
MEVEC (black bars) or MFng-MEVEC (grey bars). Symbols: *, significant difference compared to 
Dll4; #, compared to Jag1. Data are represented as mean ± S.D. (n=4 biological replicates for each 
condition, *, # P<0.05, **, ## P<0.01, ***, ### P<0.001 by Student’s t test, n.s. not significant). 
Scale bar=100µm. 
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in the triple mutant ventricular endocardium but was attenuated in coronary vessels co-stained with 
isolectin B4 (Ib4). In addition, Ib4 immunostaining evidenced reduced calibre of the coronary 
endothelium. We then examined the expression of Dll4 (Fig. 25j-n), Hey1 (Fig. 25k-o), HeyL (Fig. 
25l-p) and EphrinB2  (Fig. 25m-q) in coronary arteries of Fng-deficient embryos. All of them 
showed reduced expression. We previously described reduced arterial marker expression in E15.5 
Dll4flox;Cdh5-CreERT mutant hearts (Fig. 11e-i; k-r). These data indicated that systemic Fng 
abrogation disrupts coronary vessel development, crucial for myocardium nourishment, thus 
indirectly affecting compaction. At later stages, MFng (Fig 24e-e’), as well as, the ligands Dll4 
(Fig. 11e-i), Jag1 (Fig. 13b-b’’) and Jag2 (Fig. 19c-d), are expressed in coronary vessels. The 
observation that the phenotype from Fng null embryos resembles those observed in Dll4flox;Cdh5-
CreERT mutants, strengthens the idea that Dll4 signals to Fng-modified-Notch in the developing 
coronaries.  
Forced MFng expression disrupts Jag1/Jag2-Notch interaction  
According to our in-vitro results, we speculated whether ectopic expression of MFng in the 
endocardium would prevent the activation of Notch1 by Jag1 and Jag2 at later stages of 
development, producing a chamber phenotype similar to that caused by inactivation of both ligands 
or Mib1 inactivation. To test this hypothesis, we used a new transgenic line (MFngtg) bearing a 
Rosa26-CAG-floxNeoSTOPflox-MFng-EGFP expression cassette (Fig. 26a). Tie2-Cre-mediated 
(Kisanuki et al., 2001) removal of the NeoSTOP sequences results in MFng-EGFP expression 
driven by the Rosa26-CAG promoter in vascular endothelium and endocardium. Two-photon 
imaging of fixed E9.5 MFngtg;Tie2-Cre embryos showed expression of the transgene in the 
endothelial cells forming the dorsal aorta and all over the endocardium (Fig. 26b). Despite the 
strong expression of the MFng-EGFP in the endocardium we did not observed any obvious 
phenotype at this stage. Interestingly, at E16.5 ectopic expression of MFng produced a dilated heart, 
with severe cardiac defects (Fig. 26c-d’). Histological analysis evidenced very prominent 
ventricular septal defects (Fig. 26b). In addition, we observed a reduction of 50-60% in the 
thickness of the compact myocardium comparing with WT embryos (Fig. 26g). Concomitant with a 
thinner compact myocardium, transgenic mice showed a significant increase in trabecular 
complexity, indicating defective compaction (Fig. 26g). 
The majority of transgenic mice did not survive beyond P5, and therefore we examined the 
phenotype in heart sections from newborn (P1) mice stained with endomucin to delineate the 
chamber endocardium and labeled with wheat-germ agglutinin to visualize cardiomyocytes (Fig. 
26e-f’’).  
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Figure 25. Systemic Fng abrogation impairs coronary vessel formation. 
H&E staining of E16.5 WT (a) and M;L;RFng-deficient hearts (b). WT ventricles have compacting 
trabeculae and a thick compact myocardium. The M-/-;L-/-;R-/- heart has a thin compact myocardium 
and trabeculae. (c) Chart showing morphological parameters of compact myocardium thickness and 
complexity of trabecular myocardium in WT and M-/-;L-/-;R-/- mutants. Data are mean ± S.D. (n=3 WT 
and 3 M-/-;L-/-;R-/ ***P < 0.001, n.s. not significant, determined by Student’s t test). ISH analysis of 
Hey2 (d,g) and Cx40 (e,h). Hey2 expression delineates a reduced compact myocardium in the M-/-;L-/-
;R-/- mutants, whereas Cx40 shows few and very thin trabeculae invading the lumen of the mutant 
ventricle (h). Note the reduced expression of Cx40 in the coronary endothelium of M-/-;L-/-;R-/- 
mutants (h). (f-i’) N1ICD immunostaining in E16.5 WT and M-/-;L-/-;R-/- mutant heart sections. The 
endocardium and the endothelium are counterstained with isolectin B4 (IB4, green). Coronaries 
appear of irregular size and poorly N1ICD-stained in the M-/-;L-/-;R-/- heart (i'). (f,i’) Nuclei are 
counterstained with DAPI (blue).  (j,q) ISH analysis of markers for coronary arteries. Dll4 (j,n), Hey1 
(k,o), HeyL (l,p) and EphrinB2 (m,q) expression is reduced in M-/-;L-/-;R-/- mice (arrowhead in j,k,l,m 
indicate the transcript localization in E16.5 WT). lv=left ventricle; rv=right ventricle; ivs= 
interventricular septum. Scale bar=100µm, except in (f’; i’) where bars =50µm. 
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P1 WT mice had a thick compact myocardium with some compacting trabeculae (Fig. 26e-e’’), 
whereas MFngtg;Tie2-Cre littermates had a thin compact myocardium and non-compacted 
trabeculae in both ventricles, with no effect on cardiomyocyte size (Fig. 26f-f’). 
The data from MFngtg;Tie2-Cre embryos and neonates were in agreement with the prediction 
that forced MFng expression in the endocardium would produce a chamber phenotype similar to 
those observed by inactivation of Jag1 and Jag2 or Mib1.  
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To confirm that Notch1 activity was attenuated due to impairment of Jag1-Jag2 signaling to 
Notch receptor, we assayed N1ICD immunostaining in E16.5 WT and MFngtg;Tie2-Cre (Fig. 26h-
i’). N1ICD expression was 40% below normal in the endocardium of both ventricles of transgenic 
animals (Fig. 26j). This data clearly indicate that ectopic expression of MFng impaired Notch 
activity in the endocardium presumably impeding Jag1;Jag2-Notch interactions. 
Considering previous results showing that Notch activity mediates cardiomyocyte proliferation 
in a non-cell-autonomous manner, we performed BrdU incorporation analysis in MFngtg;Tie2-Cre 
embryos. In both ventricles of E13.5 MFngtg;Tie2-Cre, cardiomyocytes of the compact zone 
proliferated less than in the WT (Fig. 27a-b’’; c). In trabecular myocardium, the number of dividing 
cardiomyocytes was similar to the WT (Fig. 27a-b’’; c). Low proliferation in the compact 
myocardium could explain the reduction in the thickness of this layer observed at E16.5 in 
transgenic animals, but not the increasing trabecular complexity. To better characterize the chamber 
phenotype of transgenic animals at the molecular level, we assayed the expression of compact 
myocardial marker Hey2 and trabecular markers Bmp10 and Cx40. Intriguingly, Hey2 expression 
delineated a thin compact myocardium and was expanded to but did not reach the tip of the 
trabeculae in E16.5 MFngtg;Tie2-Cre mice (Fig. 27d-g), while Bmp10 (Fig. 27e-h) and Cx40 (Fig. 
27f-i) expression were restricted to the distal tip of the trabeculae. Indeed, Hey2 and Bmp10 or Cx40 
expression in the trabeculae were complementary.  
Figure 26. Forced endocardial MFng expression disrupts chamber compaction.   
(a) Gene targeting strategy used to generate the conditional M-Fngtg line. Top, The transgene is 
inserted between exons 1 and 2 of the Rosa26 locus by homologous recombination. Middle, 
transgenic MFng and IRES-GFP expression is achieved under the control of the CAG promoter after 
Cre-mediated deletion of a NeoR-STOP cassette. (b) Whole-mount two-photon microscopy image of 
an E9.5 MFngtg/+;Tie2-Cre/+ embryo showing MFng-GFP expression in endocardium and vascular 
endothelium. Detail of the heart showing endocardial expression of the transgene. (c-d) H&E staining 
of E16.5 WT (c,c’) and MFngtg/tg;Tie2-Cre/+ (MFngtg;Tie2-Cre) ventricles (d,d’). WT hearts have a 
thick compact myocardium (c, yellow bar in c') and compacting trabeculae (c', arrow). In contrast, the 
MFngtg;Tie2-Cre heart has a very thin compact myocardium (d, yellow bar in d'), disorganized 
trabeculae (d', arrows) and a defective ventricular septum (d, asterisk). (e,f’’) Wheat-germ agglutinin 
(WGA) and endomucin staining at P1 reveal a thick myocardium with almost fully compacted 
trabeculae in WT hearts (e-e'', yellow bars) and a thin compact myocardium with relatively large 
trabeculae in MFngtg;Tie2-Cre hearts (f-f'', yellow bars). (g) Chart showing morphological parameters 
of compact myocardium thickness and complexity of trabecular myocardium in WT and MFngtg;Tie2-
Cre mutants. Data are mean ± S.D. (n=3 WT and 3 MFngtg;Tie2-Cre ***P < 0.001, n.s. not 
significant, determined by Student’s t test). (h-i') N1ICD and endomucin staining. General view of the 
E16.5 WT heart (h) and detail of the right ventricle showing N1ICD expression throughout the 
endocardium delineated by endomucin expression (h', yellow arrowheads) and in coronaries (h', 
white arrowhead). General view of the E16.5 MFngtg;Tie2-Cre heart (i) and detail of the right 
ventricle (i'), with markedly reduced N1ICD expression (i', yellow arrowheads). (j) Quantification of 
N1ICD-positive cells in the heart of E16.5 WT and transgenic embryos. Data are mean ± S.D. (3 WT 
and 3 MFngtg;Tie2-Cre, * P < 0.05, determined by Student’s t test). Scale bar=100µm 
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Figure 27. Ectopic endocardial MFng expression impairs cardiomyocyte proliferation and 
chamber maturation.  
(a-b’) BrdU (green) and SMA (red) immunostaining in E13.5 WT (a-a’’), and MFngtg;Tie2-Cre 
hearts (b-b’’). In the WT hearts BrdU is predominantly incorporated in right (rv, arrowheads in a’) 
and left ventricular (lv, arrowheads in a’’) compact myocardium; in the mutant hearts the total number 
of BrdU positive cardiomyocytes in the compact layer of both ventricles (arrowheads in b’ and b’’) is 
reduced compared to the WT. (a-b’’). Nuclei are counterstained with DAPI (blue).  (c) BrdU 
quantification. The total number of BrdU positive nuclei was divided by the total number of cells 
(DAPI) for each region of interest; compact zone and trabecular myocardium of left (lv) and right 
ventricle (rv). Data are mean ± S.D. (n=3 WT and 3 MFngtg;Tie2-Cre *P < 0.01, n.s. not significant, 
determined by Student’s t test). (d-i) ISH analysis at E16.5. Hey2 expression reveals a thick compact 
myocardium in the WT heart (d) and a very thin and disorganized counterpart in the MFngtg;Tie2-Cre 
heart (g). Bmp10 and Cx40 mark the trabeculae in WT (e,f) and MFngtg;Tie2-Cre ventricles (h,i). The 
yellow bar marks the compact myocardium (CM); the green bar marks the trabecular myocardium 
(TM) in (g-i) and the red bar in (g,i) marks the intermediate myocardium (IM). Scale bar=100µm 
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It appeared that in the ventricle of MFngtg;Tie2-Cre mice, compact myocardium cardiomyocytes 
(CM, Hey2+) entered into the trabeculae and formed an "intermediate myocardium" (IM, Hey2+, 
Bmp10– or Cx40-) that defined a boundary between compact myocardium and trabecular 
myocardium (TM, Hey2–, Bmp10+ or Cx40+). A similar albeit more subtle phenotype could be 
observed in Jag2flox;cTnT-Cre (Fig. 20g-k)   and Jag1flox;Jag2flox;cTnT-Cre hearts (Fig. 23d-h).  
All these results indicate that forced MFng expression in the endocardium prevents Notch1 
activation, presumably by inhibiting Jag1 and Jag2 signaling leading to severely altered ventricular 
development and LVNC.  
Comparative Jag1, Jag2, double Jag1;Jag2 and MFngtg cardiac gene profiling 
The exacerbated cardiac phenotype and the lower Notch activity levels during chamber 
compaction observed in Jag1;Jag2 double mutant embryos comparing with Jag1 or Jag2 single 
mutants suggested that both ligands had a mutual effect on endocardial Notch activity. To 
strengthen this hypothesis and to achieve a more global perspective of specific genes responsive to 
Jag1 and Jag2-Notch1 signaling, we carried out RNA-seq experiments with E15.5 WT, 
Jag2flox;cTnT-Cre and Jag1flox;Jag2flox;cTnT-Cre ventricles. In addition, taking into account the 
ventricular phenotype observed in the MFngtg;Tie2-Cre mice and to confirm the prediction that the 
ectopic expression of MFng would block Jag1 and Jag2 signaling to Notch, we included in the 
analysis this transgenic line. By RNA-seq analysis we identified 41 differentially expressed genes 
(31 up- and 10 down-regulated) in Jag2flox;cTnT-Cre mutants, 474 differentially expressed genes 
(320 up- and 154 down-regulated) in Jag1flox;Jag2flox;cTnT-Cre mutants and 1561 differentially 
expressed genes (979 up- and 582 down-regulated) in MFngtg;Tie2-Cre hearts (Fig. 28a 
supplementary table1). Comparison of expression profiles among single and double Jag1- and 
Jag2- mutants showed that Jag1flox;cTnT-Cre and Jag2flox;cTnT-Cre mutants shared only 7 
differentially expressed genes, while Jag1flox;cTnT-Cre and Jag1flox;Jag2flox;cTnT-Cre mutants 
shared 73 altered genes and the Jag2flox;cTnT-Cre and Jag1flox;Jag2flox;cTnT-Cre mutants shared 20 
(Fig. 28b supplementary table1). We then compared the expression profiles of 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice. We found 160 common genes between the 
two different genotypes (Fig. 28c supplementary table1). These data indicated that more than 30% 
of deregulated genes in the myocardial deficient Jag1;Jag2 embryos were shared with transgenic 
embryos overexpressing MFng in endothelial-endocardial cells.      
The heat map in Fig. 28d shows the 319 genes that were differentially expressed in at least two 
of the five mutant genotypes. Interestingly, while Jag2 inactivation affected the expression of a 
small set of genes (41) compared to Jag1 (97), in the double Jag1flox;Jag2flox;cTnT-Cre mutant the 
number of deregulated genes increased decisively (474) from single mutants, indicating that both 
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Notch ligands participate in a non-redundant manner in chamber development, and thus their 
simultaneous inactivation has a synergistic effect in gene deregulation (Fig. 28d). MFngtg;Tie2-Cre 
mice presented the largest number of deregulated genes, probably because of the early onset and 
strength of Tie2-Cre (Kisanuki et al., 2001) driving the expression of two extra copies of MFng 
cDNA in the endocardium, as well as, in the whole endothelium. The majority of the genes in 
common with the Jag1flox;Jag2flox;cTnT-Cre mutants changed in the same manner (up- or down-
regulated; Fig. 28d supplementary table1), suggesting that MFng overexpression in the 
endocardium indeed blocks Jag1 and Jag2 signaling to the Notch1 receptor.  
GO analysis identified several relevant functional categories among the deregulated genes (Fig. 
28d supplementary table1). Genes involved in angiogenesis and vascular development (Hey2, 
Angpt1, Cx40/Gja5, Ctgf, Tgfβ1, Shank3, Hif1a and Cxcl12) were affected in at least two 
genotypes. Hey2 is a Notch target in the endocardium (Luna-Zurita et al., 2010) and the vasculature 
(Fischer, Schumacher et al., 2004) and accordingly, its expression was down-regulated in 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice (Fig. 28d). Within this category, some of the 
deregulated genes were involved in coronary artery development (Cxcl12	  (Ivins et al., 2015), Hey2 
(Watanabe, Koibuchi et al., 2010)) and their down-regulated expression suggested that this process 
is impaired in MFngtg;Tie2-Cre and, to a lesser extend, in Jag1flox;Jag2flox;cTnT-Cre mice. Genes 
involved in cardiac fibrosis (Ctgf and Tgfβ1; (Leask, 2015)) were up-regulated in 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice (Fig. 28d). A gene specifically up-regulated in 
Jag2flox;cTnT-Cre mice (and also in Jag1flox;Jag2flox;cTnT-Cre) was Shank3, encoding a scaffolding 
protein present in the sarcolemma of cardiomyocytes (Grubb, Luo et al., 2015). A second GO 
category included cell cycle and proliferation genes, in which negative regulators of cell cycle 
(Cdkn1a/p21, Plk2, Rps6ka2 and Romo1) were up-regulated in the majority of the genotypes (Fig. 
28d supplementary table1). These results were consistent with the reduced cardiomyocyte 
proliferation observed in Jag1- and Jag2- mutants. Romo1 transcription was specifically up-
regulated in the heart of Jag2flox;cTnT-Cre mice, while Cdkn1c/p57 up-regulation was detected only 
in Jag1flox;Jag2flox;cTnT-Cre mice. One exception was the positive cell cycle regulator 
Ccnd2/CyclinD2 whose expression was up-regulated in Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-
Cre mice (Fig. 28d). A set of cell death-related genes was deregulated in Jag2flox;cTnT-Cre, 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice, including down-regulation of the apoptosis 
inhibitors Spp1, Bcl6, Prnd, and Bcl2l11 and up-regulation of the pro-apoptotic gene Cish (Fig. 
28d), suggesting that cardiac cell homeostasis was altered in these mice. GO also predicted that a 
large set of genes involved in cellular motion, axonal guidance and migration was specifically 
deregulated in Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice, including Epha2, Sema3b, 
Sema5a, Efnb3, Lpar3, Ntn4, Epha3, Cxcl16 and Slit2 (Fig. 28d). In the case of Semaphorins, 
recent research has identified their key functions in cardiac morphogenesis and vascular patterning 
(Epstein, Aghajanian et al., 2015).  
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In particular, Sema6d modulates compact layer expansion and trabeculation in the chicken 
(Toyofuku, Zhang et al., 2004). Of note, one down-regulated gene, Efnb3, has been associated with 
the cardiac hypertrophic response in the adult heart (Dirkx, Gladka et al., 2013). 
Genes related with dilated-, hyperthrophic- and arrhythmogenic right ventricular 
cardiomyopathy (DCM, HCM and ARVC) such as Cacna2d2, Itgav, Lmna, Adcv5, Itga9 and TnC, 
were also deregulated in Jag1flox;cTnT-Cre, Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mice 
(Fig. 28d supplementary table1). Genes required for heart morphogenesis (Nkx2.5, Adamts1, 
Smad7, Gaa and Eng) were specifically up-regulated in Jag1flox;Jag2flox;cTnT-Cre mutants, while 
Bmp10 and ErbB4 expression changed in opposite directions in MFngtg;Tie2-Cre (Fig. 28d). 
Transcription of the Jag1 and Jag2 ligands was down-regulated and MFng expression was up-
regulated in the corresponding mutant genotypes confirming the reliability of the global gene 
expression analysis (Fig. 28d). Lastly, a set of genes encoding voltage-dependent potassium and 
calcium channels (Kcnd3,	   Kcne1,	   Kcnd2,	   Cacna1g), ion transporters (Slco3a1) or ion-dependent 
regulatory proteins (Camk2a,	  Atp5k, Adora2a, Bhlhe40) were deregulated in Jag1flox;Jag2flox;cTnT-
Cre and MFngtg;Tie2-Cre (Fig. 28d).  
The comparative gene expression profiling analysis highlights that the specificity of Notch 
signaling is determined by its ligands. Jag1 and Jag2 single mutants shared only few deregulated 
genes. These data indicate that depending on the interacting ligand, Notch signaling controls the 
expression of a subset of target genes. Moreover, during compaction, the combination of both 
ligands is required to triggers higher levels of Notch activity, thereby activating more target genes 
required for the progression of chamber maturation and compaction.  
Figure 28. Comparative expression profiling of Jag2flox;cTnT-Cre, Jag1flox;cTnT-Cre, 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre mutants.  (a) Chart indicating the total number of 
genes significantly (P<0.05) up- or down-regulated in E15.5 Jag2flox;cTnT-Cre mutants (J2), 
Jag1flox;Jag2flox;cTnT-Cre mutants (J1J2) and MFngtg;Tie2-Cre transgenic embryos (MFngtg). The 
total number of differentially expressed genes per genotype is indicated at the top of every column. 
Numbers in the yellow section indicate up-regulated genes; numbers in the blue section indicate 
down-regulated genes. (b) Venn diagram representation of the comparative analysis of the 
dysregulated genes in the four genotypes analyzed (Jag1flox;cTnT-Cre, Jag2flox;cTnT-Cre, 
Jag1flox;Jag2flox;cTnT-Cre and MFngtg;Tie2-Cre). Top, comparison of J1-, J2-single and J1;J2;cTnT-
Cre double mutants. Bottom, comparison of J1;J2;cTnT-Cre and MFngtg;Tie2-Cre embryos. Numbers 
in black indicate the total number of genes common to all pair-wise genotype combinations. (c) Heat 
map representation of the 372 genes differentially expressed in at least two of the four mutant 
genotypes. Yellow colour, up-regulated; blue, down-regulated; black, not signficant change. (d) 
Subsets of genes clustered into functional classes (right panels). 
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The role of the Notch signaling pathway in human development and disease has been recognized 
since 1991, when mutations in NOTCH1 were associated with a form of T-cell acute lymphoblastic 
leukemia (T-ALL) (Ellisen et al., 1991). Mutations in NOTCH1 lead to an active protein isoform 
lacking the C-terminal domain, and have been identified in over 50% of T-ALL cases (Braggio, 
Egan et al., 2013). In the majority of leukemias, as well as in other solid tumors, the intracellular 
domain of Notch1 (N1ICD) is constitutively activated and functions as an oncogene.  
In the same decade, JAG1 mutations were identified in the Alagille syndrome (ALGS) (Li, 
Krantz et al., 1997). It is a dominant, multisystem disorder caused by mutations in the Jagged1 
ligand in 94% of patients and in the NOTCH2 receptor in <1% of cases. A high percentage of 
patients with JAG1 or NOTCH2 mutations have cardiac disease, which includes (in order of 
frequency) branch pulmonary artery stenosis, peripheral pulmonary stenosis, TOF, pulmonary 
artery stenosis, VSD, ASD, coarctation of the aorta and several less common right and left sided 
lesions (Penton, Leonard et al., 2012). Double heterozygous mice for Notch signaling 
(Jag1/+;Notch2/+) have multisystem defects that strongly resemble those seen in patients with 
ALGS, including pulmonary artery stenosis and ventricular septal defects (McCright, Lozier et al., 
2002). More recently, NOTCH1 mutations were described in patients with calcific aortic valve 
disease, usually in the context of a bicuspid aortic valve (BAV) (Garg et al., 2005). Specific 
mutations of NOTCH1 that reduce ligand (JAG1)-induced NOTCH1 signaling were also found 
across the spectrum of left ventricular outflow tract (LVOT) malformations (McBride, Riley et al., 
2008). In contrast to solid or hematological tumors, where Notch1 mutations usually lead to an 
over-activation of the pathway (Puente, Pinyol et al., 2011), in the case of other human syndromes 
as well as in congenital heart defects, mutations in Notch elements induce a downregulation of the 
pathway. In agreement with this, more recently, missense mutations of MIB1 that promote 
endocytosis of Notch ligands were linked to LVNC, a cardiomyopathy characterized by prominent 
ventricular trabeculations and reduced cardiac systolic function (Luxan et al., 2013). In mice, 
conditional deletion of myocardial Mib1 induces LVNC as a consequence of reduced endocardial 
Notch1 activity during chamber compaction and maturation (Luxan et al., 2013). In contrast, in 
RBJk or Notch1 null embryos, abrogation of Notch1 signaling in the endocardium impairs EMT in 
the AVC (Timmerman et al., 2004) and trabeculation in the forming chambers (Grego-Bessa et al., 
2007), causing early embryonic lethality. The differences between the phenotypes observed in 
mutant ventricles during mid-gestation and during compaction highlight the pivotal role of Notch 
signaling during early and late stages of chamber development.  
Here we show that endocardial Notch1 is sequentially activated by its ligands Dll4, Jag1 and 
Jag2. The spatial and temporal distribution of Notch ligands defines the specificity of the ligand-
receptor interaction whereas the response of Notch1 to its ligands is modulated by the glycosyl 
transferase Manic Fringe.  
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Dll4 and MFng show overlapping expression patterns during chamber development 
Immunostaining of Notch ligands, Dll4 and Jag1, in E9.5 heart sections of the CBF1:H2B-Venus 
reporter line (Nowotschin et al., 2013) allowed us to detect the ligand expression in relation to the 
activity of Notch. Endocardial cells expressing Dll4 were in contact with neighboring Notch 
activated cells, detected by GFP. The ligand and activated receptor were expressed at the base of the 
forming trabeculae. Contrary to the endocardial expression of Dll4, Jag1 was strongly expressed in 
the trabecular myocardium in the proximity of Notch activated cells. Since the two ligands coexist 
in the developing chambers, they could either both trigger Notch activity during trabeculation or 
they could compete each other, as has been shown in retinal angiogenesis (Benedito et al., 2009). 
Specifically, Benedito and co-workers, using in vivo and in vitro approach, demonstrated that Dll4 
and Jag1 ligands have an opposite effect on Notch activity during angiogenesis. In particular, Dll4 
was shown to be a potent Notch activator, whereas Jag1 acts as an antagonist of Dll4-Notch 
signaling. Distinct biological roles for the Delta-like/Delta and Jagged/Serrate ligands have been 
demonstrated in a variety of tissues and processes, such as during inner ear development (Brooker, 
Hozumi et al., 2006, Petrovic et al., 2014) and hematopoiesis (Van de Walle et al., 2011). A 
possible mechanism that could explain how a ligand can prevent Notch signaling is considering that 
ligand–receptor interactions can also take place within the same cell. These cis-interactions reduce 
the ability of the cell to receive signals from neighboring cells by a process called ‘cis-inhibition’ of 
the receptor by the ligand (del Alamo et al., 2011). During trabeculation, immunostaining of Notch 
ligands in the CBF1:H2B-Venus reporter line show that ligands and Notch1 receptors are not co-
expressed suggesting that cis-inhibitory effect on Notch signaling could be excluded. Another 
mechanism that controls the strength of ligand-receptor interaction is the so-called "fringe effect". 
The Fringe proteins are glycosyltransferases that modulate Notch signaling by direct modification 
of O-linked fucose residues within the EGF repeats of the Notch extracellular domain (Moloney, 
Panin et al., 2000). Specifically, fringe modification of Notch potentiates signaling by Delta-like 
ligands and this could function to stimulate Notch activity when the ligand is limiting. In contrast, 
Serrate-like ligands are unable to activate fringe-modified Notch. The molecular basis of these 
differences appears to be at the level of ligand binding, such that fringe modification increases 
binding of Delta-like to Notch, whereas Serrate/Jagged binding is perturbed (D'Souza, Miyamoto et 
al., 2008).  
 During cardiac looping, the only glycosyltransferase transcribed in the endocardium is MFng. 
Its expression persists during trabeculation but, as development proceeds, MFng expression 
declines in endocardial cells. At later stage of cardiac development, it is transcribed in the 
endothelium of coronary vessels but not in endocardial cells. The expression pattern of Mfng is 
reminiscent of that of Dll4, whose expression is down-regulated after E12.5 in the endocardium and 
is restricted to the endothelium of coronary arteries during compaction. These results show a 
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relationship between Dll4 and MFng, suggesting that Dll4 could engage a Fringe-modified Notch 
receptor to trigger proper Notch activity in the endocardium during trabeculation and in the 
coronary arteries during chamber compaction.  
 Dll4 is a “superactivator” of Fringe-modified Notch receptor 
The in vitro stimulation experiments performed on MEVEC allowed us to evaluate the 
differential ligand-dependent Notch signaling response. These cells were biologically relevant 
because of their embryonic endocardial origin, the tissue where Notch is active in the mouse heart. 
In addition, MEVEC proved to be an excellent tool to perform experiments like the ligand 
stimulation assay. In the absence of any stimuli they show basal Notch activity, measured by qRT-
PCR of Notch target genes, even when cells are in contact with each other. The basal Notch activity 
in un-stimulated MEVEC is consistent with low expression of Notch ligands. In this context, upon 
exogenous ligand stimulation, we can turn on Notch signaling with a mechanism of transactivation. 
In our system, recombinant Dll4 and Jag1 activate Notch to a similar level while Jag2 has a 
weaker effect. Interestingly, pairwise combinations of these ligands show an additive effect on 
Notch activation. Overexpression of MFng, mediated by lentiviral infection, decisively enhances 
Dll4-Notch signaling. This result is in agreement with those shown in HUVEC (Benedito et al., 
2009). In the presence of MFng, Jag1 and Jag2 activate Notch quite poorly. In addition, they do not 
affect the response to Dll4 in pairwise combinations, suggesting that the Jag ligands do not have 
inhibitory effects on Notch activity, contrary to the effect of Jag1 observed in HUVEC (Benedito et 
al., 2009). In our setting, the transactivation of Notch mediated by recombinant ligands suggests 
that Dll4 behaves as a  “superactivator” of the Fringe-modified Notch receptor. In presence of the 
same concentration of ligands glycosylated Notch is very strongly activated by Dll4 but not Jag1 or 
Jag2 and pairwise ligand combinations (Dll4+Jag1 or Dll4+Jag2) do not show an inhibitory effect 
of the Jag ligands on Notch signaling. This could perhaps be achieved if Jag1 or Jag2 were in 
excess in relation to Dll4.  
These in vitro experiments, along with the observed endocardial-endothelial expression of Mfng 
and Dll4, indicate that the ligand-dependent Notch signaling response can be modulated by the 
glycosyltransferase MFng. Therefore, glycosylated Notch1 receptor would interact preferentially 
with Dll4 at the expense of Jag1, in the endocardium and in coronary endothelium during chamber 
development. 
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Manic Fringe favors Dll4-Notch interaction during trabeculation 
Conditional deletion of Dll4 with Tie2-cre or Nfat-Cre impaired heart development. EMT was 
abrogated and trabeculation was dramatically affected in both mutants. The cardiac defects 
observed in Dll4 mutants were reminiscent of those observed in the Notch1flox;Nfat-Cre, indicating 
that Dll4 interacts with Notch1 in the endocardium and consequently triggers its nuclear 
translocation. Indeed, in the Dll4flox;Tie2-Cre as well as in the Dll4flox;Nfatc-Cre the expression of 
N1ICD was strongly down-regulated. In agreement with reduced Notch activity during 
trabeculation, the expression of endocardial Notch target genes, Hey2 and EphrinB2, was markedly 
decreased in Dll4 mutants. All these data indicate that Dll4-Notch1 signaling is crucial for 
trabeculation in the developing chambers. In contrast, myocardial deletion of Jag1 did not affect this 
process. The heart of E10.5 Jag1flox;cTnT-Cre mutant embryos appeared normal. The thickness of 
the compact myocardium was similar to controls as well as the expression of Hey2 in this region. 
The trabeculae were well developed as indicated by the expression of the trabecular marker Bmp10. 
Despite the complete deletion of Jag1, we did not observe differences of N1ICD expression in 
Jag1flox;cTnT-Cre mutant embryos. These results indicate that myocardial Jag1 is dispensable for 
endocardial Notch activity and does not have an inhibitory effect on Notch signaling during 
trabeculation, contrary to what has been shown during angiogenesis (Benedito et al., 2009).  
The reduction of Notch activity observed in Dll4-deficient embryos, the endocardial expression 
of MFng and the in vitro experiments in MEVEC confirmed that the response of Notch1 to its 
ligands during trabeculation is modulated by the glycosyl transferase MFng. In this context, early 
MFng expression favors endocardial Dll4-Notch1 signaling at the base of the developing ventricle 
and prevents Notch1 activation by myocardial Jag1.  
Endocardial Dll4-Notch1 signaling orchestrates growth and differentiation of trabecular 
myocardium.  
The obligatory role of the endocardium in orchestrating proliferation and differentiation of the 
trabecular myocardium has been extensively demonstrated by using systemic or conditional 
deletion of endocardial genes, such as Nrg1 (Lee et al., 1995, Meyer & Birchmeier, 1995). To 
decipher the signals connecting endocardium to myocardium during trabeculation depending on 
Dll4-induced Notch activity, we performed comparative global gene expression analysis in hearts of 
endocardial-specific Dll4 or Notch1 mutants. 
In the RNA-seq data obtained from these mutants we identified a common set of genes involved 
in cardiovascular system development and function, intercellular signaling, cellular proliferation 
and cardiovascular disease. Among them, Gpr126 was of particular interest for us. Recently, Patra 
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and co-workers demonstrated that inactivation of the G protein-coupled receptor Gpr126 in mice 
was crucial for chamber development (Patra et al., 2013). Gpr126 null embryos show 
hypotrabeculation and a marked thinning of the ventricular wall, a phenotype reminiscent of those 
observed in endocardial Dll4 or Notch1 mutant embryos. We showed that Gpr126 expression is 
dependent on Notch signaling in mouse, zebrafish and mammalian endothelial cells. In addition, 
computational analysis identified RBPJ/CBF1 binding sites within an intronic region of Gpr126. A 
Gpr126 luciferase reporter with this intronic region was transiently activated upon transfection of 
the vector expressing N1ICD in a dose-dependent manner. All these data indicate that Notch1 
activity enhances the expression of Gpr126. To demonstrate physical binding of the N1ICD/RBPJ 
complex on the Grp126 intronic locus, chromatin immunoprecipitation would have to be 
performed. In the report from Patra and co-workers it was shown that a functional N-terminal 
fragment of Gpr126 (Gpr126-NTF) is able to rescue the trabeculation phenotype in gpr126 
zebrafish morphants, suggesting that the NTF can function as a secreted protein able to signal in a 
paracrine manner to nearby trabecular cardiomyocytes (Patra et al., 2013). We propose that in 
response to Notch activity, Gpr126 might influence the proliferation and differentiation of 
neighboring cardiomyocytes within the developing chamber in a similar manner. Concomitantly, 
cardiomyocyte proliferation is also affected in endocardial Dll4 and Notch1 mutants. The 
mechanism of how Gpr126 functions as a secreted ligand and which myocardial receptors could be 
involved in Gpr126-NTF binding remain to be elucidated. However, it seems clear that Gpr126 
from the endocardium plays an essential role for the initiation of trabeculation. For further 
deciphering its role during heart development a Gpr126flox line would have to be generated in order 
to delete the gene only the endocardium. In addition, it would be very interesting to rescue, at least 
in part, the trabecular phenotype of Dll4 or Notch1 mutant embryos by overexpressing Gpr126 
specifically in endocardial cells of these mutants.  
Furthermore, our RNA-seq data showed increased expression of various negative regulators of 
the cell cycle, suggesting that Notch signaling plays a more general role in the regulation of 
cardiomyocyte proliferation. Proliferation and differentiation of embryonic cardiomyocytes are 
intimately connected (Hertig, Kubalak et al., 1999) and our data strongly suggest that Fringe-
modified Notch1 activated by Dll4 in the endocardium regulates both processes in the developing 
chamber (Fig 29a). 
Dll4 engages and activates Fringe-modified Notch receptor during coronary vessel 
development 
In the ventricles of mouse embryos between E9.5 and E13.5, trabeculae and compact 
myocardium increase in size. Exuberant cell proliferation can be observed in both layers of the 
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developing chamber. Later, cardiomyocytes from the compact zone undergo extensive cell division, 
whereas trabecular myocardium proliferates less (de Boer et al., 2012). The differences in cell 
proliferation between these two layers could explain how the trabecular myocardium undergoes 
“compaction” and coalesces with the compact myocardium (Tian et al., 2013).  
The rapid expansion in cardiac size (E11.5-E13.5) coincides with the formation of the coronary 
vascular system (Ivins et al., 2015). Despite the fact that the origin of coronary vessels is still a 
matter of debate, its function in the heart is very well understood. Myocardial growth requires 
enhanced oxygen delivery and triggers an influx of endothelial cells that undergo vasculogenesis to 
form a capillary plexus (Mikawa & Fischman, 1992). After birth, proper coronary blood circulation 
is required to support heart homeostasis, and altered coronary function frequently leads to 
myocardial ischemia, infarction and heart failure (Ruiz-Villalba & Perez-Pomares, 2012). Previous 
works have demonstrated that Notch signaling from the epicardium, a tissue that contributes highly 
to coronary vessel morphogenesis is indispensable	   for coronary artery development (Del Monte et 
al., 2011, Grieskamp, Rudat et al., 2011). Epicardium-specific ablation of Notch1 or Rbpj using 
Wt1-Cre or Tbx18-Cre driver lines impaired coronary artery formation (Del Monte et al., 2011) and 
smooth muscle cell differentiation of epicardial-derived cells (EPDCs) (Grieskamp et al., 2011). 
Defects in this process directly affect myocardial wall thickness and myocyte proliferation (Del 
Monte et al., 2011). However, in these reports the role of ligand-specific induction of Notch activity 
during coronary vessel formation was not addressed. In agreement with previous reports (Del 
Monte et al., 2011, Grieskamp et al., 2011) we found widespread expression of ligands (Dll4, Jag1 
and Jag2) as well as N1ICD in the developing coronary arteries. In addition, we detected expression 
of MFng in this tissue. Interestingly, MFng mirrors the expression of Dll4. Since the formation of 
the linear heart tube both Dll4 and MFng are expressed in the endocardium. Once trabeculation 
ends, the two transcripts are down-regulated in the endocardium and start to be expressed in 
coronary endothelial cells. These data indicate that after trabeculation, Dll4 is not the ligand-
inducing Notch signaling in the endocardium. Similarly to our observations on trabeculation, it 
seems likely that during coronary vessel formation MFng enhances the interaction between Dll4 
and Notch1. To examine this hypothesis and avoid the early embryonic lethality of conditional Dll4 
mutant embryos we used the tamoxifen-inducible Cdh5-CreERT driver line, which is active in the 
endocardium, vascular endothelium and coronary vessels (Luna-Zurita et al., 2010, Wang et al., 
2010). E15.5 Dll4flox;Cdh5-CreERT mutant embryos show downregulated expression of Notch target 
genes, such as Hey1, HeyL and EphrinB2, in the coronary vessels as a consequence of reduced 
Notch activity in this tissue. Consistent with the endocardial down-regulation of Dll4 and Mfng 
expression at this stage, we did not observe differences in Notch1 activity in the endocardium, 
confirming that Dll4 is not activating Notch1 during chamber compaction. In addition, in the Dll4 
mutants, Hey2 expression was not expanded to the trabeculae but delineated a thin compact layer of 
myocardium, a phenotype reminiscent of those observed in the epicardial deficient Notch1 mutants. 
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These data identify Dll4 as the ligand required to trigger Notch activity in the endothelium of 
coronary vessels. Consistent with the expression of MFng during late mid-gestation, systemic Fng 
abrogation disrupts coronary vessel development. The down-regulated expression of coronary 
endothelial markers as well as the reduced N1ICD expression cause a phenotype very similar to 
those observed in Dll4flox;Cdh5-CreERT mutant embryos. All these data indicate that Dll4 signals to 
glycosylated Notch1 receptor in the endothelium of coronary arteries (Fig. 29b). Therefore, it 
becomes clear that the MFng-Dll4 relationship not only exists in the endocardium during 
trabeculation, but also in the endothelium of the forming coronary arteries. This scenario resembles 
the situation described in retinal angiogenesis (Benedito et al., 2009) in which Delta-like/Delta and 
Jagged/Serrate ligands are co-expressed. To clarify the role of Jag1 and Jag2 during coronary vessel 
formation, we need to specifically delete the two ligands in endothelial cells. This would allow us to 
decipher whether Jag1 and Jag2 compete with Dll4 to activate the Notch1 receptor or whether 
Jagged ligands are dispensable for triggering Notch1 activity during coronary vessel formation. 
Myocardial Jag1 activates Notch1 during chamber compaction and maturation  
Recently, we showed that myocardial inactivation of the ubiquitin ligase Mib1 causes LVNC in 
mice and that heterozygous germ-line mutations of the human counterpart cause the human disease 
(Luxan et al., 2013).  Myocardium-specific Mib1 mutants showed reduced Notch1 activity in the 
endocardium during chamber compaction. In addition, compact zone markers (Hey2; Tbx20) 
expanded to the trabeculae, suggesting that trabecular maturation and patterning were arrested. 
These data indicate that abrogation of endocardial Notch activity via deletion of myocardial Mib1 
caused LVNC, furthermore demonstrating LVNC as a cardiomyopathy with developmental basis 
(Luxan et al., 2013). The role of Mib1 for generating functional ligands to activate Notch signaling 
has been well established (Koo, Lim et al., 2005). Null Mib1 mice die prior to E11.5, with pan-
Notch defects in somitogenesis, neurogenesis, vasculogenesis and cardiac development (Koo et al., 
2005). In addition, conditional inactivation of Mib1 in various tissues revealed representative Notch 
phenotypes: defects of arterial specification as Dll4 mutants, abnormal cerebellum and skin 
development as Jag1 conditional mutants, and syndactylism as Jag2 mutants	  (Koo et al., 2007).	  	  At 
later stages of cardiac development, Jag1 is strongly expressed in the already formed trabeculae and 
MFng is down-regulated in the endocardium. In this scenario, unglycosylated Notch1 in endocardial 
cells surrounding the myocardium would be activated by myocardial Jag1.  Considering all these 
data in addition to the known role of Mib1, we speculated that the myocardial deletion of Jag1 
should resemble the inactivation of Mib1 in the myocardium, producing a LVNC phenotype.  
Inactivation of Jag1 in the embryonic myocardium results in mice with a dilated heart and a thin 
compact myocardium (Fig. 29c). The echocardiographic and CMRI data confirm this phenotype 
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showing below-normal ejection fraction, reduced myocardial mass and thinner free wall of the right 
ventricle compared to WT counterparts. The RNA-seq analysis of Jag1flox;cTnT-Cre mutants 
reveals dysregulated expression of genes involved in cardiovascular system development and 
function, cardiovascular disease, cell-to-cell signaling and cellular growth and proliferation. From 
this analysis we observed that a set of genes changes in the same direction (up or down) as in 
endocardial-Dll4 or Notch1 mutants. This was the case for the negative regulator of cell cycle 
cdkn1b/p21. In agreement with this result, Jag1 mutants show reduced myocardial proliferation 
with concomitant increased p21 expression in compact zone cardiomyocytes. In addition, 
expression of Gpr126 is impaired in Jag1 mutant embryos similarly to Dll4 mutants. This result 
could suggest that Gpr126, from the endocardium, mediates the initial trabecular growth and at later 
stages sustains cardiomyocyte proliferation in the compact layer. The RNA-seq analysis reveals that 
Dll4- and Jag1-Notch signaling in the developing ventricles is required for the normal expression of 
a set of genes involved in the communication between endocardium and myocardium. These signals 
are crucial for the regulation of cardiomyocyte differentiation and proliferation during trabeculation 
(Fringe-modified Notch1 interacting with endocardial Dll4, Fig. 29a) and for later trabecular 
maturation and compaction (Fringe-unmodified Notch1 interacting with myocardial Jag1, Fig 
29b;c).  
Jag2 is the second ligand responsible for Notch1 activity during chamber compaction and 
maturation 
The initial prediction that the cardiac phenotypes of Mib1flox;cTnT-Cre and Jag1flox;cTnT-Cre 
mutants would be similar, based on the assumption that Jag1 was the only ligand expressed in the 
myocardium, was assessed. In fact, the heart phenotype of Jag1 mutant embryos was less severe 
and only partially phenocopied Mib1 mutants. For instance, Mib1flox;cTnT-Cre mutant mice develop 
LVNC cardiomyopathy (Luxan et al., 2013), while Jag1flox;cTnT-Cre mutants show structural and 
functional signs of dilated cardiomyopathy with systolic dysfunction (Fig. 29c). 
The finding that myocardial expression of Jag2 increases from E12.5 to E14.5, mirroring the 
expression of Jag1, suggested that Jag2 could be an important Notch1 activator in the myocardium 
and a second substrate for Mib1. Indeed, myocardial inactivation of Jag2 gave rise to defects in 
chamber maturation as a consequence of reduced endocardial Notch1 activity, similarly to those 
observed in Jag1flox;cTnT-Cre mutants. The resulting cardiac phenotype observed in Jag2flox;cTnT-
Cre mutants suggests that both Jag1 and Jag2 activate Notch1 in a non-redundant manner. These 
findings raise further questions, for instance why the expression of Jag2 appears relatively late in 
chamber myocardium development or why a second ligand is required for proper Notch activation 
during compaction.  
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The ligands Jag1-Jag2 trigger endocardial Notch activity during chamber compaction and 
maturation and are both substrates of Mib1 
An intriguing possibility is to consider the Notch receptor as a homodimer. In this context two 
extracellular domains (2NECD) could directly interact with two ligands. The binding regions of the 
ligands and the receptor have been characterized by X-ray crystallography and nuclear magnetic 
resonance (NMR) (Chillakuri et al., 2013, Cordle et al., 2008a). These data have allowed us to 
clearly define the molecular mechanisms that govern the ligand-receptor interaction. Unfortunately, 
due to technical limitations, it is impossible to define the whole ligand-receptor interacting 
complex. Recently, using scanning transmission electron microscopy (STEM), it has been shown 
that the extracellular domain of human and Drosophila Notch1 forms a dimer and adopts distinct 
conformations (Kelly, Lake et al., 2010).  
In agreement with published results (Blacklow, 2013, Chillakuri et al., 2012, Hambleton et al., 
2004), we generated in silico models of the interaction between the ligands Dll4, Jag1 and Jag2 and 
the extracellular domain of the Notch1 homodimer. The biologically active Notch1 dimer binds 
Dll4 in a 1:1 stoichiometry (Narui & Salaita, 2013) and we assumed that this stoichiometry would 
be the same for all Notch ligands. The 2Dll4:2N1ECD complex is the most stable. Remarkably, the 
Jag1/Jag2:2N1ECD complex is more stable than the 2Jag1:2N1ECD complex. Our molecular 
docking suggests that when both ligands are expressed in the ventricle at similar levels (E12.5-
E14.5) formation of the Jag1/Jag2:2N1ECD complex would be favored. In agreement to this 
hypothesis, the cardiac defects as well as the reduction of N1ICD in the double Jag1;Jag2 
myocardial mutants are exacerbated compared to single Jag1 or Jag2 mutants and the resulting 
phenotype resembles the one observed in Mib1flox;cTnT-Cre mutant embryos. These data indicate 
that Jag1 and Jag2 are both required for proper chamber compaction and maturation and both are 
substrates of Mib1 in the myocardium. Comparative global gene expression analysis performed in 
E15.5 WT, Jag1flox;cTnT-Cre, Jag2flox;cTnT-Cre and Jag1flox; Jag2flox;cTnT-Cre ventricles revealed 
that the number of deregulated genes increased decisively when both ligands were deleted in the 
myocardium. Interestingly, we noted that Jag1 or Jag2-induced Notch activity differentially control 
the expression of a subset of genes. The specificity in terms of gene expression could reside in the 
differential ligand-dependent Notch signaling strength. The differentially expressed genes in each 
single mutant change in the same direction as in the double Jag1;Jag2 mutants. These results 
reinforce the conclusion that Jag1 and Jag2 have non-redundant functions and both are necessary 
for properly triggering Notch activity, thereby activating more target genes required for the 
progression of chamber maturation and compaction. During T-cell maturation and leukemic 
transformation, it has been shown that a dimeric form of NICD exists and is required for the 
expression of Notch target genes, such as c-Myc and pre-T-cell antigen receptor α (Ptcra), whereas 
in the case of targets like Hey1 or CD25 such a dimeric Notch transcriptional complex is not formed 
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(Liu, Chi et al., 2010). These findings identify functionally important differences in the 
responsiveness among Notch target genes attributable to the formation of higher-order complexes 
(Liu et al., 2010). In our case, we could speculate that in endocardial cells Notch1 receptors can 
coexist and adopt a monomeric or a dimeric form. In this scenario, myocardial Jag1 and Jag2 
engage the different forms of the receptor. The final amount of transcriptionally activated Notch 
receptor (N1ICD) will be defined by the different ligand-receptor interacting complexes that may be 
formed, assuming Notch will be present either as a monomer or as a dimer. It would be very 
interesting to provide in vivo evidence on the mechanism of ligand-receptor forming complex. This 
would be possible by taking advantage of the Bimolecular Fluorescent Complementation (BIFC) 
technology. This is a powerful tool to validate protein-protein interactions. Two separated 
fragments, C and N-terminus, of a fluorescent protein (i.e. half-GFP) can form a fluorescent 
complex (GFP) when they are fused to two proteins that interact with each other (Kerppola, 2006). 
Ideally, we could generate a Notch1 receptor carrying half-N-GFP and a Notch1 receptor carrying 
half-C-GFP. This experiment would allow us to understand whether two receptors interact with 
each other and form a homodimer. In addition, measuring GFP signal intensity, we can confirm 
whether the Jag1/Jag2:2N1ECD complex would be favored, reinforcing the hypothesis that Jag1 
and Jag2 during compaction (E12.5-E14.5) interact with a homodimer of  Notch1. 
The expression of Manic Fringe defines the specificity of ligand-receptor interaction during 
chamber development 
The down-regulation of Mfng in the endocardium would allow Jag1 and Jag2 to trigger Notch1 
activity in the endocardium during chamber compaction (Fig. 29b); a proposal consistent with 
results obtained overexpressing Mfng throughout the endocardium. Similar to the myocardial 
inactivation of Jag1;Jag2 or Mib1, the ectopic expression of MFng causes a very severe chamber 
phenotype, reminiscent of LVNC (Fig. 29c). The phenotype observed in the Mfgtg;Tie2-Cre is 
caused by a down-regulation of Notch1 activity in the endocardium. As we have previously shown, 
during compaction N1ICD expression is crucial to sustain cardiomyocyte proliferation in the 
compact myocardium. In the Mfgtg;Tie2-Cre, Hey2 expression delineates a very thin compact layer 
and marks an intermediate region in between the compact myocardium and the trabecuale 
indicating defects in chamber maturation and compaction. Moreover, gene profiling identified a 
large set of differentially expressed genes implicated in cell cycle and proliferation that partially 
overlaps with those affected in Jag1flox;Jag2flox;cTnT-Cre mutants. The stronger phenotype and the 
higher number of deregulated genes observed in Mfgtg;Tie2-Cre compared with 
Jag1flox;Jag2flox;cTnT-Cre can be explained considering the pan endothelial-endocardial expression 
of the Tie-2 driver line. In this setting, ectopic expression of MFng in the coronary endothelium 
would favor Dll4 signaling to Notch and would resemble a GOF of Notch1 in the vasculature and 
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coronary development. In according to this hypothesis, GO-terms analysis in Mfgtg;Tie2-Cre revels 
angiogenesis as the most enriched category. Thus, the morphological and molecular data indicate 
that MFng overexpression throughout the endocardium effectively blocks Jag1 and Jag2 myocardial 
signaling to Notch1 and presumably, its ectopic expression in the endothelium overactivates Notch 
signaling mediated by Dll4. 
We propose that during chamber development, the endocardial expression of MFng determines 
the specificity of Notch1 towards its ligands, so that ligand-receptor interactions follow a temporal 
sequence. In this model, Dll4 acts in the early ventricle to promote cardiomyocyte proliferation and 
differentiation leading to trabeculation. Subsequent MFng (and Dll4) down-regulation in the 
endocardium allows signaling by Jag1 and Jag2 to sustain trabecular patterning, cardiomyocyte 
proliferation and chamber maturation (Fig29 a-c). Simultaneously, Dll4 signals to the MFng-
modified Notch1 receptor in developing coronary vessels to stimulate coronary development and 
sustain compaction (Fig29 b). As aforementioned, inactivation of the ubiquitin ligase MIB1 causes 
LVNC in mice and humans (Luxan et al., 2013). Here we show that combined myocardial 
inactivation of Jag1 and Jag2 causes a chamber phenotype reminiscent of Mib1 mutants, suggesting 
that both ligands are substrates of Mib1 in the myocardium (Fig29 c). This is independently 
supported by the LVNC-like phenotype found after forced MFng expression in the endocardium 
(Fig29 c).  
Taken altogether, we have shown that the Notch signaling pathway is crucial for ventricular 
chamber development, first for the formation of the trabecular network and later for chamber 
maturation, that includes the process of trabecular compaction and coronary vessel formation.  
To further understand the clinical implications of the Notch pathway, Exome Sequencing of 
different Notch elements from patients with various types of cardiomyopathies, including LVNC, 
would be necessary in order to identify potential new diagnostic and therapeutic disease targets.  
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Figure 29. Sequential Notch Ligand-Receptor activation during ventricular chamber 
development. In the early ventricle (a) endocardial Dll4 and myocardial Jag1 can activate Notch1 in 
the endocardium. Expression of MFng in the endocardium favors Dll4 signaling to Notch1 (large 
green arrow) and Jag1 signaling is low (small blue arrow). Notch1 activation (red) promotes 
cardiomyocyte proliferation, trabecular growth and patterning. As chamber development proceeds, 
endocardial MFng expression reduces progressively (similarly to Dll4) allowing myocardial Jag1 to 
activate Notch1 in the myocardium (b). As Jag2 expression is progressively upregulated in chamber 
myocardium, it acts together with Jag1 to promote chamber proliferation; patterning and trabecular 
compaction to give rise to the functional ventricular wall (large blue arrow, b). At this time, MFng 
and Dll4 are required for Notch1 activation in coronary vessels (small green arrow, b). Inactivation of 
Jag1 (or Jag2) in the myocardium disrupts chamber maturation and leads to cardiomyopathy (c). 
Mib1 acts upstream of Jag1 and Jag2 in this process: Mib1 inactivation in the myocardium causes 
LVNC. A similar phenotype is produced when both Jag1 and Jag2 are deleted in the myocardium and 
when MFng is constitutively expressed in the endocardium (presumably causing persistent inhibition 
of Jag1 and Jag2 signaling, c).  
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1. Dll4 is the ligand activating Notch1 during trabeculation. Dll4-Notch1 signaling 
mediates cardiomyocyte proliferation and differentiation in a non-cell autonomous manner.	  
 
2. Gpr126 is a potential Notch target gene in the endocardium during chamber 
development. Its expression is strongly dependent on Dll4-Notch1 during trabeculation and 
of Jag1/Jag2-Notch1 at during chamber maturation and compaction. 	  
 
3. Dll4 signaling to MFng-modified Notch1 is crucial during coronary vessel 
development. Reduced Notch signaling activity in the coronary endothelium also indirectly 
affects compaction.	  
 
4. Myocardial Jag1 is dispensable for Notch activation during trabeculation, but is 
required during chamber compaction and maturation by activating Notch1 in the 
endocardium. 	  
 
5. Myocardial expression of Jag2 increases from E12.5 onwards. Myocardial deletion 
of Jag2 also disrupts chamber maturation, and the combined deletion of Jag1 and Jag2 
causes a very severe chamber phenotype, reminiscent of LVNC. Both Jag ligands are likely 
targets of Mib1-mediated regulation in the myocardium.	  
 
6. Gene profiling identified a specific set of Jag1- or Jag2-dependent genes that is 
widely expanded after combined Jag1 and Jag2 inactivation, indicating that the two 
ligands have non-redundant roles in chamber development.	  
 
7. The LVNC-like phenotype was also observed after forced MFng expression in the 
endocardium, suggesting that MFng overexpression effectively blocks Jag1- and Jag2- 
signaling and  confirming the requirement of these ligands for compaction.	  
 
8. The expression pattern of the glycosyltransferase Manic Fringe defines the 
glycosylation status of the Notch1 receptor. By doing so it determines the spatio-temporal 
specificity of ligand-receptor interactions during chamber development, favoring Dll4-
Notch1 and preventing Jag-Notch1 activation.	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1. Durante el proceso de trabeculación, el ligando Dll4 activa desde el endocardio a 
Notch1. La activación de Notch1 mediada por Dll4 dirige efectos no celulares autónomos 
en el miocardio esenciales para la proliferación y la diferenciación de cardiomiocitos	  
 
2. Gpr126 es una diana potencial de Notch en el endocardio durante el desarrollo de 
las cámaras ventriculares. Su expresión depende de la activación de Notch1 mediada por 
Dll4 durante la trabeculación y de los ligandos Jag1/Jag2 durante el proceso de 
compactación.	  	  
3. En el endotelio coronario, Dll4 interactúa y activa Notch1 modificado por MFng. 
Dicha activación resulta indispensable para el desarrollo de este tejido. La reducción de la 
actividad de Notch en el endotelio coronario afecta indirectamente a la compactación. 
 
4. Desde el miocardio, el ligando Jag1 no activa Notch1 durante la trabeculación, pero 
es indispensable para la activación de Notch1 en el endocardio durante el proceso de 
maduración y compactación de los ventrículos.	  
 
5. La expresión de Jag2 en el miocardio aumenta a partir de E12.5 y en adelante. La 
eliminación de  Jag2 afecta la maduración de las cámaras. La inactivación combinada de 
Jag1 y Jag2 en el miocardio causa un fenotipo similar a la cardiomiopatía humana LVNC. 
La función de ambos ligandos es regulada por MIB1 en el miocardio. 
 
6. El análisis comparativo del transcriptoma identificó un conjunto de genes 
específicos de la señalización mediata bien por Jag1 o por Jag2. Sin embargo la eliminación 
combinada de ambos ligandos afecta a un numero de genes mucho mas amplio que la 
inactivación de cada ligando por separado. Este dato indica que los dos ligandos tienen 
papeles no redundantes en el desarrollo de la cámara. 
 
7. La expresión ectópica de MFng en el endocardio produce un fenotipo similar a la 
cardiomiopatía humana LVNC, lo que sugiere que la sobreexpresión de MFng bloquea de 
facto la señalización mediada por Jag1 y Jag2, confirmando el papel de estos ligandos como 
activadores secuenciales de Notch durante la compactación de los ventriculos. 
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8. El patrón de expresión de Manic Fringe define el estado de glicosilación del 
receptor Notch1. Esta glicosilación determina la especificidad espacio-temporal de Notch1 
con sus distintos ligandos. Durante el desarrollo de los ventrículos favorece la activación 
Dll4-Notch1 lo que previene la activación por parte de los otros ligandos 
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Video Legends 
Video 1. Imaris 3D reconstruction of whole-mount stained E9.5 CBF1:2HB-Venus heart. The 
myocardial surface in red was built from the SMA staining. Venus (white nuclei), revealing Notch 
activity in CD31/Pecam1-positive cells (green), can be observed in the ventricular endocardium. 
Nuclei are counterstained with DAPI. 
Video 2. Representative Z-stack of CMRI short axis views of hearts from 6-month-old WT and 
Jag1flox;cTnT-Cre mice. The mutant heart exhibits dilated ventricles and a thinner septum than the 
WT heart.  
Video 3. Representative M-mode echocardiography analysis of the hearts of 6-month-old WT and 
Jag1flox;cTnT-Cre mice. The mutant heart shows contraction defects.  
Video 4. Representative Z-stack of CMRI short axis views of hearts from 6-month-old WT and 
Jag1flox;cTnT-Cre mice. The mutant heart exhibits a remarked segmental dyskinesia in the RV free 
wall. 
Video 5. Docking between the Notch1 extracellular domain homodimer (NECD, green and cyan) 
and Dll4 (yellow), Jag1 (orange) and Jag1 and Jag2 (gray).   
 
Supplementary Table Legend 
Supplementary Table 1. Excel file containing the list of deregulated genes identified by RNA-seq 
analysis (upregulated genes in red and downregulated genes in green). E9.5 Dll4flox;Tie2-Cre (sheet 
1); E9.5 Dll4flox;Nfat-Cre (sheet 2); E9.5 Notch1flox;Nfat-Cre (sheet 3). 144 common deregulated 
genes from E9.5 Dll4flox;Tie2-Cre, Dll4flox;Nfat-Cre and Notch1flox;Nfat-Cre listed by the log fold 
change (logFC) of the Dll4flox;Tie2-Cre (sheet 4, related to Fig. 1k). E15.5 Jag1flox;cTnT–Cre (sheet 
5); E15.5 Jag2flox;cTnT–Cre (sheet 6); E15.5 Jag1flox;Jag2flox;cTnT–Cre (sheet 7); E15.5 
MFngGOF;Tie2–Cre (sheet 8). Combined analysis of E15.5 Jag1flox;cTnT–Cre, Jag2flox;cTnT–Cre 
and Jag1flox;Jag2flox;cTnT–Cre with batch correction; deregulated genes are organized according to 
the logFC of the Jag1flox;Jag2flox;cTnT–Cre (sheet 9). Genes represented in the circular plot of 
Dll4flox and Notch1flox mutants (sheet 11, related to Fig. 1l); genes represented in the circular plot of 
Jag1flox;cTnT –Cre mutants (sheet 12, related to Fig. 3b); logFC of the 319 genes shown in the heat 
map of Figure 7c (sheet 13). 
  
	   
 
 
Cover Page. Whole-mount two-photon 
microscopy image of an E9.5 
MFngtg;Tie2-Cre embryo showing 
MFng-GFP expression in endocardium. 
Back Cover. E16.5 MFngtg;Tie2-Cre heart 
sections stained with N1ICD (red nuclei). 
Myocardium was counterstained with cardiac 
Troponin T antiboby (blue) and endocardium 
with endomucin (green). Ectopic expression of 
MFng in the endocardium impairs myocardial 
Jag1-Jag2 signaling to Notch1 (red nuclei), 
inducing a severe Left Ventricular Non 
Compaction (LVNC) phenotype. 

	  
